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According  to  the  central  dogma  of molecular  biology,  access  to  the  genetic  information 
contained within the DNA requires the synthesis of messenger RNA (mRNA), which is decoded 
in order  to  generate proteins  (Crick,  1970; Crick,  1958; Nirenberg  and Matthaei,  1961).  In 
eukaryotic cells, this process of gene expression consists of several consecutive, but integrated 
steps (Moore and Proudfoot, 2009). The first step  is the RNA polymerase II (Pol II) mediated 
transcription  of  the  DNA  into  pre‐mRNA,  which  is  generally  accompanied  by  three  co‐
transcriptional processing actions to modify the transcript (Bentley, 2014; Lee and Tarn, 2013). 
These  involve the addition of a 7‐methylguanosine cap to the 5′ end, the splicing of  intronic 
sequences,  and  the  cleavage  at  the  3′  end  followed  by  addition  of  the  poly(A)  tail. Upon 
completion of these steps, the mature mRNA is exported through the nuclear pores into the 
cytoplasm where ribosomes translate the transcript  into a polypeptide chain. Eventually the 





to prevent  the  generation of  faulty RNA or proteins  (Doma  and Parker, 2007;  Schmid  and 
Jensen,  2010;  Shoemaker  and  Green,  2012).  These  mistakes  are,  for  example,  the 
misincorporation of nucleotides or amino acids by Pol II or the ribosome during transcription 
or  translation,  respectively. Moreover,  different  stimuli,  chemical  agents  or  environmental 
influences can increase the error frequency of these processes, thereby potentially producing 
more  aberrant  gene  expression  products  (Drummond  and Wilke,  2009;  Jack  et  al.,  2011; 
Remenyi et al., 2004; Wurtmann and Wolin, 2009; Zaher and Green, 2009). Eukaryotic cells 
employ several quality control mechanisms at basically every nuclear and cytoplasmic gene 
expression  step  in  order  to  detect  abnormalities  (Figure  1B)  (Ghosh  and  Jacobson,  2010; 
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the mRNA to form ribonucleoproteins (RNP) (Muller-McNicoll and Neugebauer, 2013; 
Rodriguez-Navarro and Hurt, 2011). The composition of the mRNP changes dramatically during 
the progression of gene expression and determines the fate of the transcript (Figure 1A) 
(Mitchell and Parker, 2014; Singh et al., 2015).  
 
Figure 1: Overview of mRNP composition and quality control during gene expression. (A) Central steps of gene expression are 
depicted schematically. mRNA processing factors are recruited to the mRNA co-transcriptionally by the C-terminal domain 
(CTD) of Pol II. The Legend of mRNP components is shown at the bottom (A). (B) The ﬁdelity of each step of the gene expression 
cascade (white boxes) is monitored by quality control mechanisms, which initiate the degradation or retention of erroneous 
product. Only correctly processed or quality control evading gene expression intermediates are handed over to the next step 
(green arrows). Finally, the mRNA is translated in the cytoplasm and eventually degraded. Abbreviations: Pol II = RNA 
polymerase II; ppp = triphosphate; EJC = exon-junction complex; CBC = cap-binding complex; PABP = Poly(A) binding protein. 
In metazoan cells, one key regulator of gene expression is the exon-junction complex (EJC), 
which is a well-studied example of a multi-protein complex that shapes the mRNP and 
inﬂuences many subsequent gene expression steps. EJCs are deposited in the nucleus on 







EJC  is  comprised  of  the  DEAD‐box  helicase  eIF4A3,  Barentsz  (BTZ;  also MLN51)  and  the 
heterodimer Y14/MAGOH. Of the core EJC proteins, ATP‐loaded eIF4A3 directly binds the RNA 









factors,  the  dynamic  composition  of  the  EJC  changes  and  allows  for  the  activation  of 
downstream processes in the mRNP lifecycle, such as mRNA export or translation (Chazal et al., 
2013; Gudikote  et  al.,  2005;  Le Hir  et  al.,  2001; Nott  et  al.,  2004; Wiegand  et  al.,  2003). 
Therefore,  the  EJC  is  not  only  an  example  for  the  tight  interplay  of  the  gene  expression 




steps  and  are  therefore  supposed  to  contain  the  proper mRNA modifications  and mRNP 
composition needed  for  the synthesis of  functional protein. Major errors should have been 
corrected at  this point,  for example newly  transcribed mRNA, which  fail  to be  correctly 5′‐
capped, will be degraded or retained in the nucleus until properly processed (Doma and Parker, 
2007). However, not all potentially occurring errors can be recognized and corrected by the 
quality  control mechanisms,  especially  if  the mistakes  are  subtle.  For  instance,  nucleotide 












mutations,  as well  as  deletions  and  insertions  that  shift  the  reading  frame.  Furthermore, 
mutations in functional elements or motifs such as splice sites or splicing regulatory sites can 
lead  to differently spliced, PTC containing  transcripts  (Nicholson et al., 2010). PTCs can also 
arise  on  the  RNA  level  by  transcription  errors  (incorporation  of  incorrect  bases  or  loss  of 




efficiently  produced,  but  that  the mRNA  itself  is  degraded  (Chang  and  Kan,  1979).  Active 
translation is required for this process, as the presence of translation inhibiting antibiotics or 
stable secondary structures in the 5′ UTR of the PTC‐containing mRNA result in increased PTC‐
mRNA  levels  (Belgrader et al., 1993; Carter et al., 1995). This  implicates  that a  translation‐
coupled surveillance system monitors the identity of the stop codon and decides whether the 
ribosome stalls at a normal or a premature termination codon. This mechanism was termed 



















































Figure 2: Comparison of translation-coupled quality control mechanisms. (A) Normal mRNAs are translated and give rise to full 
length, functional proteins. These mRNAs are not targeted for accelerated degradation in a translation-dependent manner. (B) 
The presence of a premature translation termination codon (PTC) disrupts the open reading frame (ORF) and results in 
shortened proteins upon translation. PTC-containing mRNA are removed by nonsense-mediated mRNA decay (NMD) during 
translation. (C) Strong secondary structures or other components of the mRNP can stall ribosomes upstream of the termination 
codon. This results, similarly to (B), in the potential generation of truncated protein. No-go decay (NGD) detects and degrades 
these mRNAs. (D) Transcripts without stop codons are translated until the ribosome reaches the 3ʹ end of the mRNA. The 
potential production of elongated protein is prevented by degradation of the mRNA by non-stop decay (NSD). Alternatively, 
translation of the poly(A) tail leads to stalling of the ribosome and induction of NGD. 
1.3 Mechanism of eukaryotic translation termination  
Since NMD has the potential to discriminate between normal and abnormal termination 
codons, it is important for the understanding of NMD to analyze the molecular events occurring 
during translation termination. During the elongation phase of translation, the eukaryotic 
elongation factor 1 (eEF1) complex guides cognate aminoacyl-tRNA to the A site of the 
ribosome in order to elongate the peptide chain (Figure 3, step 1) (Sasikumar et al., 2012). 
However, when the ribosome encounters a stop codon (UAA, UGA or UAG) in the A site, this 
codon is not recognized by tRNA, but by the eukaryotic release factors 1 and 3 (eRF1 and eRF3) 
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Figure 3: Schematic overview of eukaryotic translation termination. After initiation of translation, aminoacyl-tRNAs are 
recruited to the ribosome by eEF1 in the elongation phase in order to generate the peptide chain (Step 1). Upon entry of a 
stop codon in the A site, eRF1 and eRF3 interact with the ribosome and decode the stop codon (Step 2). Hydrolysis of the eRF3-
bound GTP can be activated by interacting factors and results in the dissociation of eRF3 from the ribosome (Step 3). Thereby, 
the GGQ motif of eRF1 can be positioned properly to enable the hydrolysis of the tRNA-peptide bond (Step4). This positioning 
is further enhanced by the association of the recycling factor ABCE1, which ﬁlls the space previously occupied by eRF3 (Step 
5). Translation termination is completed by ATP-mediated splitting of the ribosomal subunits, accompanied by peptide 
hydrolysis mediated by eRF1 (Step 6). Of note, peptide release can also take place during steps 4 and 5. Finally, the single 
components are used for another round of translation.  
The proteins eRF1 and eRF3 form a complex which is structurally reminiscent to the tRNA-eEF1 
complex, with eRF1 decoding the stop codon via multiple conserved sequence motifs and eRF3 
serving as the eRF1-delivering factor (Figure 3, step 2) (Kong et al., 2004; Song et al., 2000). 
Furthermore, eRF1 catalyzes the hydrolysis of the peptidyl-tRNA ester bond using a GGQ motif 
that can be positioned in the peptidyl transferase center of the ribosome (Cheng et al., 2009). 
To accomplish this step, the GTPase eRF3 has to hydrolyze GTP and dissociate from the 
ribosome, therefore making space for the main recycling factor ABCE1 (Figure 3, step 3) 
(Pisarev et al., 2010; Salas-Marco and Bedwell, 2004). Either because of the GTP hydrolysis and 









these  steps  of  translation  termination,  the decision whether  the  stop  codon  is  considered 
normal or aberrant has to be made. Due to its central role in regulating the progression in the 











during  translation  termination.  Despite  NMD  being  a  general  and  evolutionary  conserved 
mRNA surveillance mechanism, different models for the activation in various organisms have 
been  proposed  (Rebbapragada  and  Lykke‐Andersen,  2009;  Schweingruber  et  al.,  2013). 





terminating  ribosome  and  downstream  factors, which  are  required  for  proper  termination 
(Figure 4A; also see 1.3). The poly(A) binding protein  (PABP,  in yeast Pab1 and  in mammals 
PABPC1), which binds the poly(A) tail of mRNAs via its two first RNA recognition motifs (RRM), 
is one of these potential downstream factors (Adam et al., 1986; Deo et al., 1999). Specifically, 
the direct  interaction of eRF3 and PABP  is believed to be  impaired due to the  long distance 
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domain with the N-terminal PAM2 motifs of eRF3, whereas the yeast bindings sites are less well 
deﬁned (Cosson et al., 2002; Kozlov and Gehring, 2010; Kozlov et al., 2001; Roque et al., 2015). 
Since PABP binding stimulates the GTP hydrolysis of eRF3, loss of this interaction results in 
decreased translation termination eﬃciency (Amrani et al., 2006; Hoshino et al., 1999; 
Kononenko et al., 2010; Uchida et al., 2002). This in turn is supposed to enable proteins from 
the NMD machinery to interact with eRF3 in order to activate NMD (Czaplinski et al., 1998; 
Ivanov et al., 2008; Kashima et al., 2006; Singh et al., 2008; Wang et al., 2001). This “faux 3ʹ 
UTR” model of NMD activation was further supported by the observation that artiﬁcial 
recruitment of PABP closely downstream of a PTC suppresses NMD (Amrani et al., 2004; Behm-
Ansmant et al., 2007a; Silva et al., 2008). Despite many observations being in agreement with 
the faux 3ʹ UTR model, recent studies revealed discrepancies, which are not covered by this 
model (Kervestin et al., 2012; Meaux et al., 2008; Roque et al., 2015).    
 
Figure 4: Key concepts of NMD activation. (A) In transcripts with short 3ʹ UTR, the stop codon and the downstream poly(A) tail 
populated by cytoplasmic poly(A) binding proteins (PABP) are positioned in close proximity. Translation termination is 
stimulated by PABP and therefore prevents NMD factors to initiate degradation. (B) According to the faux 3ʹ UTR model, 
translation of PTC-containing mRNA results in ribosome stalling at a position where PABP is unable to eﬃciently promote 
translation termination. In turn, NMD factors can initiate the NMD pathway. (C) EJCs deposited on the mRNA are displaced and 
removed by the translating ribosome, preventing the EJC-induced recruitment of NMD factors. (D) The presence of a PTC 
suﬃciently upstream of an exon-exon junction results in incomplete EJC removal. This enables the EJC to initiate NMD. 
Contrary to the situation in yeast, early studies showed that PTCs are distinguished from normal 







or are  followed by  introns not more  than 50 nucleotides downstream  (Brocke et al., 2002; 
Maquat and Li, 2001; Nagy and Maquat, 1998). As a consequence of this so‐called position rule, 











on  the mRNA and  is  characterized by  the nuclear  cap‐binding  complex  (CBC) heterodimer, 



































































expression, but it also regulates wild type transcripts. Accordingly, genome-wide analyses in 
various eukaryotic organisms showed that about 3-10% of all cellular mRNAs are upregulated 
upon NMD inhibition (Guan et al., 2006; He et al., 2003; Johansson et al., 2007; Lelivelt and 
Culbertson, 1999; Mendell et al., 2004; Ramani et al., 2009; Rehwinkel et al., 2005; Tani et al., 
2012; Wittmann et al., 2006; Yepiskoposyan et al., 2011). 
 
Figure 5: Examples of mRNPs targeted by NMD. (A) Normal mRNP composition with no EJC or long 3ʹ UTR downstream of the 
stop codon represents a NMD-resistant transcript. (B) Diﬀerent causes exist for irregular EJC positioning relative to the stop 
codon, leading to NMD. Mutations, errors during transcription or splicing, and induced frameshifts are examples for generating 
a PTC in the regular ORF of the mRNP (top). Regulated splicing of 3ʹ UTR introns results in the deposition of EJC downstream 
of the physiological stop codon (second from top). Usage of upstream ORF (uORF) for translation initiation normally leads to 
premature translation termination, rendering all downstream EJC as potentially NMD-active (second from bottom). Lack of 
aminoacyl-tRNASec which would encode the stop codon UGA for selenocysteine, results in premature translation termination. 
(C) Elongated distance between stop codon and poly(A) tail activates NMD. 
In the light of the several molecular circumstances, which can potentially lead to NMD 
activation, NMD targets represent a heterogeneous class of mRNPs (Figure 5). NMD-resistant 
mRNPs in general contain the correct 3ʹ UTR architecture required for proper translation 
termination and lack downstream EJCs (Figure 5A). In contrast, various reasons for EJC-induced 
degradation of mRNPs exist (Figure 5B). As already discussed, PTC-containing transcripts, which 
can be generated by a multitude of potential errors during gene expression, frequently exhibit 
















of NMD  targets encode  for selenoproteins, which are characterized by  the  incorporation of 
selenocysteine (Sec) by the UGA codon. Upon low selenium levels in the cell, the tRNASec cannot 
be aminoacylated and the UGA codon will be recognized as a stop codon (Moriarty et al., 1998). 















have  evolved  later  and  are  found,  with  exceptions,  mostly  in  metazoans.  The  initially 















UPF1  is  the most essential NMD  factor  in  all  investigated organisms.  This  is because UPF1 









equal extent,  suggesting  that a  regulated  loading on NMD  targets  is unlikely. Furthermore, 
UPF1 occupies preferentially the 3′ UTR region of mRNA due to displacement from the 5′ UTR 
and  coding  region  by  scanning  and  translating  ribosomes,  respectively  (Hurt  et  al.,  2013; 
Kurosaki and Maquat, 2013; Zund et al., 2013). Since UPF1 is able to compete with PABPC1 for 





























2013).  Therefore,  usage  of  the  helicase  domain  for  enabling  a  direct  interaction  with 
downstream  factors  on  the mRNP  in  the  activation  phase  of  NMD  seems  unlikely. More 
specifically, conformational changes induced by the direct interaction of the UPF1 CH domain 





























































































Figure 6: Interaction and domain architecture of UPF1 and UPF2. (A) Schematic domain representation of UPF1, indicating 
functional domains. The SQ and TQ motifs, which are potentially phosphorylated in the N- and C-terminus are indicated, the 
major functional ones are highlighted. Two insertions in the RecA1 domain, called 1B and 1C are unique for UPF1. (B) UPF2 
domains are depicted as in (A), highlighting the three MIF4G domains and the UPF1-binding domain (U1BD). (C) Crystal 
structure of UPF1 core domains and co-crystallized UPF2 C-terminus. Atomic coordinates of PDB accession code 2WJV were 
modeled with PyMol (Schrodinger, 2010) according to Clerici et al. (2009). 
1.5.2 UPF2 provides the scaffold for the NMD assembly 
As a core factor for NMD, UPF2 has additional roles besides the above-discussed stimulation of 
UPF1 helicase activity. UPF2 consists of three tandem MIF4G domains (Middle portion of 
eIF4G), followed by the U1BD (Figure 6B) (Aravind and Koonin, 2000; Clerici et al., 2014; 
Ponting, 2000). MIF4G domains frequently provide the surface for critical interactions for 
factors involved in general mRNP metabolism (Ponting, 2000). In line with this role, the MIF4G-
3 domain of UPF2 interacts with UPF3, establishing a physical bridge between UPF1 and UPF3 
(Chamieh et al., 2008; Kadlec et al., 2004; Serin et al., 2001). Cryo-EM studies identiﬁed that 
the three N-terminal MIF4G domains form a ring-like structure together with the C-terminal 
U1BD (Melero et al., 2012). Besides providing potential structural functions, the role of the two 











Whereas  in  yeast  and other  invertebrates only one UPF3 protein exists, higher eukaryotes 
contain two UPF3 paralogs with high sequence similarity, UPF3a and UPF3b, the latter being 
expressed from the X chromosome in mammals (Lykke‐Andersen et al., 2000; Serin et al., 2001). 












al.,  2004).  It  was  proposed  that  for mammalian  NMD,  EJCs  downstream  of  a  translation 
termination event could  increase  the concentration of UPF1‐UPF2  in  the mRNP due  to  the 
specific  recruitment  via  UPF3b  (Kervestin  and  Jacobson,  2012).  Yet,  the  exact  molecular 
function of UPF3  in NMD remains elusive, since this UPF1‐UPF2 recruiting function does not 
explain  the  function of UPF3  in EJC‐independent NMD  (Chamieh et al., 2008; Melero et al., 
2012; Metze et al., 2013). This is especially interesting in case of organisms that do not employ 
EJC‐enhanced NMD as  the standard pathway, but still  rely on UPF3  for NMD. Examples are 
yeast, flies and worms, which either contain a very small number of spliced transcripts, lack EJC 
proteins and the EBM in the C‐terminus of UPF3, or do not require EJC core components for 
NMD,  respectively  (Culbertson and  Leeds, 2003; Gatfield et al., 2003; Gehring et al., 2003; 










SMG1, UPF2  and UPF3  (SMG3  and  SMG4  in C.  elegans)  and negatively by  SMG5‐7.  SMG1 





The  binding  of  regulatory  proteins  termed  SMG8  and  SMG9  to  the  arm  region  of  SMG1 
modulates  the  kinase  activity  of  SMG1  (Arias‐Palomo  et  al.,  2011;  Fernandez  et  al.,  2011; 
Yamashita  et  al.,  2009).  The  head  region  including  the  catalytic  PIKK  domain  and  the  FRB 
domain mediates the interaction with UPF1 and UPF2, respectively (Melero et al., 2014). The 






PIKK members,  like SMG1, preferentially phosphorylate  serines and  threonines  followed by 
glutamines  (SQ and TQ motifs)  (Bensimon et al., 2011; Yamashita et al., 2001). The SMG1‐
phoshorylated  SQ  and  TQ motifs  of mammalian  UPF1  are  clustered  in  the  extended  and 



















































































































share one common domain feature, a 14-3-3-like domain which folds similar to 14-3-3 proteins 
and is able to interact with phosphorylated peptides (Figure 7B) (Fukuhara et al., 2005).  
 
Figure 7: Domain structure of SMG proteins. (A) The complex domain architecture of SMG1 is depicted schematically. The N-
terminal HEAT repeats form the arm, whereas the C-terminal domains form the globular head. (B) The decay inducing SMG5-
7 proteins share a 14-3-3-like domain, which is followed by α-helical extensions required for the stabilization of the domain. 
The remaining domains or functional regions are indicated. PC = proline-rich region. 
SMG5 and SMG7 form a heterodimer by perpendicular back-to-back interactions of their N-
terminal 14-3-3-like domains. This is an uncommon arrangement, compared to the normal 
head-to-head interaction found in most 14-3-3 dimers and could explain why normal 14-3-3 
proteins do not interact with UPF1 (Gardino et al., 2006; Jonas et al., 2013; Obsil and Obsilova, 
2011). The 14-3-3-like domain of SMG7 is mostly responsible for the phosphorylation-
dependent interaction between phosphorylated amino acids (e.g. S1096) in the C-terminus of 
UPF1 and the heterodimer SMG5-SMG7 (Chakrabarti et al., 2014; Fukuhara et al., 2005; Jonas 
et al., 2013; Okada-Katsuhata et al., 2012). The 14-3-3-like domain of SMG5, which by itself is 
not able to interact with UPF1, supposedly provides additional binding strength and speciﬁcity 
(Jonas et al., 2013; Okada-Katsuhata et al., 2012).  
1.5.6 Initiation of exonucleolytic degradation 
Early work showed that artiﬁcial recruitment of full length SMG7 or the C-terminal proline-rich 
(PC) region to tethering reporter mRNA induces mRNA degradation in a position-independent 
and XRN1-/DCP2-dependent manner (Unterholzner and Izaurralde, 2004). DCP2 is the catalytic 











however,  it was unclear  if  this  interaction  is direct or mediated by another  factor  (He and 
Jacobson, 1995, 2001; Lejeune et al., 2003; Lykke‐Andersen, 2002). The proline‐rich nuclear 




NMD  is  impaired  under  conditions  where  UPF1  accumulates  in  the  hyper‐  or  hypo‐





terminal PilT N‐terminus  (PIN) domain, which  is potentially  involved  in  the  interaction with 
PP2A. Deletion of the very C‐terminal amino acids or the replacement of a conserved aspartate 
at position 860 in this domain increased the phosphorylation of UPF1 (Ohnishi et al., 2003). PIN 
domains  are  commonly  found  in  proteins  executing  endonuclease  activity,  however,  the 
catalytic triad normally consisting of three aspartate residues is absent in the SMG5 PIN domain 
and no endocleavage activity was reported neither  in vivo nor  in vitro (Clissold and Ponting, 
2000;  Glavan  et  al.,  2006;  Schoenberg,  2011).  Interestingly,  D860  is  the  one  remaining 
aspartate  residue  in  the  active  site,  which  was  implicated  in  the  regulation  of  UPF1 
phosphorylation status (Ohnishi et al., 2003). Of note, evidence for SMG6 association with the 
PP2 complex was provided as well, suggesting  that,  in  line with  the  initial observation  in C. 







Studies  on  the  preferred  nucleolytic  degradation  pathway  of  PTC  containing  mRNA  in 
Drosophila melanogaster S2 cells showed that the knockdown of exonucleolytic machineries 
employing deadenylation, decapping, 3′‐5′ and 5′‐3′ degradation could not stabilize reporter 
mRNA  levels  (Gatfield  and  Izaurralde,  2004).  However,  evidence  for  PTC‐dependent 
endonucleolytic  cleavage was  found due  to  the  accumulation of 3′  and 5′  fragments upon 
depletion  of  XRN1  and  components  of  the  5′‐3′  degrading  exosome  complex,  respectively 
(Gatfield  and  Izaurralde,  2004).  In metazoans,  SMG6  was  identified  as  the  endonuclease 

















































































































EBMs were characterized in the very N-terminus of SMG6, which similarly to the EBM of UPF3b, 
mediate the interaction with the EJC (Kashima et al., 2010). These EBM motifs were found to 
be essential for NMD (Kashima et al., 2010). Given the multitude of possible interactions, the 
exact mechanisms by which SMG6 is recruited to the target mRNA remain elusive. 
1.6 Model of the EJC-NMD mechanism 
As the details of functions and interplay between NMD factors has been discussed above, the 
following model aims to present the most important steps from NMD initiation to mRNA 
degradation (Figure 8). This is exempliﬁed for EJC-induced NMD, because the molecular events 
during long 3ʹ UTR-induced NMD are only poorly understood in mammalian cells.  
 
Figure 8: Schematic model of EJC-induced NMD. (1) For EJC-NMD to be initiated, the ribosome has to stall at a stop codon 
upstream of an EJC. (2) Following the interaction of UPF1 with eRF3, UPF2 and SMG1 are recruited. This is enhanced due to 
the EJC-bound UPF3 recruitment of UPF2. (3) Activated SMG1 phosphorylates UPF1 at the N- and C-terminus. It is currently 
unclear, if the ribosome is already disassembled at this point. (4) Phosphorylated UPF1 recruits SMG5/7 and SMG6, which 
initiate degradation via deadenylation or endocleavage, respectively. 
In short, after association with the ribosome (Figure 8, step 1), the release factors eRF1/3 
interact with mRNA bound UPF1 and by an unknown mechanism activate it to bind UPF2/SMG1 
(Figure 8, step 2). This is facilitated by the UPF3-mediated recruitment of these factors. By UPF2 
stimulation of the SMG1 kinase activity, UPF1 becomes phosphorylated at N- and C-terminal 
SQ and TQ motifs (Figure 8, step 3). These sites are recognized by SMG6 at the N-terminus, 









frameshift  mutations  (Miller  and  Pearce,  2014).  Moreover,  20%  of  all  single‐base  pair 
mutations affecting the coding region and leading to diseases, produce nonsense codons (Mort 
et al., 2008). NMD was  identified as an  important modifier of  the clinical outcome of  these 





thalassemia, which  results  from NMD‐insensitive nonsense mutations  in  the  β‐globin gene. 
These  transcripts produce C‐terminally  truncated  β‐globin which causes  toxic precipitations 
(Baserga and Benz, 1988; Hall and Thein, 1994; Thein et al., 1990). 
In the case of NMD‐activation, monoallelic PTC mutations result in only partial depletion of the 





for  the  cell.  Examples  for  this  are mutations  in  the dystrophin  gene, which  lead  to  severe 
Duchenne muscular dystrophy (DMD) phenotypes when the mRNA  is degraded, while NMD‐











to  the  incorporation  of  an  amino  acid  instead  of  release  factor‐mediated  translation 
termination. Normally, the release factors are far more potent in recognizing the stop codon, 




One  alternative way  for  potential  treatment  of  nonsense‐associated  diseases  is  to  directly 
target and inhibit the NMD machinery. This requires the detailed knowledge of the molecular 
pathway of NMD activation and execution,  in order  to avoid  side effects.  Interestingly,  the 
depletion of NMD factors has different phenotypical outcome depending on the complexity of 
the investigated organism. Whereas deletion of NMD factors in budding yeast or nematodes 
only results  in mild phenotypes,  fruit  flies and zebrafish require core NMD components  like 
UPF1 and UPF2  for embryonic development and viability  (Hodgkin et al., 1989; Leeds et al., 














Although  the  underlying  principles  of  substrate  recognition,  NMD  activation  and  mRNA 
degradation  have  been  extensively  studied  in  various  organisms, we  still  lack  the  detailed 
understanding of fundamental processes and decisions  in this pathway.  In this work, several 
key aspects along the pathway of NMD were studied in order to refine and expand our model 
of  the molecular mechanism  of  this mRNA  surveillance  process.  Specifically  the  following 
questions were addressed: 
 During translation termination, the interaction of PABPC1 with eRF3 is considered as 
the  signal  that prevents NMD. The  faux 3′ UTR model predicts  that because of  this 
interaction,  UPF1  is  outcompeted  and  translation  termination  is  accelerated. 
Recruitment  of  PABPC1  downstream  of  an  otherwise  NMD‐inducing  stop  codon 
inhibits NMD. The molecular requirements for this NMD suppression are, however, not 
fully characterized.  It remains to be  investigated, whether the competition between 
PABPC1  and  UPF1  is  the  only  determinant  deciding  if  NMD  is  activated  or  not. 
(Investigated in Fatscher et al. (2014) “The interaction of cytoplasmic poly(A)‐binding 
protein  with  eukaryotic  initiation  factor  4G  suppresses  nonsense‐mediated mRNA 
decay”) 
 EJCs are deposited during splicing on the mRNA, thereby influencing downstream gene 
expression  steps  and  also  serving  as  potent  NMD  activating  signals  if  positioned 





connecting  the  upstream  ribosome‐associated  UPF1  with  downstream  EJC‐bound 
UPF3b. Furthermore, UPF2 regulates the helicase activity of UPF1 and is involved in the 
activation  of  SMG1‐mediated  phosphorylation  of UPF1. Whereas  specific  functions 
were assigned to the C‐terminal MIF4G3 and U1BD, it remains unsolved whether the 
N‐terminal  half  of  the  protein,  containing MIF4G1  and  ‐2,  serves  an  essential  role 
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The interaction of cytoplasmic poly(A)-binding protein
with eukaryotic initiation factor 4G suppresses
nonsense-mediated mRNA decay
TOBIAS FATSCHER,1,2 VOLKER BOEHM,1,2 BENJAMIN WEICHE,1 and NIELS H. GEHRING1
1Institute for Genetics, University of Cologne, 50674 Cologne, Germany
ABSTRACT
Nonsense-mediated mRNA decay (NMD) eliminates different classes of mRNA substrates including transcripts with long 3′ UTRs.
Current models of NMD suggest that the long physical distance between the poly(A) tail and the termination codon reduces the
interaction between cytoplasmic poly(A)-binding protein (PABPC1) and the eukaryotic release factor 3a (eRF3a) during
translation termination. In the absence of PABPC1 binding, eRF3a recruits the NMD factor UPF1 to the terminating ribosome,
triggering mRNA degradation. Here, we have used the MS2 tethering system to investigate the suppression of NMD by
PABPC1. We show that tethering of PABPC1 between the termination codon and a long 3′ UTR specifically inhibits NMD-
mediated mRNA degradation. Contrary to the current model, tethered PABPC1 mutants unable to interact with eRF3a
still efficiently suppress NMD. We find that the interaction of PABPC1 with eukaryotic initiation factor 4G (eIF4G), which
mediates the circularization of mRNAs, is essential for NMD inhibition by tethered PABPC1. Furthermore, recruiting either
eRF3a or eIF4G in proximity to an upstream termination codon antagonizes NMD. While tethering of an eRF3a mutant unable
to interact with PABPC1 fails to suppress NMD, tethered eIF4G inhibits NMD in a PABPC1-independent manner, indicating a
sequential arrangement of NMD antagonizing factors. In conclusion, our results establish a previously unrecognized link
between translation termination, mRNA circularization, and NMD suppression, thereby suggesting a revised model for the
activation of NMD at termination codons upstream of long 3′ UTR.
Keywords: PABPC1; eIF4G; NMD; ribosome recycling; translation termination
INTRODUCTION
NMD represents a surveillance mechanism that removes
transcripts with premature translation termination codons
(PTCs) from eukaryotic cells (Chang et al. 2007; Rebbapra-
gada and Lykke-Andersen 2009; Nicholson et al. 2010).
The core NMD factors are present in all eukaryotes and their
activity prevents the synthesis of C-terminally truncated
proteins with potentially dominant negative effects (Bhuva-
nagiri et al. 2010). Furthermore, NMD directly or indirectly
regulates the expression of many physiological mRNAs,
although only some of them contain PTCs, for example, as
a result of alternative splicing or upstream open reading
frames (Yepiskoposyan et al. 2011; Tani et al. 2012). The
function of NMD as a general regulator of gene expression
explains why NMD factors are essential for normal animal
development (Hwang and Maquat 2011).
In human cells, NMD is efficiently activated when at least
one intron is located >50 nt downstream from the termina-
tion codon (Thermann et al. 1998; Zhang et al. 1998). During
splicing in the nucleus, exon–exon junctions are marked
by exon-junction complexes (EJCs), which serve as NMD-
activating signals during translation in the cytoplasm. In
addition to the aforementioned EJC-dependent NMD, an al-
ternative EJC-independent NMD pathway targets mRNAs
with a long 3′ UTR (Eberle et al. 2008; Singh et al. 2008;
Yepiskoposyan et al. 2011). During eukaryotic translation
termination, the interaction of PABP (in humans PABPC1)
with the ribosome-bound eRF3 (in humans eRF3a) stimu-
lates polypeptide release and the subsequent recycling of
ribosomes (Hoshino et al. 1999; Uchida et al. 2002). How-
ever, when the interaction of PABPC1 with eRF3a is reduced
by an unusually long 3′ UTR, UPF1 binds to eRF3a and acti-
vates NMD (Singh et al. 2008). Hence, tethering of PABPC1
in the proximity of a termination codon can inhibit NMD by
simulating the presence of a poly(A) tail (Amrani et al. 2004;
2These authors contributed equally to this work.
Corresponding author: ngehring@uni-koeln.de
Article published online ahead of print. Article and publication date are at
http://www.rnajournal.org/cgi/doi/10.1261/rna.044933.114. Freely available
online through the RNA Open Access option.
© 2014 Fatscher et al. This article, published in RNA, is available under a
Creative Commons License (Attribution 4.0 International), as described at
http://creativecommons.org/licenses/by/4.0/.
RNA 20:1579–1592; Published by Cold Spring Harbor Laboratory Press for the RNA Society 1579
 Cold Spring Harbor Laboratory Press on December 13, 2014 - Published by rnajournal.cshlp.orgDownloaded from 
26
Behm-Ansmant et al. 2007; Eberle et al. 2008; Silva et al.
2008; Singh et al. 2008).
In the case of premature translation termination, UPF1
is phosphorylated by SMG1 within its extended N- and C-
terminal regions (Kashima et al. 2006). UPF2 binds directly
to the C-terminal part of SMG1 and stimulates the phosphor-
ylation of UPF1 (Kashima et al. 2006; Clerici et al. 2013).
Phosphorylated UPF1 recruits the homologous proteins
SMG5/SMG7 and SMG6, leading to the degradation of the
target mRNA (Okada-Katsuhata et al. 2012). While the exo-
nucleolytic decay is coordinated by the SMG5-SMG7 het-
erodimer (Loh et al. 2013), the endonucleolytic cleavage of
NMD targets is mediated by the C-terminal PIN (PilT N ter-
minus) domain of SMG6 (Glavan et al. 2006; Huntzinger
et al. 2008; Eberle et al. 2009).
A large distance between the poly(A) tail and the termina-
tion codon promotes NMD. Therefore, long 3′ UTRs repre-
sent an NMD activating characteristic of endogenous NMD
targets (Eberle et al. 2008; Singh et al. 2008; Yepiskoposyan
et al. 2011). In view of the many endogenous mRNAs that
are potentially regulated by this pathway, it is important to
elucidate the molecular mechanism of NMD suppression
by PABPC1. Using the MS2 tethering system, we have inves-
tigated which molecular interactions of PABPC1 are required
to inhibit NMD of a reporter mRNA with a long 3′ UTR. We
find that tethered PABPC1 suppresses NMD induced by a
long 3′ UTR. Moreover, PABPC1 does not require the inter-
action with eRF3a to retain its NMD suppressing activity. In
contrast, a mutant of PABPC1 unable to bind eIF4G does not
inhibit NMD. Furthermore, tethered eIF4G or eRF3a sup-
press NMD as well. Our observations suggest a tight coupl-
ing between mRNA circularization via eIF4G and NMD
suppression.
RESULTS
Reporter-bound PABPC1 increases long 3′
UTR-containing mRNA levels
PABPC1 plays a pivotal role in gene expression because it
promotes mRNA circularization, facilitates ribosome recy-
cling, and suppresses NMD at normal termination codons
(Wells et al. 1998; Behm-Ansmant et al. 2007). To analyze
NMD suppression by PABPC1, we used a reporter construct
consisting of the triosephosphate-isomerase (TPI) open
reading frame (ORF) to which we added the 3′ UTR of
SMG5. The SMG5 mRNA has been previously shown to un-
dergo NMD mediated by its long 3′ UTR (Singh et al. 2008)
and owing to the presence of the SMG5 3′ UTR, the reporter
mRNA is degraded (V Boehm, N Haberman, F Ottens, J Ule,
and NH Gehring, in prep.). We inserted four MS2 binding
sites downstream from the termination codon to enable
tethering of MS2-fusion proteins to a position at the begin-
ning of the 3′ UTR (TPI-4MS2-SMG5) (Fig. 1A). Upon co-
expression (i.e., tethering) of MS2V5-tagged PABPC1, the
levels of the reporter mRNA increased by a factor of four
compared with the MS2V5-GST that served as negative con-
trol (Fig. 1B). This suggests that PABPC1 counteracts NMD
of the reporter mRNA. To confirm that the observed increase
in mRNA abundance is an NMD-specific effect and not due
to general mRNA stabilization by PABPC1, we used two
additional TPI control reporter constructs. In one construct,
the termination codon was shifted downstream from the
MS2 binding sites by deleting the original termination codon
(TPI-Δter-4MS2-SMG5) (Fig. 1A). In the other construct,
the four MS2-binding sites were moved to a position at the
3′ end of the 3′ UTR (TPI-SMG5-4MS2) (Fig. 1A). In both
cases, tethering of PABPC1 only marginally changes the levels
of the reporter mRNAs (Fig. 1C,D). To exclude possible
trans-effects of PABPC1 expression, we coexpressed either
FLAG-PABPC1 together with the TPI-4MS2-SMG5 reporter
(Fig. 1E), or MS2V5-PABPC1 with a TPI-SMG5 reporter
lacking MS2-binding sites (Fig. 1A,F). In both cases, we ob-
served only slight increases in mRNA levels when PABPC1
was not directly bound. In summary, our results suggest
that PABPC1 is able to antagonize NMD induced by the
long 3′ UTR of the reporter mRNA when it is tethered in
close proximity downstream from the termination codon.
PABPC1 stabilizes mRNA by inhibition of NMD
The previous experiments analyzed the steady-state levels of
reporter mRNA. To confirm that tethered PABPC1 stabilizes
the mRNA, we next determined the decay rates of the re-
porter mRNA upon transcriptional shutoff by Actinomycin
D treatment. We observed a half-life of ∼4.8 h of the TPI-
4MS2-SMG5 reporter construct when MS2V5-GST is teth-
ered as a control (Fig. 2A). Upon PABPC1 tethering to the
same reporter the mRNA is stabilized with a half-life of
∼30 h (Fig. 2A). This demonstrates that MS2V5-PABPC1
is in fact able to suppress NMD by preventing the degra-
dation of the reporter mRNA construct. Because NMD is
restricted to actively translated mRNAs (Thermann et al.
1998), we aimed to confirm that the observed effects are
not caused by decreased translation rates of the reporter
mRNAs. To this end, we used an N-terminally FLAG-tagged
TPI-4MS2-SMG5 reporter construct, enabling us to measure
translation efficiency by Western blotting and to correlate
these effects with the mRNA levels detected by Northern
blotting. FLAG-tagged emGFP was cotransfected as a loading
control for both the mRNA as well as protein expression
levels. Tethering MS2V5-PABPC1 to the FLAG-tagged TPI
reporter mRNA led to a similar increase in FLAG-TPI pro-
tein and mRNA levels compared with the GST control (Fig.
2B, left), indicating that tethered PABPC1 does not change
overall translation rates (Fig. 2B, right). We obtained simi-
lar results using a dual luciferase reporter system (data not
shown). These results indicate that the NMD antagonizing
effect of tethered PABPC1 is not caused by decreased
Fatscher et al.
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FIGURE 1. Tethering PABPC1 to a reporter mRNA containing a long 3′ UTR increases mRNA abundance. (A) Schematic representation of the tri-
osephosphate isomerase (TPI) reporter constructs. White boxes depict exons, introns are shown as two connecting black lines, and Northern probe
binding sites as white boxes without intron lines. Gray boxes represent MS2-binding area with MS2-stem–loops shown in black. The SMG5 3′ UTR is
depicted as a light-gray box and the length in nucleotides is shown in brackets. (B–F) Northern blot analysis of total RNA extracted from HeLa cells
transfected with plasmids expressing the indicated TPI reporter mRNA and MS2V5- or FLAG-tagged fusion proteins. A β-globin construct was
cotransfected as control. Protein expression was detected by immunoblotting with α-V5 or α-FLAG antibody. Cotransfected GFP served as a loading
control. Asterisks indicate unspecific bands (C,D). mRNA levels were normalized to MS2V5-GST (B–D,F) or pCI-FLAG (E). Bars represent the mean
values of mRNA levels±SD upon tethering MS2V5-GST or MS2V5-PABPC1 (B–D,F), or pCI-FLAG and FLAG-PABPC1 (E). Concentrations of
MS2V5-tagged protein expressing plasmids were increased from 1 µg (F, lanes 1,3,5,7) to 3 µg (F, lanes 2,4,6,8).
mRNA circularization counteracts NMD
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t  4.8 h1/2 
t  30 h1/2 
FIGURE 2. PABPC1 stabilizes reporter mRNA by suppressing NMD. (A) HeLa cells expressing reporter (TPI-4MS2-SMG5) and control mRNA, as
well as MS2V5-tagged GST or PABPC1, were treated with Actinomycin D (5 µg/mL final concentration) for the indicated time prior to harvesting.
Reporter mRNA levels were quantified by Northern blotting, normalized to control mRNA and GST control tethering, and plotted against time of
Actinomycin D treatment. (B) Tethering of MS2V5-GST and -PABPC1 in HeLa cells cotransfected with N-terminally FLAG-tagged TPI-4MS2-SMG5
reporter and FLAG-tagged emGFP control expressing vectors. Both reporter and control mRNA contained heterologous binding sites in the 3′ UTR
that enable the detection with the same Northern probe. Northern blot (top) and α-FLAG Western blot (bottom) analyses are shown. The signals for
emGFP and TPI in Northern andWestern blot experiments were quantified, normalized to the GST control lane, and the final ratio was calculated by
normalizing protein expression levels to the respective mRNA expression levels. (C,E) siRNA-mediated knockdown of UPF2, UPF1, and SMG6. HeLa
cells were transfected with siRNAs targeting UPF2, UPF1, SMG6, or Luciferase (negative control). The knockdown efficiency was assessed by immu-
noblotting with UPF2, UPF1, and SMG6-specific antibodies. Tubulin served as a loading control. (D,F) Northern blot analysis of TPI-4MS2-SMG5
reporter mRNA with β-globin mRNA as control in UPF2 (D, lanes 3,4), UPF1 (D, lanes 5,6), and SMG6 (F, lanes 3,4) knockdown and control (D,F,
lanes 1,2) cells. HeLa cells were transfected with plasmids expressing MS2V5-GST and -PABPC1 proteins. Protein expression was detected by immu-
noblotting with a V5 antibody. GFP served as a loading control. mRNA levels were normalized to MS2V5-GST. Bars represent the mean values of
mRNA levels ±SD upon tethering MS2V5-GST and -PABPC1 fusion proteins.
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translation efficiency but rather by protecting the mRNA
from degradation.
Human NMD is executed by a core machinery includ-
ing the central NMD factors UPF1 and UPF2. To confirm
that PABPC1 inhibits the canonical NMD pathway, we
used small-interfering RNAs (siRNAs) to deplete UPF1 and
UPF2 in human cell culture. Numerous studies have shown
that NMD is impaired in cells lacking either of these two
factors (Mendell et al. 2002; Gatfield et al. 2003). UPF1 and
UPF2 were reduced to ∼10% of regular expression levels
by RNAi, as shown by immunoblotting (Fig. 2C). The levels
of the reporter mRNAs were increased when UPF1 or UPF2
were depleted, confirming the inhibition of NMD by the
transfected siRNAs (Fig. 2D, cf. lanes 1,3,5). Tethering of
PABPC1 to the TPI-4MS2-SMG5 reporter mRNA increased
reporter mRNA levels by a factor of more than four in control
cells (Fig. 2D, lane 2), in line with our previous results. In
contrast, tethering PABPC1 to the reporter only increased
the mRNA levels by a factor of about two in both UPF2-
and UPF1-knockdown cells (Fig. 2D, lanes 4,6). Notably,
even though the change of mRNA levels by PABPC1 tether-
ing was reduced in the UPF1 and UPF2 knockdown cells,
the total levels of stabilized reporter mRNA under all three
conditions reached a similar level (Fig. 2D, cf. lanes 2,4,6).
These results indicate that PABPC1 acts as a strong suppres-
sor in the canonical NMD pathway that involves the central
NMD factors UPF1 and UPF2.
As described above, PABPC1 suppresses UPF1- and UPF2-
dependent NMD. Several decay pathways act downstream
from UPF1 to ensure efficient degradation of substrate
mRNAs (Nicholson and Muhlemann 2010). We speculated
that the NMD inhibiting effect of PABPC1 also impinges on
the degradation phase of NMD. To test this hypothesis, we es-
tablished the depletion of the NMD-specific endonuclease
SMG6 by RNAi. In knockdown cells, the SMG6 protein levels
were reduced to ∼10% of regular expression levels (Fig. 2E).
Similar to our results in UPF1- andUPF2-depleted cells, teth-
ered PABPC1 stabilized the mRNA levels by a factor of less
than two in SMG6-depleted cells (Fig. 2F, cf. lanes 2,4), while
stabilized reporter levels remained unchanged comparedwith
control knockdown cells. Taken together with the results
obtained so far, this shows that PABPC1 indeed inhibits
NMD by preventing the degradation of the substrate mRNA.
The interaction of PABPC1 and eRF3a is dispensable
for NMD suppression
Current models of NMD suggest that PABPC1 competes
with the NMD factor UPF1 for eRF3a binding (Singh et al.
2008). To more specifically elucidate which domains and in-
teraction regions of PABPC1 are responsible for the NMD
suppression effect observed in Figure 1, we generated six
mutants of PABPC1 (Fig. 3A). PABPC1 interacts via its C-
terminal MLLE domain with two PAM2 motifs present in
the N terminus of eRF3a (Kozlov and Gehring 2010). We de-
signed two mutants to impair this interaction: one consisting
of RNA recognition motifs (RRMs) one to four of PABPC1
(PABPC1 RRM1234) (Fig. 3A), i.e., lacking the C-terminal
domain; the second containing a mutation of the MLLE
motif to GAAR (PABPC1 MLLEMut) (Fig. 3A). The tether-
ing assay shows that both PABPC1 RRM1234 and PABPC1
MLLEMut suppressed NMD to almost the same extent as
PABPC1 (Fig. 3B, lanes 2,3,5). We further tested two addi-
tional PABPC1 mutants abrogating PAM2 binding, one con-
taining the MLLE mutation with additional point mutations
known to further abolish PAM2 motif binding (Kozlov
et al. 2004) (PABPC1 MLLEMut2) (Fig. 3A) and a longer ver-
sion of RRM1234 including additional C-terminal amino
acids (PABPC1 1-496) (Fig. 3A). Tethering either of these
mutants to the TPI-4MS2-SMG5 reporter construct increas-
es the mRNA abundance of the reporter to the same degree as
PABPC1 (Fig. 3C). Notably, it was postulated that the direct
binding of PABPC1 to eRF3a outcompetes the eRF3a-UPF1
interaction. However, our results suggest that this inter-
action, as well as other interactions involving theMLLEmotif
of PABPC1, is not strictly necessary for tethered PABPC1 to
suppress NMD.
PABPC1 unable to bind eIF4G fails to stabilize
reporter mRNA
TheRRM1234 region of PABPC1 contains RRM2,which binds
to a short N-terminal motif within eIF4G (Safaee et al. 2012).
This interaction is important for mRNA circularization and
the efficient expression of polyadenylated mRNAs (Wells
et al. 1998; Amrani et al. 2008). Guided by the molecular
structure of the PABPC1-eIF4G-RNA ternary complex (Sa-
faee et al. 2012), we introduced two point mutations into
PABPC1, which abolish binding to eIF4G (PABPC1M161A/
D165K) (Fig. 3A; Kahvejian et al. 2005). Strikingly, tether-
ing of PABPC1M161A/D165K to the reporter no longer sup-
pressed NMD and mRNA levels remained unchanged (Fig.
3B, lane 4). A similar result was obtained with the PABPC1
MLLEMut M161A/D165K mutant that can neither interact with
eIF4G nor eRF3a (Fig. 3B, lane 6). These results indicate
that the interaction between PABPC1 and eIF4G is critical
for the inhibition of NMD by tethered PABPC1.
To show that the results we have generated so far are indeed
due to interactions or lack thereof between PABPC1 with
eIF4G and eRF3a, we have performed in vitro interaction
studies. Pull-down assays of C-terminally FLAG-tagged
eRF3a with both of the PABPC1 MLLEMut and PABPC1
1–496 mutants show that they are no longer able to interact
with eRF3a, whereas the wild-type as well as the
PABPC1M161A/D165K mutant are still able to be pulled down
by eRF3a (Fig. 3D). The same experiment was performed
with a shortened version of FLAG-tagged eIF4G (eIF4G
84–294) containing the PABPC1 binding site. In this experi-
mental setup eIF4G 84–294 was no longer able to pull-down
the PABPC1M161A/D165K mutant (Fig. 3E). The wild-type as
mRNA circularization counteracts NMD
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well as the PABPC1 MLLEMut and PABPC1 1–496 mutants
were still able to interact with eIF4G 84–294 (Fig. 3E).
In summary, our results demonstrate that PABPC1 inhib-
its NMDwhen tethered upstream of an NMD-activating long
3′ UTR. Furthermore, binding of eIF4G but not eRF3a
contributes to NMD suppression by tethered PABPC1.
Interestingly, our findings suggest a previously unrecognized
role of eIF4G-mediated mRNA circularization and ribosome
recycling as modulators of NMD.
EJC-dependent NMD is mostly unaffected
by PABPC1
So far, we have examined the suppression of NMD activated
by the SMG5 3′ UTR. However, NMD of many nonsense-
containing mRNAs occurs in a splicing-dependent man-
ner and involves EJCs deposited at exon–exon junctions.
Therefore, we wanted to analyze whether PABPC1 is able
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FIGURE 3. PABPC1 interaction with eIF4G, but not eRF3a, is essential for NMD suppression. (A) Schematic representation of PABPC1 domains and
mutants. RNA recognition motifs (RRMs) and C-terminal region (C-ter) of PABPC1 are highlighted. Point mutations and binding sites are indicated.
(B,C) HeLa cells were transfected with plasmids expressing the indicated MS2V5-tagged fusion proteins and the indicated TPI reporter mRNA.
Northern blot analysis was performed and cotransfected β-globin mRNA construct served as control. Protein expression was detected by immuno-
blotting with a V5 antibody. GFP served as a loading control. mRNA levels were normalized to MS2V5-GST. Bars represent mean values of mRNA
levels ±SD upon tethering of different MS2V5-tagged fusion proteins. (D,E) Pull-down assays of in vitro interaction studies using PABPC1 mutants
and FLAG-tagged eRF3a or eIF4G 84-294. Proteins were visualized with Coomassie Brilliant Blue.
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constructed a reporter with an intron (MINX) downstream
from the 4MS2-binding sites and upstream of the long 3′
UTR (TPI-4MS2-MINX-SMG5) (Fig. 4A). Splicing of the
intron deposits an EJC that will activate NMD at the ter-
mination codon of the reporter mRNA. Strikingly, tethering
of PABPC1 only weakly inhibited EJC-dependent NMD
and slightly increased the MINX-containing mRNA levels
by a factor of less than two (Fig. 4B,C, lane 2). In general,
the inhibition of EJC-dependent NMD by PABPC1 variants
was clearly reduced when compared with the inhibition
of EJC-independent NMD (cf. Figs. 3B and 4C). Hence,
the presence of an EJC appears to reduce the ability of
PABPC1 to antagonize NMD, which explains why EJC-
dependent NMD efficiently degrades mRNAs with short 3′
UTRs.
The weak inhibition of EJC-dependent NMD observed in
Figure 4C was completely lost when we used a reporter con-
struct, in which the MINX intron was inserted between
the tethering sites and the termination codon (TPI-MINX-
4MS2-SMG5) (Fig. 4A). Neither PABPC1 nor any of its
mutants were able to increase mRNA levels of this reporter
(Fig. 4B,D), which demonstrates that PABPC1 cannot antag-
onize the activation of NMD in the presence of an upstream
EJC. Since an EJC in close proximity downstream from
tethered PABPC1 is able to decrease the NMD suppression by
PABPC1, we conclude that PABPC1 mainly regulates the
EJC-independent NMD of mRNAs with long 3′ UTRs.
Tethered eRF3a relies on interaction with PABPC1
to antagonize NMD
To gain further insight into the role of eRF3a in NMD sup-
pression, we tethered eRF3a to the TPI-4MS2-SMG5 reporter
construct, which led to increased reporter mRNA abundance
by a factor of four, demonstrating eRF3a’s ability to suppress
NMD similar to PABPC1 (Fig. 5A, lane 2). To investigate the
importance of the interaction between eRF3a and PABPC1
in NMD suppression, we used an eRF3a mutant carrying a
point mutation (eRF3a F76A), which is essential for bind-
ing to PABPC1 (Kononenko et al. 2010; Kozlov and Gehring
2010; Osawa et al. 2012). Compared with eRF3a WT, the
eRF3a F76A mutant has lost its NMD suppressing activity
(Fig. 5A, lane 3).
To ensure that the observed effects are in fact due to NMD
suppression, we determined mRNA half-life when tethering
eRF3a. Similar to PABPC1, eRF3a clearly increased mRNA
half-life, confirming that it specifically suppresses NMD





































































































































































































































FIGURE 4. PABPC1 primarily functions as a suppressor in EJC-independent NMD. (A) Schematic representation of the TPI reporters as in Figure
1A. Dark-gray boxes indicate intron-containing MINX cassette. (B) Representative Western blot showing MS2V5-tagged protein expression, as ana-
lyzed by immunoblotting with a V5 antibody. (C,D) HeLa cells were transfected with plasmids expressing the indicatedMS2V5-tagged fusion proteins
and the indicated TPI reporter mRNA. Northern blot analysis was performed and cotransfected β-globin mRNA construct served as control. mRNA
levels were normalized to MS2V5-GST. Bars represent mean values of mRNA levels ±SD upon tethering of different MS2V5-tagged fusion proteins.
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the specificity of the effects observed for tethered eRF3a were
confirmed with both control reporter constructs described
in Figure 1. Tethering eRF3a to either reporter did only
marginally change mRNA abundance (Fig. 5C,D).
In summary, these results demonstrate that the interaction
with PABPC1 is essential for eRF3a to suppress NMD initiat-
ed by a long 3′ UTR.
Recruitment of eIF4G increases mRNA
abundance independently of interaction
with PABPC1
Next, we aimed to further investigate NMD suppression by
eIF4G and the role of the interaction between PABPC1 and
eIF4G. An N-terminally truncated version of eIF4G (eIF4G
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FIGURE 5. Tethered eRF3a unable to interact with PABPC1 fails to stabilize reporter mRNA levels. (A,C,D) HeLa cells were transfected with plasmids
expressing the indicated MS2V5-tagged fusion proteins and the indicated TPI reporter mRNA. Northern blot analysis was performed and cotrans-
fected β-globin mRNA construct served as control. Protein expression was detected by immunoblotting with a V5 antibody. GFP served as a loading
control. Asterisks indicate unspecific bands (C,D). mRNA levels were normalized to MS2V5-GST. Bars represent mean values of mRNA levels ±SD
upon tethering of different MS2V5-tagged fusion proteins. (B) HeLa cells expressing MS2V5-tagged GST or eRF3a were treated with Actinomycin D
for the indicated time. mRNA levels were quantified after Northern blot analysis and plotted as described in Figure 2.
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ΔN83) was used to analyze the function of eIF4G in NMD
suppression (Fig. 6A).
Similar to PABPC1, we find that eIF4G ΔN83 is able to
antagonize NMD, increasing the levels of the reporter
mRNA by a factor of three (Fig. 6B, lane 2). To further elu-
cidate the role of the interaction between eIF4G and PABPC1
in NMD suppression, we tethered different deletion mutants
of eIF4G to the reporter construct (Fig. 6A). A shortened ver-
sion of eIF4G ranging from amino acids 84 to 1089 (eIF4G
84–1089) (Fig. 6A) was still able to fully suppress NMD,
which is indicated by an increase in mRNA reporter levels
of a factor of three (Fig. 6B, lane 4). Surprisingly, a shortened
version of eIF4G carrying a mutation of the KRERK motif at
position 187–191 (eIF4G 84–1089 KRERK) (Fig. 6A), which
is responsible for PABPC1 binding (Wakiyama et al. 2000),
efficiently antagonized NMD (Fig. 6B, lane 5). Although
the eIF4G KRERK mutant has previously been shown to ab-
rogate binding between eIF4G and PABPC1 (Wakiyama et al.
2000), our pull-down assay indicates that the eIF4G KRERK
mutant is still able to interact with PABPC1, albeit to a lesser
degree (Fig. 6C). Hence, the full NMD suppression activity
of tethered eIF4G 84–1089 KRERK might be due to partially
retained PABPC1-binding. However, an eIF4G deletion mu-
tant lacking the PABPC1-binding domain (eIF4G 206–1089)
(Fig. 6A) had a slightly decreased NMD suppression rate, but
was still able to increase mRNA abundance by a factor of two
(Fig. 6B, lane 3). These results indicate that the interaction of
eIF4G with PABPC1 is favorable but not absolutely necessary
for eIF4G’s ability to suppress NMD.
mRNA half-life was measured to ensure that the ob-
served effects are in fact due to NMD suppression. Similar
to PABPC1 and eRF3a, but less efficiently, eIF4G ΔN83 in-
creased mRNA half-life, confirming that it specifically sup-
presses NMD and stabilizes the reporter mRNA (Fig. 6D).
Notably, the low expression levels of the eIF4G constructs
may account for the less prominent stabilization effects com-
pared with tethered PABPC1 and eRF3a.
We confirmed the specificity of the effects observed for
tethered eIF4G with both control reporter constructs de-
scribed in Figure 1. Tethering eIF4G to either reporter only
marginally changed mRNA abundance (Fig. 6E–G).
The results presented here indicate that suppression of
NMD by tethered eIF4G does not strictly require binding
to PABPC1, albeit this interaction might enhance the func-
tion of eIF4G.
DISCUSSION
While the process and the function of NMD has been eluci-
dated in great detail and many factors and determinants that
activate NMD are known, the mechanism of NMD suppres-
sion is far less understood. In this study, we report that the
inhibition of EJC-independent NMD requires the interaction
of PABPC1 with the initiation factor eIF4G. We further show
that PABPC1 suppresses a SMG6-dependent canonical NMD
pathway involving the central NMD factors UPF1 and UPF2.
Our data suggest that the molecular processes of translation
termination and mRNA circularization impinge on the acti-
vation of NMD.
The NMD-inhibitory function of PABPs has been ob-
served in different eukaryotic organisms, such as yeast
(Amrani et al. 2004), fly (Behm-Ansmant et al. 2007), and
humans (Eberle et al. 2008; Ivanov et al. 2008; Silva et al.
2008; Singh et al. 2008). However, the NMD-specific func-
tion of PABP has proven to be difficult to study separately
from its other important functions in mRNA translation
and stabilization. Furthermore, human NMD is character-
ized by different signals for NMD activation and multiple
pathways for degradation, contrary to many other organisms
that use one main NMD mechanism (Hwang and Maquat
2011).
Human NMD occurs either in an EJC-dependent man-
ner, when a PTC is located upstream of the last intron posi-
tion, or independently of EJCs at termination codons that are
followed by long 3′ UTRs (Schweingruber et al. 2013). We
used a reporter mRNA with a long 3′ UTR to study the sup-
pression of NMD by PABPC1. Our results demonstrate that
tethering PABPC1 in close proximity of the termination co-
don impaired NMD of the reporter mRNA. We also con-
firmed that this effect is NMD-specific and does not occur
on mRNAs with the tethering sites downstream from the 3′
UTR, without direct binding of PABPC1, or when the termi-
nation codon is moved to a position downstream from the
tethering sites. Notably, the siRNA-mediated depletion of
UPF1 or UPF2 is epistatic to NMD suppression by PABPC1,
demonstrating that PABPC1 acts in the same pathway as,
but antagonistically to, UPF1 and UPF2. We also provide ev-
idence that PABPC1 antagonizes the SMG6-dependent de-
gradation pathway that initiates NMD by endocleavage in
the vicinity of the termination codon. Since we have not
investigated the role of other NMD factors, it will remain
an important challenge for future studies to test whether
the suppression of NMD affects additional degradation path-
ways, such as SMG5/SMG7-dependent deadenylation or
mRNA decapping.
Although previous studies suggested that PABPC1 also an-
tagonizes EJC-dependent NMD (Ivanov et al. 2008; Singh
et al. 2008), in our experiments the NMD inhibition by
PABPC1 is reduced in the presence of a downstream EJC.
This suggests that the NMD of the reporter mRNA without
3′ UTR introns occurs in an EJC-independent manner and
does not involve EJCs bound at noncanonical positions with-
in the long 3′ UTR (Sauliere et al. 2012; Singh et al. 2012). We
interpret the weak inhibition of EJC-dependent NMD by
PABPC1 as a nonspecific effect that is comparable to the ef-
fects observed with unrelated reporter mRNAs. However, it is
conceivable that the specific composition of EJCs determines
their amenability to NMD suppression or that a subset of
EJC components are inhibited by PABPC1. Hence, it remains
to be determined whether PABPC1 is able to antagonize
www.rnajournal.org 1587
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FIGURE 6. The interaction with PABPC1 is dispensable for NMD suppression by tethered eIF4G. (A) Illustration of eIF4G domain architecture and
mutants. MIF4G, MI, and W2 domains are highlighted. Point mutations and binding sites are indicated. (B,E,F) HeLa cells were transfected with
plasmids expressing the indicated MS2V5-tagged fusion proteins and the indicated TPI reporter mRNA. Northern blot analysis was performed
and cotransfected β-globin mRNA construct served as control. Protein expression was detected by immunoblotting with a V5 antibody. GFP served
as a loading control. Asterisk indicates an unspecific band (B). mRNA levels were normalized to MS2V5-GST. Bars represent mean values of mRNA
levels ±SD upon tethering of different MS2V5-tagged fusion proteins. (C) Pull-down assays of in vitro interaction studies using PABPC1 and FLAG-
tagged eIF4G 84-294WT or KRERKmutant. Proteins were visualized with Coomassie Brilliant Blue. (D) HeLa cells expressingMS2V5-tagged GST or
eIF4G ΔN83 were treated with Actinomycin D for the indicated time. mRNA levels were quantified after Northern blot analysis and plotted as de-
scribed in Figure 2. (G) Representative Western blot showing MS2V5-tagged protein expression, as analyzed by immunoblotting with a V5 antibody.
GFP served as a loading control. Asterisk indicates an unspecific band.
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NMD activated by EJCs or other mRNA-bound proteins, or
whether its function is restricted to long 3′ UTRs.
Current models of NMD suggest that a translation termi-
nation event in the proximity of the poly(A) tail prevents
the interaction of UPF1 with eRF3a and therefore inhibits
NMD, whereas translation termination upstream of a long
3′ UTR enables the association of UPF1 with eRF3a and
activates NMD. In contrast to this model, we find that teth-
ered PABPC1 does not require the interaction with eRF3a,
but needs to bind to eIF4G to suppress NMD. Similar to
PABPC1, tethered eIF4G also inhibits NMD. Additionally,
mutants of eIF4G lacking the binding region for PABPC1
either by deletion or point mutation are still able to suppress
NMD. These results suggest that binding of PABPC1 to
eIF4G is at least partially dispensable for NMD suppression
by eIF4G. We suggest that tethering of eIF4G downstream
from the termination codon establishes a link of the site of
translation termination to the 5′ end of the mRNA and facil-
itates ribosome recycling in a PABPC1-independent manner.
Surprisingly, we also observe a strong suppression of NMD
by tethered eRF3a. This result was unexpected in light of
our PABPC1 results, which demonstrate that eRF3a is
dispensable for NMD suppression by PABPC1. However,
we hypothesize that tethering of eRF3a enhances ribosome
recycling at the termination codon by the recruitment of
PABPC1, which explains the inhibition of NMD by eRF3a.
This hypothesis is supported by our observation that a mu-
tant of eRF3a (F76A), which is unable to interact with
PABPC1, is no longer able to inhibit NMD in the tethering
assay. Of note, additional binding partners of PABPC1 known
to compete with the interaction of eIF4G and eRF3a may be
involved in the regulation of NMD suppression, but were not
studied here. Furthermore, PABPC4 and eRF3b may confer
tissue-specific NMD suppression comparable to their homo-
logs PABPC1 and eRF3a, respectively (Chauvin et al. 2005;
Burgess et al. 2011). In summary, we have started to map
NMD-suppressing domains of eIF4G and eRF3a, but a pre-
cise identification of critical interactions will be required to
delineate the network of proteins that contribute to NMD
suppression.
The interaction of PABPC1 with eIF4G is thought to facil-
itate circularization of mRNAs, support ribosome recycling,
and initiate translation (Wells et al. 1998; Kahvejian et al.
2005; Amrani et al. 2008). These processes, albeit being
important for general translation, have not been previously
linked to NMD. Hence, we suggest a revised model of
NMD to include our findings (Fig. 7). According to this
model, closed loop formation of the mRNA via PABPC1-
eIF4G is important not only for translation initiation and
ribosome recycling, but also for the suppression of NMD
(Fig. 7A,C). We suggest that the interaction of PABPC1
with eRF3a establishes a branch connection from the site of
translation termination to the 5′ end of the mRNA through
the eIF4G-PABPC1 binding (Jackson et al. 2010). While
the interaction of PABPC1 with eIF4G stimulates the removal
of ribosomes from the site of termination, the inability to
remove a ribosome after termination serves as an NMD acti-
vating signal and enables the recruitment of the NMD ma-
chinery to the position of the termination codon (Fig. 7B).















































































































FIGURE 7. Model for a link between eIF4G-mediated ribosome recy-
cling and NMD inhibition. (A) Normal translation termination and ri-
bosome recycling of a short 3′ UTR-containing mRNA is enabled by
PABPC1 interacting with both eRF3a and eIF4G, thereby preventing
NMD. (B) Aberrant translation termination of long 3′ UTR-containing
mRNAs activates NMD. The interaction of PABPC1 with eRF3a is de-
creased due to a large physical distance, preventing efficient ribosome
recycling by eIF4G. Consequently, UPF1 is postulated to interact with
eRF3a and elicit NMD. (C) Tethered PABPC1 inhibits NMD of a
long 3′ UTR-containing substrate by bringing eIF4G in close proximity
to the terminating ribosome. This proximity promotes a proper trans-
lation termination event and facilitates ribosome recycling, thereby
antagonizing NMD activation.
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differ from normal termination codons most likely in the rate
of ribosome dissociation subsequent to peptide hydrolysis
(Kervestin and Jacobson 2012). We propose that the inability
to recycle ribosomes is a stochastic event that can occur dur-
ing every round of translation termination and no difference
whatsoever is expected between different modes of transla-
tion initiation (Durand and Lykke-Andersen 2013; Rufener
andMuhlemann 2013). While it is conceivable that many ab-
errant mRNAs are efficiently recognized during the first ter-
mination event, the correct position of the termination
codon will be monitored during every translation cycle and
serves to eliminate mRNAs that once escaped decay. Hence,
the continuous recycling of ribosomes via mRNA circulariza-
tion at the termination codon may represent a main mecha-
nism to prevent the degradation of mRNAs with short 3′
UTRs. The precise molecular signal that recruits the surveil-
lance complex to the site of termination still remains to be
determined. UPF1 likely represents the factor that directly in-
terprets the signals of terminating ribosomes, either via a di-
rect interaction with the ribosome (Min et al. 2013) or by
communicating with the eukaryotic release factors (Ivanov
et al. 2008; Singh et al. 2008). However, it is unclear how
phosphorylation of UPF1 is activated in the absence of a
downstream EJC (Kashima et al. 2006). While our work
complements the current model of NMD with an important
role of the eRF3a-PABPC1-eIF4G interaction, the molecular
function of many additional factors involved in NMD, such
as components of the EJC, still needs to be integrated.
MATERIALS AND METHODS
Plasmids constructs
Plasmid constructs β-globin, WT300+e3, pCI-FLAG, pCI-MS2V5,
pCI-mVenus, pCI-TPI, and expression vectors for PABPC1 and
eIF4G were described previously (Gehring et al. 2005, 2009; Hunds-
doerfer et al. 2005; Ivanov et al. 2008; Steckelberg et al. 2012). The
modification of pCI-TPI with four copies of binding sites for the
heterologous probe used in Northern blot analysis, as well as the in-
sertion of the SMG5 3′ UTR and 4MS2 binding sites in the 3′ UTR
of TPI were described elsewhere (V Boehm, N Haberman, F Ottens,
J Ule, and NH Gehring, in prep.). Using the same cassette cloning
strategy, the MINX splicing cassette was introduced in the vectors
(TPI-4MS2-MINX-SMG5, TPI-MINX-4MS2-SMG5). Deletion
and point mutants of PABPC1, eRF3a and eIF4G were generated
by PCR, cloned in the designated expression vector, and verified
by sequencing.
siRNA transfections
HeLa cells were grown in 6-cm plates and transiently transfected
with 300 pmol siRNA using Lipofectamine RNAiMAX (Life Tech-
nologies). At 24 h post-transfection the cells were transferred to
10-cm plates and 1 d later transfected again with 600 pmol siRNA.
The following siRNA target sequences were used for Luciferase 5′-
AACGTACGCGGAATACTTCGA-3′, for SMG6 5′-AAGGGTCAC
AGTGCTGAAGTA-3′, for UPF1 5′-AAGATGCAGTTCCGCTCC
ATT-3′, and for UPF2 5′-CACGTTGTGGATGGAGTGTTA-3′.
Plasmid transfections
HeLa cells were grown in 6-well plates or transferred 1 d after siRNA
transfection to 6-well plates and transfected by calcium phosphate
precipitation with 0.3 µg of a mVenus expression plasmid, 0.5 µg
control plasmid (β-globin or WT300+e3), and 2 µg plasmid encod-
ing for reporter mRNA. For tethering or overexpression of tagged-
protein, 0.8 µg of the FLAG- or MS2V5 expression plasmid was in-
cluded in the transfection mix. For mRNA half-life experiments,
cells were incubated with medium supplemented with 5 µg/mL
Actinomycin D for 3 or 6 h prior to harvesting.
RNA extraction and Northern blotting
Total RNA was extracted with Isol-RNA Lysis Reagent (5PRIME)
and analyzed by Northern blotting as described (Gehring et al.
2009). Signals were quantified using a Typhoon Trio (GE
Healthcare).
Immunoblot analysis
SDS-PAGE and immunoblot analysis was performed using protein
samples derived from Isol-RNA Lysis Reagent extractions. The
antibodies against tubulin (T6074) and FLAG (F7425) were from
Sigma, the antibody against V5 (18870) was from QED Bioscience,
the antibodies against GFP (ab290) and SMG6 (ab87539) were from
Abcam, and the antibodies against UPF1 and UPF2 were kindly pro-
vided by Jens Lykke-Andersen.
Expression and purification of recombinant proteins
Strep-tagged PABPC1 wild type and mutants, GST-tagged PABPC1
1–496 and N-terminally GST-, C-terminally FLAG-tagged eRF3a
and eIF4G constructs were expressed in E. coli Rosetta 2. Cells
were grown to exponential phase in LB medium (OD600 = 0.6–0.8)
and expression was induced with 0.2 mM IPTG overnight at 20°
C. Strep-tagged proteins were purified via affinity chromatography
using StrepTactin Superflow Plus columns (Qiagen). GST-tagged
proteins were purified via affinity chromatography using GSTrap
columns (GE Healthcare) followed by size exclusion chromatogra-
phy using a Superdex 200 10/300 GL column (GE Healthcare). Cell
lysis was performed in 40 mM Tris (pH 7.8), 250 mM NaCl with
protease inhibitors (Protease inhibitor cocktail [Sigma], and 1 mM
PMSF). All constructs were stored in 40 mM Tris (pH 7.8) and
150 mM NaCl.
In vitro pull-down analysis
Three hundred picomoles of FLAG-tagged proteins (eIF4G 84-294
or eRF3a) were incubated with 250 pmol PABPC1 constructs in a
final volume of 400 µL binding buffer (25 mM HEPES at pH 7.8;
150 mM NaCl; 2 mM MgCl2; 0.1% NP-40; 0.01% Triton X-100)
in the presence of magnetic beads coupled to anti-FLAG antibodies
(M2 magnetic beads; Sigma). After incubation for 2 h at 4°C, beads
were washed twice with 500 µL wash buffer (25 mM HEPES at pH
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7.8; 300 mMNaCl; 2 mMMgCl2; 0.1% NP-40; 0.2% Triton X-100)
and coprecipitated proteins were eluted with 1x SDS loading buffer.
10% of the protein mix was used as input control, all samples were
separated on 12% SDS–polyacrylamide gels and stained with
Coomassie Brilliant Blue.
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The exon junction complex (EJC) is a key regulator
of posttranscriptional mRNA fate and binds to
mRNA during splicing. Although the composition of
EJCs is well understood, the mechanism mediating
splicing-dependent EJC assembly and the factor(s)
recruiting the EJC remain elusive. Here, we identify
CWC22 as an essential splicing factor that is required
for EJC assembly. In CWC22-depleted cells, pre-
mRNA splicing is impaired but is rescued by a central
fragment of CWC22. We show that the MIF4G
domain of CWC22 initiates EJC assembly via a direct
interaction with the EJC core protein eIF4A3, and
we characterize mutations in eIF4A3 that abolish
binding to CWC22. These eIF4A3 mutants efficiently
nucleate splicing-independent recombinant EJC
core complexes, but they fail to support splicing-
dependent EJC deposition. Our work establishes
a direct link between the splicing machinery and
the EJC, hence uncovering a molecular interaction
at the center of a posttranscriptional gene regulation
network.INTRODUCTION
The molecular apparatus required for eukaryotic gene expres-
sion forms a network that is able to communicate across the
nuclear envelope and includes the transcription, splicing, and
translation machinery (Moore and Proudfoot, 2009). Interac-
tions between the different processing steps are mediated by
RNA-binding proteins that form messenger ribonucleoprotein
complexes (mRNPs) (Rodrı´guez-Navarro and Hurt, 2011). The
protein composition of the mRNP reflects the history and deter-
mines the fate of each mRNA molecule. A key regulator within
this mRNP network is the exon junction complex (EJC).
The EJC is a protein complex that assembles on spliced
mRNA 20–24 nts upstream of exon-exon boundaries in a
sequence-independent manner (Le Hir et al., 2000). It remains
bound to the mRNA, thereby marking the position of splice
sites, until it is disassembled during translation in the cytoplasm
(Gehring et al., 2009b). In mammals, EJCs are involved in
the detection of mRNAs containing premature translation termi-
nation codons (Lykke-Andersen et al., 2001). Furthermore,454 Cell Reports 2, 454–461, September 27, 2012 ª2012 The Author
41components of the EJC have been shown to be responsible for
the increased export and translational efficiency of spliced
mRNAs (Le Hir et al., 2001; Ma et al., 2008). They also regulate
the splicing of a subset of pre-mRNAs, particularly those
containing long introns, such as mitogen-activated protein
kinase (MAPK) (Ashton-Beaucage et al., 2010; Roignant and
Treisman, 2010).
The EJC core consists of four subunits, eIF4A3 (DDX48),
MAGOH, Y14 (RBM8A), and BTZ (CASC3, MLN51), of which
MAGOH and Y14 constitute a stable heterodimer (Tange et al.,
2005). The crystal structure of the EJC core reveals how these
subunits are organized into a complex (Andersen et al., 2006;
Bono et al., 2006). In the presence of ATP, the DEAD-box heli-
case eIF4A3 adopts a closed conformation and binds to RNA.
The closed conformation and therefore the RNA interaction is
stabilized upon binding of the MAGOH-Y14 heterodimer to
eIF4A3 (Ballut et al., 2005). The core component BTZ binds to
eIF4A3 in a conformation-independent manner, although the
interaction is stabilized within the EJC by additional protein-
protein and protein-RNA interactions. Although the EJC can
form spontaneously in vitro from recombinant components,
its assembly in living cells or cell extracts is strictly splicing
dependent (Bono and Gehring, 2011). However, the underlying
molecular mechanism of EJC loading, the reason for the splicing
dependence, and the spliceosomal proteins involved in EJC
assembly remain unknown.
Here, we show that the protein CWC22 is required for pre-
mRNA splicing in mammalian cells and represents an essential
EJC loading factor. CWC22 interacts directly with eIF4A3
via its MIF4G domain, and this interaction contributes to the
splicing-dependent assembly of EJCs. In cells depleted of
CWC22, pre-mRNA splicing is impaired, while a construct com-
prising the MIF4G andMA3 domain of CWC22 suffices to rescue
the splicing defect. Taken together, our results highlight the
functional interconnection between splicing and EJC recruit-
ment and indicate that eIF4G-eIF4A-like interactions emerge
as common principle in mRNP remodeling.
RESULTS
CWC22 Is an eIF4A3-Interacting Protein
The EJC core protein eIF4A3 directly contacts RNA and there-
fore serves as an interaction platform for all other EJC proteins
(Andersen et al., 2006; Bono et al., 2006). In order to identify
putative factors within the spliceosome that recruit eIF4A3
and initiate EJC assembly, we searched the human genomes
Figure 1. eIF4A3 Binds to CWC22 via Its MIF4G Domain
(A) FLAG-CWC22 was immunoprecipitated from RNase-A-treated cell lysates. Coprecipitated endogenous proteins were detected by immunostaining with
specific antibodies. Unfused FLAG was used as a negative control.
(B) FLAG-eIF4A3 was immunoprecipitated as described in (A). Asterisks denote nonspecific bands.
(C) Schematic representation of N- and C-terminal truncations of CWC22 used for FLAG immunoprecipitation.
(D) FLAG-CWC22 deletion mutants were immunoprecipitated as described in (A).
(E) Immunoprecipitation of recombinant CWC22 and eIF4A3. FLAG-Strep-eIF4A3, GST-CWC22 (110–409),GST-CWC22 (110–665), and GST-CWC22 (340–665)
were purified from E.coli, incubated in binding buffer, and immunoprecipitated. Proteins were separated by SDS-PAGE and stained with Coomassie. S2:
Strep-tag.
(F) FLAG-CWC22 and FLAG-BTZ were immunoprecipitated as described in (A).
(G) Immunoprecipitation of CWC22 and EJC proteins in vitro. Recombinant Strep-eIF4A3, MAGOH, Y14-Strep, BTZ (110–372)-Strep (lanes 1 and 2), or Flag-BTZ
(110–372)-Strep (lane 3) were incubated under EJC-assembly conditions (see Experimental Procedures) in the presence (lane 2) or absence (lanes 1 and 3) of
recombinant GST-CWC22 (110–409)-Flag. Immunoprecipitation was performed as in (E).
See also Figure S1.database for spliceosomal proteins with homology to known
eIF4A3-interacting proteins. Interestingly, we found that
NOM1, a protein previously shown to interact with eIF4A3 during
rRNA biogenesis in yeast and humans, shares significant
sequence identity with the spliceosomal protein CWC22 (Fig-
ure S1). Notably, the highest sequence conservation between
CWC22 and NOM1 was found within their MIF4G (middle
domain of eukaryotic initiation factor 4G [eIF4G]) and MA3
domains. The MIF4G and MA3 domains of eIF4G have been
shown to confer eIF4A binding during eukaryotic translation
initiation (Marintchev et al., 2009), and likewise, mutations in
the MIF4G domain of NOM1 defined its genetic interaction
with eIF4A3 during pre-rRNA processing (Alexandrov et al.,
2011).
To test whether CWC22 is indeed an eIF4A3-interacting
factor, we immunoprecipitated FLAG-tagged CWC22 from
HeLa cell lysates treated with RNase A (Figure 1A) or RNase I
(Figure S1B) and analyzed the interaction with eIF4A3. Endoge-
nous eIF4A3 coprecipitated with FLAG-CWC22 (Figures 1A and
S1B), and this interaction was confirmed by the coprecipitation
of endogenous CWC22 with FLAG-eIF4A3 (Figures 1B andCel
4S1C). Notably, two bands of coprecipitated CWC22were visible,
suggesting that posttranslational modifications may modulate
its interaction with eIF4A3 (Figure 1B). The interaction of
eIF4A3 with CWC22 is specific, because the RNA-binding pro-
teins eIF4A1 and CBP80 fail to coprecipitate with CWC22 and
eIF4A3, respectively (Figures 1A, 1B, S1B, and S1C).
The high degree of sequence conservation between the
MIF4G and MA3 domains of NOM1 and CWC22 suggests that
either one or both of these domains are involved in the bind-
ing of eIF4A3. To identify the eIF4A3-interacting domain(s) of
CWC22, we performed coimmunoprecipitation experiments
with N- and C-terminal truncations of FLAG-CWC22 (Figures
1C and 1D). The minimal eIF4A3-binding module identified
consisted of the amino acid residues 110–409 of CWC22
(Figure 1D, lane 5). Notably, this part of CWC22 contains
the MIF4G domain. In contrast, the MA3-domain-containing
fragment (340–665) of CWC22 did not interact with eIF4A3
(Figure 1D, lane 6).
To analyze whether CWC22 interacts directly with eIF4A3, we
purified full-length FLAG-Strep-tagged eIF4A3 and GST-tagged
CWC22 from E. coli. We were not able to obtain the full-lengthl Reports 2, 454–461, September 27, 2012 ª2012 The Authors 455
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CWC22 protein from bacterial cultures, but three truncated
versions, comprising residues 110–665, 110–409 and 340–665
of CWC22, were highly expressed. These recombinant CWC22
protein variants were preincubated with eIF4A3, and complex
formation was analyzed by FLAG immunoprecipitation (Fig-
ure 1E). Both MIF4G-containing variants of CWC22 (110–665
and 110–409) but not the MA3 domain (340–665) readily copuri-
fiedwith eIF4A3, clearly demonstrating that theMIF4G domain of
CWC22 directly interacts with eIF4A3 in vitro.
CWC22 Binds to eIF4A3 but Not MAGOH and Y14
Our data show that CWC22 directly binds eIF4A3, but whether
this interaction involves the other core EJC proteins remains
unsolved. To this end, we immunoprecipitated FLAG-BTZ
(110–372) and FLAG-CWC22 from HeLa cell lysates and
compared their interaction with the endogenous EJC core
proteins eIF4A3, Y14, and MAGOH (Figure 1F). Both FLAG-
BTZ (110–372) and FLAG-CWC22 copurified comparable
amounts of endogenous eIF4A3. In contrast to FLAG-BTZ
(110–372), FLAG-CWC22 did not coprecipitate the other EJC
core proteins MAGOH and Y14 (Figure 1F, lane 2). Likewise,
no interaction of BTZ with CWC22 was observed (Figure S1D).
This indicates that CWC22 specifically binds to eIF4A3 outside
of the assembled EJC.
This finding was confirmed in vitro with recombinant compo-
nents (Figure 1G). The human EJC core was assembled from
eIF4A3, MAGOH-Y14, and BTZ (110–372) as described previ-
ously (Ballut et al., 2005; Bono et al., 2006). Whereas FLAG-
BTZ (110–372) coprecipitated all three core proteins of the EJC
(lane 3), FLAG-CWC22 (110–409) coprecipitated only eIF4A3
and BTZ (lane 2). Although the short version of BTZ used here
is coprecipitated together with eIF4A3 by CWC22, the full-length
BTZ protein did not interact with CWC22 in cell lysates (Fig-
ure S1D). Hence, CWC22 recruits only eIF4A3 to the spliceo-
some, while the additional EJC components are presumably
loaded by an alternative factor.
CWC22 Is Required for Pre-mRNA Splicing in Humans
We know that in yeast, Cwc22 is an essential splicing factor that
is involved in the regulation of the first catalytic step via the
DExD/H-box helicase Prp2 (Yeh et al., 2011). In contrast, the
human CWC22 protein is only poorly characterized.
To assess whether human CWC22 is required for pre-mRNA
splicing, we used two different small-interfering RNAs (siRNAs)
to deplete CWC22 in human cell culture. In knockdown cells,
CWC22 protein levels were reduced to 20%, as shown by
immunoblotting (Figure 2A). Northern blot analysis revealed
that the levels of mature b-globin mRNA, expressed from an
intron-containing reporter plasmid, were clearly reduced in
CWC22-knockdown cells as compared to control cells (Fig-
ure 2B, lane 2; Figure S2C). At the same time, we observed
a higher molecular weight band on the Northern blot at the size
of the unspliced b-globin pre-mRNA.mRNAexpressed froma tri-
sosephosphate isomerase (TPI) reporter (Figure 2C) and a T cell
receptor (TCR) reporter (Figure S2D) showed a similar, but quan-
titatively more pronounced, effect. We used quantitative RT-
PCR with intron- and exon-specific primer pairs (Figure S2A) to
further analyze the b-globin and TPI mRNAs and pre-mRNAs456 Cell Reports 2, 454–461, September 27, 2012 ª2012 The Author
43from knockdown and control cells. In line with our Northern
blot results, the levels of the pre-mRNA-specific PCR product
were strongly increased, whereas the levels of the mRNA-
specific PCR product were reduced in CWC22-knockdown cells
(Figure 2D). To explore whether the CWC22 knockdown also
impinges on endogenously expressed mRNAs, we quantified
pre-mRNAs and mRNAs of two housekeeping genes, actin-
beta (ACTB) and glyceraldehyde 3-phosphate dehydrogenase
(GAPDH). Notably, the primer pairs amplify different regions of
pre-mRNA and mRNA, respectively, (Figure S2A) and therefore
cannot discriminate between unspliced and partially spliced
transcripts that may accumulate as a result of CWC22 depletion.
However, decreased amounts of the spliced mRNA and
increased amounts of the intron-containing pre-mRNA were
observed for both genes in CWC22-depleted cells (Figure 2D).
The splicing defect of CWC22-depleted cells was rescued by
the expression of siRNA-resistant CWC22 (Figure 2B, lane 3; Fig-
ure 2C, lane 3; Figure S2D, lane 3). This finding confirmed the
specificity of the knockdown and enabled us to test which of
the variants of CWC22 is sufficient to support splicing in HeLa
cells. We expressed the N- and C-terminal truncations of
CWC22 that were previously used to identify the binding domain
of eIF4A3 in CWC22-knockdown cells. Interestingly, the CWC22
fragment containing both the MIF4G domain and adjacent MA3
domain (residues 110–665) was able to rescue the splicing
defect. In contrast, the MIF4G domain (residues 110–409) or
the MA3 domain (340–665) alone was insufficient to restore
splicing in knockdown cells (Figure 2E), despite showing expres-
sion levels comparable to full-length CWC22 (Figure S2E).
Together, our data demonstrate that the depletion of CWC22
strongly impairs pre-mRNA splicing in human cells and suggest
a critical role for the MIF4G and MA3 domains during splicing.
The Interaction of eIF4A3 and CWC22 Displays
Characteristics of an eIF4A-eIF4G Complex
So far, we have demonstrated that the MIF4G domains of
CWC22 and eIF4A3 form a complex. Because of the high degree
of sequence conservation between the DExD/H-box helicases
eIF4A3 and eIF4A, the CWC22-eIF4A3 complex could resemble
the well-characterized eIF4G-eIF4A complex. To generate
a molecular model of the CWC22-eIF4A3 interaction, we super-
imposed the structures of eIF4A3 (Bono et al., 2006) and eIF4A
(Schu¨tz et al., 2008) and used the cocrystallized MIF4G of
eIF4G as surrogate of CWC22 (Figure 3A). On the basis of this
model, we generated mutants of CWC22 and eIF4A3 and tested
them for their ability to form the CWC22-eIF4A3 complex.
We identified mutations (DLYD270KLYK, TI276GD,
NFT301LAG), at three different positions in eIF4A3, that abol-
ished the interaction with endogenous CWC22 in FLAG-immu-
noprecipitation assays (Figures 3B and S3A). The same muta-
tions also abrogated the binding between recombinant eIF4A3
and CWC22 (110–409) (Figure 3C).
Likewise, the mutation of two amino acid residues at the pre-
dicted binding surface of CWC22 (NK171DE) impaired the co-
precipitation of endogenous eIF4A3 from cell lysates (Figure 3D)
as well as the interaction between recombinant eIF4A3 and
CWC22 (Figures 3E and S3B). Interestingly, the mutation at
position 171/172 of CWC22 maps to a 12-amino-acid-longs
Figure 2. CWC22 Is an Essential Splicing Factor in Human Cells
(A) siRNA knockdown of CWC22 in human cell culture. HeLa cells were transfected with siRNAs targeting CWC22 (CWC[A] and CWC[B]) or Luciferase (negative
control). The knockdown efficiency was assessed by immunoblotting with a CWC22-specific antibody. Tubulin served as a loading control.
(B, C, and E) Northern blot analysis of b-globin and TPI reporter mRNAs in CWC22-depleted cells.
(B and C) An intron-containing b-globin (B) or TPI (C) reporter was coexpressed with a transfection control (LacZ-HBB) and siRNA-resistant FLAG-CWC22R
(lane 3) or unfused FLAG (lanes 1 and 2) in CWC22-knockdown (lanes 2 and 3) and control cells (lane 1). The mRNA and pre-mRNA was detected by Northern
blotting with a specific probe. An asterisk denotes an unspecific band. The bottom panel (B) shows a shorter exposure of the fully spliced b-globin band.
(D) Expression levels of pre-mRNA and mRNA were determined by quantitative RT-PCR. Bars represent the fold change in mRNA or pre-mRNA levels upon
CWC22 depletion, and standard deviations are indicated by error bars. Numbers next to bars represent the calculated fold splicing inhibition (see Experimental
Procedures).
(E) CWC22-knockdown cells were cotransfected with the indicated N- andC-terminal truncations of FLAG-CWC22R and the b-globin reporter as described in (B).
An asterisk denotes an unspecific band.
See also Figure S2.conserved sequence motif in eIF4G that has been shown to
compose the largest contiguous interface with eIF4A in yeast
(Schu¨tz et al., 2008). Moreover, the corresponding surface resi-
dues of the yeast NOM1 ortholog, Sgd1p, mediate its genetic
interaction with yeast eIF4A3 (Fal1p) (Figure S1, asterisk)
(Alexandrov et al., 2011). The identification of binding residues
at the predicted eIF4A3-CWC22 interface thus corroborates
the hypothesis that CWC22 and eIF4A3 constitute an eIF4A-
eIF4G-like interaction pair.
Binding of eIF4A3 to CWC22 Is Required for Splicing-
Dependent EJC Assembly
Our data revealed that CWC22 is an essential splicing factor in
human cells and interacts with eIF4A3. Since EJC-assembly is
a strictly splicing-dependent process, we hypothesized that
CWC22 functionally bridges the spliceosome and the EJC.
To test the effect of CWC22 on EJC assembly in vitro, we
incubated purified CWC22 (110–409) with equal amounts ofCel
4recombinant EJC core components eIF4A3, BTZ, Y14, and
MAGOH. In line with the results of our immunoprecipitations
from cell lysates (Figure 1F), CWC22 did not coprecipitate
together with FLAG-Y14 and the assembled EJC (Figure S4A,
lane 3). Interestingly, the presence of wild-type CWC22, but
not of the eIF4A3-interaction-deficient mutant of CWC22
(171DE), clearly reduced the amounts of coprecipitated eIF4A3
and BTZ (Figure S4A). Hence, the interaction of CWC22 with
eIF4A3 impairs the assembly of recombinant EJCs in vitro. This
suggests that additional spliceosomal factors or full-length
CWC22 are required in order to recapitulate splicing-dependent
EJC assembly in vitro.
Splicing-dependent EJC assembly has previously been
studied by means of in vitro splicing reactions (Gehring et al.,
2009a). Hence, we utilized splicing assays to test whether the
CWC22-binding-deficient eIF4A3 mutants (DLYD270KLYK,
TI276GD, NFT301LAG) are incorporated into EJCs. To this
end, FLAG-containing mRNPs were immunoprecipitated,l Reports 2, 454–461, September 27, 2012 ª2012 The Authors 457
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Figure 3. The Interaction of eIF4A3 and
CWC22-MIF4G Features Characteristics of
the eIF4A-eIF4G Complex
(A) The crystal structure of eIF4A and the MIF4G
domain of eIF4G (left side, PDB 2VSO) was used
to generate a model (right side) of the eIF4A3-
CWC22 interaction by superposition of the struc-
tures of eIF4A3 (as part of the EJC; PDB 2JOS)
and eIF4A. Putative contact sites (depicted in red)
of eIF4A3 and CWC22 were mutated and char-
acterized in (B–E). The superposition was gener-
ated by DaliLite (Holm and Park, 2000); the draw-
ing was rendered with PyMOL (DeLano, 2010).
(B and C) Analysis of eIF4A3 mutant proteins.
(B) FLAG-eIF4A3 and mutants of FLAG-eIF4A3
were immunoprecipitated from RNase-A-treated
cell lysates. Coprecipitated endogenous CWC22
was detected by immunostaining with a specific
antibody.
(C) Recombinant Strep-eIF4A3, Strep-eIF4A3
mutants, and GST-CWC22 (110–409)-FLAG were
incubated in binding buffer and immunoprecipi-
tated. Proteins were separated by SDS-PAGE and
stained with Coomassie.
(D and E) Analysis of a CWC22 mutant protein.
(D) FLAG-CWC22 and FLAG-CWC22 (NK171DE)
were immunoprecipitated from RNase-A-treated
cell lysates. Coprecipitated endogenous eIF4A3
was detected by immunostaining with a specific
antibody.
(E) Recombinant FLAG-Strep-eIF4A3, GST-
CWC22 (110–409) and GST-CWC22 (110–409/
NK171DE) were incubated in binding buffer and
immunoprecipitated as described in (C).
See also Figure S3.followed by RNA extraction and denaturing PAGE. As expected,
wild-type FLAG-eIF4A3 specifically coprecipitated spliced
mRNA (Figure 4A, lane 2, top panel), demonstrating that it
had been incorporated into an EJC (Gehring et al., 2009a). In
contrast, none of the CWC22-binding-deficient variants of
eIF4A3 precipitated any mRNA, indicating that the inability
to interact with CWC22 prevents splicing-dependent EJC
assembly (Figure 4A, lanes 3–5). Likewise, only the wild-type
eIF4A3, but none of the mutants, precipitated splicing intermedi-
ates when the splicing reactions were stalled at the step of spli-
ceosomal C-complex formation (MINX-GG; Figure 4A, bottom
panel). Hence, CWC22 recruits eIF4A3 during the first catalytic
step of splicing and thereby initiates EJC assembly.
The mutated residues in eIF4A3 (DLYD270KLYK, TI276GD,
NFT301LAG) do not overlap with the interaction surfaces of
Y14, MAGOH, or BTZ on eIF4A3 (Figure S4B). Nevertheless,
we wanted to validate that the mutations do not disrupt the
interaction of eIF4A3 with the other EJC components. To this
end, we used recombinant proteins to assemble a splicing-
independent EJC in vitro. Recombinant EJCs were assembled458 Cell Reports 2, 454–461, September 27, 2012 ª2012 The Authors
45from the core proteins eIF4A3, Y14,
MAGOH, and FLAG-BTZ (110–372) and
immunoprecipitated via FLAG (Figure 4B).
As expected, all core EJC proteinscoprecipitated with FLAG-BTZ (110–372) (Figure 4B, lane 1). In
contrast, no EJCs formed in the absence of ssRNA and AMP-
PNP, and FLAG-BTZ (110–372) coprecipitated only eIF4A3 (Fig-
ure 4B, lane 5).
Notably, all three eIF4A3 mutants formed recombinant EJCs
as efficiently as the wild-type (Figure 4B, lanes 2–4), clearly
showing that the mutations affect not the ability to interact with
the EJC core but, rather, the splicing-dependent loading of
the complex. Hence, our results identify key residues of eIF4A3
that mediate both the interaction with the MIF4G domain of
CWC22 and the assembly of EJCs by the spliceosome. Together
with previously published data, our work thus redefines the
framework of interactions required for the formation of EJCs in
living cells.
DISCUSSION
Exon junction complexes are important functional mRNP
components that assemble on maturing mRNA during splicing
in the nucleus. In this work, we have identified the protein
Figure 4. The Interaction of eIF4A3 and CWC22 Contributes to Splicing-Dependent EJC Assembly
(A) Analysis of splicing-dependent EJC assembly. Splicing reactions using MINX (top panel) or MINX-GG (mutated 30 splice site, bottom panel) as substrate
mRNA were carried out in splicing extracts composed of HeLa nuclear extracts and 293 whole-cell extracts expressing FLAG-eIF4A3, the indicated mutants of
eIF4A3, or unfused FLAG. FLAG-containing mRNPs were immunoprecipitated, and coprecipitated RNA was separated by denaturing PAGE. Positions of
unspliced precursor transcript, splicing intermediates (MINX-GG), and spliced product (MINX) are indicated schematically. Expression levels of the eIF4A3
mutants were determined by immunoblotting (a-FLAG, bottom).
(B) Analysis of splicing-independent EJC assembly in vitro from recombinant components. Strep-eIF4A3 (wild-type or the indicated mutants), FLAG-BTZ
(110–372)-Strep, Y14-Strep, and MAGOH were incubated under EJC-assembly conditions in the presence (lanes 1–4) or absence (lanes 5–8) of AMP-PNP and
ssRNA. Protein complexes were immunoprecipitated, separated by SDS-PAGE, and stained with Coomassie.
(C) The three-step model of splicing-dependent EJC deposition. For details, see Discussion.
See also Figure S4.CWC22 as a central EJC-assembly factor. CWC22 is an abun-
dant component of the activated spliceosome and the spliceo-
somal C complex (Bessonov et al., 2008). This supports the
prior notion that eIF4A3 is recruited to the spliceosome during
an early step of splicing (Gehring et al., 2009a; Mishler et al.,Cel
42008). Considering the molecular architecture of CWC22, its
resemblance to other DExD-box-helicase-interacting proteins
and its exclusive binding to eIF4A3, but not MAGOH and
Y14, we propose a three-step model for EJC assembly
(Figure 4C).l Reports 2, 454–461, September 27, 2012 ª2012 The Authors 459
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The binding of eIF4A3 to CWC22 represents the first step of
EJC assembly (step 1). Although biochemically well defined,
more details of this interaction need to be determined; in partic-
ular, whether CWC22 and eIF4A3 are recruited to the spliceo-
some individually or as a heterodimer. Previous studies showed
that the binding of DExD-box helicases (e.g., eIF4A and the
nuclear export factor Dbp5) to their interacting proteins (eIF4G
and Gle1, respectively) stabilizes them in a ‘‘half-open’’ and
activated conformation (Hilbert et al., 2011; Montpetit et al.,
2011; Schu¨tz et al., 2008). We therefore propose that eIF4A3
adopts a similar ‘‘half-open’’ conformation upon binding to
CWC22 (step 2). This activated conformation would prevent
premature RNA binding and prime eIF4A3 for receipt of the
MAGOH-Y14 heterodimer. At the same time, the activated
conformation of eIF4A3 enables it to be loaded to the mRNA in
a single step through a conformational change imposed by
MAGOH-Y14 binding (step 3). However, the molecular details
of the MAGOH-Y14 recruitment to the spliceosome remain
elusive and thus represent an interesting subject for future
research.
The function of CWC22 within the spliceosome of mammalian
cells is poorly understood. Although our data demonstrate that
CWC22 is required for pre-mRNA splicing, its precise role in
this process remains to be determined. Interactions between
CWC22 and two spliceosomal proteins, FAM32A and FRG1,
have been discovered in a large-scale Y2H-screen, but neither
of these direct interaction partners elucidates the role of
CWC22 in splicing (Hegele et al., 2012). Interestingly, the central
part of CWC22 comprising the MIF4G and the MA3 domain, but
not the MIF4G domain alone, is sufficient to rescue the splicing
defect of CWC22-depleted cells. This suggests that an interac-
tion involving the MA3 domain is required for the proper function
of CWC22 during splicing. The yeast ortholog, Cwc22, has been
described as an essential pre-mRNA splicing factor that is
required for the function of Prp2 in promoting the release of
SF3a and SF3b during the first catalytic step of splicing (Yeh
et al., 2011). Similar to human CWC22, the MA3 domain of
Cwc22 is required to rescue the splicing defect of Cwc22
knockout cells (Yeh et al., 2011). In order to shed light on the
splicing function of CWC22, it will be instrumental to identify
interaction partners of Cwc22 and CWC22 within the spliceo-
some that bind specifically to the MA3 domain.
Recently, a specific splicing function of the EJC core proteins
eIF4A3, MAGOH, and Y14 has been described, but the precise
role of the EJC during splicing remains obscure (Ashton-Beau-
cage et al., 2010; Roignant and Treisman, 2010). Considering
the direct interaction between eIF4A3 and CWC22, it is tempting
to speculate that the splicing function of the EJC is mediated via
this molecular contact, although the deposition of EJCs is
presumably not important for the general splicing function of
CWC22.
Our description of the CWC22-eIF4A3 interaction provides
a rationale for the intimate coupling of EJC deposition and
pre-mRNA splicing. The conserved mode of interaction sug-
gests that the activation and loading of eIF4A3 by CWC22 obeys
the rules described for eIF4G, Gle1, and their DExD -box heli-
case interaction partners and proposes a general mechanism
for DEAD-box helicase recruitment. Future studies will provide460 Cell Reports 2, 454–461, September 27, 2012 ª2012 The Author
47insight into the mechanistic and structural details of this inter-
action and reveal additional factors that are employed by the
spliceosome to deposit the EJC.
EXPERIMENTAL PROCEDURES
Cell Culture, Plasmid Transfections, and siRNA Transfections
HeLa cells were grown and transfected with plasmid DNA or siRNA as previ-
ously described (Gehring et al., 2009a). For transfections of b-globin, TPI,
and TCR, we used 1.5 mg reporter plasmid, 1.5 mg LacZ-HBB control plasmid,
0.5 mg rescue plasmid, and 0.3 mg GFP expression vector. Transfections for
immunoprecipitations and 293 whole extracts were performed as previously
described (Gehring et al., 2009a).
RNA Extraction and Analysis
Total RNA was extracted with TRIzol and analyzed by Northern blotting as
previously described (Gehring et al., 2009a).
Immunoblot Analysis and Immunoprecipitation
FLAG-complexes were immunoprecipitated from RNase A (50 mg/ml)- or
RNase I (25 U/ml)-treated HeLa cell lysates with M2 anti-FLAG magnetic
beads (Sigma) at 4C for 2 hr in lysis buffer (50 mM Tris [pH 7.2], 150 mM
NaCl, 0.5% Triton X-100, + protease inhibitor). Beads were washed with lysis
buffer, and complexes were eluted with SDS-sample buffer, separated by
SDS-PAGE, and analyzed by immunoblotting.
In Vitro Transcription, In Vitro Splicing, and RNP
Immunoprecipitation
Capped transcripts were generated by in vitro transcription with SP6 RNA
polymerase in the presence of a32P-GTP and cap analog (Promega). In vitro
splicing reactions were performed in HeLa cell nuclear extract (CIL Biotech)
that was supplemented with 293 whole-cell extracts (Gehring et al., 2009a).
FLAG immunoprecipitations of RNPs were performed with FLAG-M2 affinity
gel in mRNP IP buffer (20 mM HEPES KOH [pH 7.9], 200 mM NaCl, 2 mM
MgCl2, 0.2% Triton X-100, 0.1% NP-40, 0.05% Na-Deoxycholate). RNAs
were recovered by TRIzol extraction and analyzed by denaturing PAGE.
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49EXTENDED EXPERIMENTAL PROCEDURES
Plasmids
Plasmid constructs MINX, MINX-GG, b-globin wt, pCI-FLAG, pCI-V5, and expression vectors for eIF4A3 and BTZ(110-372) were
described previously (Gehring et al., 2009a; Gehring et al., 2009b). TPI (synthetic gene, Geneart) and TCR (kindly provided by Miles
Wilkinson) reporter constructs were cloned into pCI-neo and fused at their 30end to a b-globin 30UTR sequence to enable detection by
a b-globin probe. The LacZ-HBB control plasmid was generated by inserting a b-globin 30UTR sequence to pcDNA4/TO/lacZ. Full
length CWC22 cDNA was obtained by RT-PCR using total HeLa cell RNA and inserted into pCI-neo-FLAG. Mutants of eIF4A3 and
CWC22 were generated by site-directed mutagenesis. All constructs were verified by DNA sequencing.
siRNA Transfection
The siRNA target sequences for CWC22 are 50-AAAGTAGTGTGGCACAGATAA-30 (siRNA CWC[A]) and 50-CTCGCACTGGTGGAG
CATATA-30 (siRNA CWC[B]). For the complementation of the CWC22 depletion 0.5 mg of a siRNA insensitive CWC22 expression
plasmid was transfected together with the reporter plasmid. This construct was generated by replacing the siRNA CWC(A) targeting
sequence 50-AAA AGT AGTGTGGCACAG ATA AAA-30 (codons 2-9 of the CWC22 ORF) by the resistant sequence 50-AAA TCA TCA
GTG GCC CAA ATC AAA-30.
Antibodies
The antibodies against CWC22, Y14, FLAG and V5 were from Sigma, the antibodies against MAGOH and eIF4A1 were from Abcam.
The eIF4A3 polyclonal antibody was made by GenScript with an N-terminal peptide of eIF4A3. The CBP80 antibody was kindly
provided by Elisa Izaurralde.
Protein Preparation
Codon-optimized eIF4A3 with an N-terminal Strep-tag was inserted into pET51 (Novagen). Y14 with a C-terminal Strep-tag and
MAGOH were cloned into MCS1 and MCS2 of pETDuet-1 (Novagen), respectively. The SELOR domain of BTZ (residues 110-372)
with a C-terminal Strep-tag, with or without an N-terminal FLAG-tag was inserted into pETDuet-1. Three fragments of CWC22 con-
taining the MIF4G domain (residues 110-665, 110-409 or 340-665) were cloned into pGEX6P3 (GE Healthcare).
Recombinant proteins were expressed in E.coli BL21 star or Rosetta II pLysS over night at 28C in autoinduction medium (Studier,
2005). Strep-eIF4A3, MAGOH/ Y14-Strep, FLAG-BTZ (110-372)-Strep and BTZ (110-372)-Strep were purified on a StrepTactin
Superflow Plus Cartridge (QIAGEN). GST-CWC22 (110-409), GST-CWC22 (110-665) and GST-CWC22 (340-665) were purified on
a GSTrap FF (GE Healthcare) column. Proteins were concentrated by ultrafiltration and stored in EJC binding buffer (20mM HEPES
KOH (pH7.9), 125mM NaCl, 1mM MgCl2, 2mM CaCl2, 1mM DTT, 2.5% Glycerol, 0.1% NP-40).
Binding Assays with Recombinant Proteins
For in vitro EJC assembly, recombinant proteins (15mg each), 0.5mmole AMP-PNP and 1nmole poly(U)15 ssRNAwheremixed in a total
volume of 60ml EJC binding buffer and incubated over night at 4C. FLAG-immunoprecipitations were performed with FLAG-M2
magnetic beads (Sigma) in EJC binding buffer for 2 hr at 4C. Precipitated complexes were elutedwith SDS-sample buffer, separated
by SDS-PAGE and visualized by Coomassie staining. When indicated, binding was performed in the absence of AMP-PNP and
ssRNA to prevent EJC formation.
For in vitro interaction studies, recombinant proteins (15mg each) weremixed in EJC binding buffer, preincubated 30min on ice and
immunoprecipitated with FLAG-M2 magnetic beads as described above.
Quantitative RT-PCR
Quantitative RT-PCR measuring SYBR Green incorporation was used to quantify pre-mRNA and mRNA expression levels of trans-
fected reporters (b-globin and TPI reporter constructs) and endogenous genes (b-actin (ACTB) and GAPDH). Expression of reporter
pre-mRNA and mRNA were normalized to the intronless APH 30 II (neomycin resistance gene) expressed from the pCI-neo plasmid.
To calculate the fold splicing inhibition, the pre-mRNA increase was divided by the mRNA reduction. Primer sequences were:
50-AAGGCTCATGGCAAGAAAG-30 and 50-ACACCAGCCACCACTTTCT-30 (b-globin mRNA)
50-AGTCCAAGCTAGGCCCTTT-30 and 50-ACACCAGCCACCACTTTCT-30 (b-globin pre-mRNA)
50-AGTTCTTCGTTGGGGGAAAC-30 and 50-CCACAGCAATCTTGGGATCT-30 (TPI mRNA)
50-CTGGAAGGCTCTTCGAGTTG-30 and 50-CCACAGCAATCTTGGGATCT-30 (TPI pre-mRNA)
50-ATACTTTCTCGGCAGGAGCA-30 and 50-TGAATGAACTGCAGGACGAG-30 (APH 30 II)
50-GGACTTCGAGCAAGAGATGG-30 and 50-AGCACTGTGTTGGCGTACAG-30 (ACTB mRNA)
50- AGAAAATCTGGCACCACACC-30 and 50-AACGGCAGAAGAGAGAACCA-30 (ACTB pre-mRNA)
50-GAGTCAACGGATTTGGTCGT-30 and 50-TTGATTTTGGAGGGATCTCG-30 (GAPDH mRNA)
50-GAGCTGGGGAATGGGACT-30 and 50-TGATGGCATGGACTGTGG-30 (GAPDH pre-mRNA)
S2 Cell Reports 2, 454–461, September 27, 2012 ª2012 The Authors
50Microscopy
HeLa cells were transfected with 100 ng of pCI-mVenus and 100 ng pCI-Kate2 plasmids. Cells were plated on coverslips 24 hr post
transfection. 48 hr after transfection cells were fixedwith 3.7% formaldehyde. Imageswere taken using FV1000 confocal microscope
(Olympus).
Protein-Complex Purification on Strep-Tactin Spin Columns
Proteins (15mg each) were pre-incubated for 30 min on ice and purified with the Strep-Tactin SpinPrep kit (Novagen) according to the
manufacturer’s instructions. Eluted proteins were separated by SDS-PAGE and stained with Coomassie.
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Figure S1. CWC22 Interacts with eIF4A3, Related to Figure 1
(A) Alignment of the protein sequences of human CWC22 (Q9HCG8) and NOM1 (Q5C9Z4). The alignment was generated using ClustalW and boxshade 3.21. The
red asterisks indicate the eIF4A3-binding residues at position 171/172 of CWC22. (B) FLAG-CWC22 and FLAG-CBP80 were immunoprecipitated from RNase I
treated cell lysates. Co-precipitated endogenous eIF4A3was detected by immunostaining with a specific antibody. Unfused FLAG served as negative control. (C)
FLAG-eIF4A3 and FLAG-eIF4A1 were immunoprecipitated as described in (B) and co-precipitated endogenous CWC22 detected by immunostaining with
a specific antibody. Unfused FLAG served as a negative control. (D) HeLa cells were transfected with plasmids expressing V5-eIF4A3 and V5-BTZ together with
FLAG-CWC22 (lane 2) or unfused FLAG (lane 1, negative control). Immunoprecipitation was performed as described in (B) and precipitated proteins were de-
tected by immunostaining with the indicated antibodies.
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Figure S2. Functional Analysis and Subcellular Localization of CWC22, Related to Figure 2
(A) Exon-intron structure of intron-containing reporter genes (b-globin, TPI), endogenous genes (ACTB, GAPDH) and the intronless neomycin-resistance gene
(APH 30 II) that were analyzed by quantitative RT-PCR (see Figure 2D). Arrows denote the binding sites of mRNA- and pre-mRNA-specific primers. Numbers
represent the lengths (in base pairs) of exons and introns.
(B) Expression levels of siRNA-resistant mVenus-CWC22R-constructs. CWC22-knockdown cells were co-transfected with the indicated concentrations of
plasmid expressing siRNA-resistant mVenus-CWC22R. Expression levels were analyzed by immunostaining with anti-CWC22-antibody. Luciferase siRNA was
used as a negative control; tubulin served as a loading control.
(C, D) Northern blot analyses of b-globin and TCR reporter mRNAs in CWC22-depleted cells.
(C) Cells were co-transfected with the b-globin reporter, siRNAs targeting Luciferase (lane 1) or CWC22 (lane 2,3 (siRNA[A]) and 4 (siRNA[B]) and mVenus-
CWC22R (lane 3) or unfused FLAG (lane 1, 2, 4). The mRNA and pre-mRNA was detected by Northern blotting with a specific probe. The asterisk denotes an
unspecific band. Bottom panel: Expression of CWC22 protein in knockdown and control cells was analyzed by immunostaining with a specific antibody.
(D) Cells were co-transfected with the TCR reporter, siRNAs targeting Luciferase (lane 1) or CWC22 (lane 2,3, siRNA[A]) and FLAG-CWC22R (lane 3) or unfused
FLAG (lane 1, 2). Northern blot analysis was performed as described in (C). The asterisk denotes an unspecific band.
(E) Expression levels of the indicated CWC22R-rescue constructs were analyzed by immunostaining with anti-FLAG-antibody.
(F) Subcellular localization of mVenus-CWC22 constructs. HeLa cells were grown on coverslips and transfected with plasmids expressing the indicated mVenus-
CWC22-constructs and Kate2-SC35 as amarker for nuclear speckles. Cells were fixed 48hrs post-transfection and analyzed by confocal microscopy. Images of
representative cells from each transfection were selected. Scale bar = 5mm. Full-lengths mVenus-CWC22 co-localizes with Kate2-SC35 in nuclear speckles
whereas mVenus-CWC22 (110-665) and mVenus-CWC22 (110-409) display a diffuse nuclear pattern. mVenus-CWC22 (340-665) is cytoplasmic.
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Figure S3. The Interaction of eIF4A3 and CWC22-MIF4G Features Characteristics of the eIF4A-eIF4G Complex, Related to Figure 3
(A) FLAG-immunoprecipitation of HeLa cell lysates expressing FLAG-tagged CWC22 or unfused FLAG (negative control) together with V5-tagged eIF4A3 (wt and
indicated mutants). Co-precipitation of V5-eIF4A3 was shown by immunostaining with anti-V5 antibody.
(B) Strep-pulldown of recombinant proteins. Strep-eIF4A3 and indicated GST-CWC22-versions were purified from E.coli, incubated in binding buffer and purified
on StrepTactin spin columns. Purified proteins were separated by SDS-PAGE and stained with Coomassie.
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Figure S4. CWC22 Is Not Required for In Vitro EJC Assembly, Related to Figure 4
(A) CWC22 impairs EJC assembly in vitro. Recombinant Strep-eIF4A3, BTZ (110-372)-Strep, MAGOH and Y14-Strep (lane 1) or FLAG-Y14 (1-154)-Strep (lanes 2,
3, 4) were incubated under EJC assembly conditions in the presence of GST-CWC22 (110-409) (lane 3) or GST-CWC22 (110-409/171DE) (lane 4). Protein
complexes were immunoprecipitated via FLAG. Precipitated proteins were separated by SDS-PAGE and stained with Coomassie.
(B) The mutated residues in eIF4A3 do not overlap with the interaction surfaces of Y14 or MAGOH. X-ray structure of the core EJC (PDB ID code 2JOS). Depicted
are eIF4A3 (orange), Y14 (cyan) and MAGOH (red). The residues of eIF4A3 (270-274(DLYD), 276/277(TI), 301-303(NFT)) that are required for CWC22-binding are
highlighted in red. BTZ binds at the opposite side of the eIF4A3 molecule and is not shown.
S6 Cell Reports 2, 454–461, September 27, 2012 ª2012 The Authors
54
Structural and functional analysis of the three
MIF4G domains of nonsense-mediated decay
factor UPF2
Marcello Clerici1,2, Aure´lien Deniaud1,2, Volker Boehm3, Niels H. Gehring3,
Christiane Schaffitzel1,2,* and Stephen Cusack1,2,*
1European Molecular Biology Laboratory, Grenoble Outstation, 6 rue Jules Horowitz, 38042 Grenoble Cedex 9,
France, 2Unit of Virus Host-Cell Interactions, University of Grenoble Alpes-EMBL-CNRS, UMI 3265,
6 rue Jules Horowitz, 38042 Grenoble Cedex 9, France and 3University of Cologne, Institute for Genetics,
Zuelpicher Street 47a, 50674 Cologne, Germany
Received July 16, 2013; Revised November 2, 2013; Accepted November 4, 2013
ABSTRACT
Nonsense-mediated decay (NMD) is a eukaryotic
quality control pathway, involving conserved
proteins UPF1, UPF2 and UPF3b, which detects
and degrades mRNAs with premature stop
codons. Human UPF2 comprises three tandem
MIF4G domains and a C-terminal UPF1 binding
region. MIF4G-3 binds UPF3b, but the specific func-
tions of MIF4G-1 and MIF4G-2 are unknown. Crystal
structures show that both MIF4G-1 and MIF4G-2
contain N-terminal capping helices essential for sta-
bilization of the 10-helix MIF4G core and that
MIF4G-2 interacts with MIF4G-3, forming a rigid
assembly. The UPF2/UPF3b/SMG1 complex is
thought to activate the kinase SMG1 to phosphoryl-
ate UPF1 in vivo. We identify MIF4G-3 as the binding
site and in vitro substrate of SMG1 kinase and show
that a ternary UPF2 MIF4G-3/UPF3b/SMG1 complex
can form in vitro. Whereas in vivo complementation
assays show that MIF4G-1 and MIF4G-2 are essen-
tial for NMD, tethering assays reveal that UPF2
truncated to only MIF4G-3 and the UPF1-binding
region can still partially accomplish NMD. Thus
UPF2 MIF4G-1 and MIF4G-2 appear to have a
crucial scaffolding role, while MIF4G-3 is the key
module required for triggering NMD.
INTRODUCTION
Nonsense-mediated mRNA decay (NMD) is a eukaryotic
mRNA quality control mechanism that recognizes
transcripts with premature termination codons (PTC)
and promotes their degradation. Thereby, NMD
protects the cell from the potentially deleterious effects
of C-terminally truncated proteins (1–6). In fact, 30%
of all known disease-causing mutations in humans involve
production of PTC-containing mRNAs (7). NMD also
contributes to regulate the abundance of several physio-
logical substrates, targeting 3–10% of the transcriptome in
different organisms (8–10).
Nine NMD protein factors, SMG1-9, have been
identiﬁed in most metazoans (11,12), and recently four
additional factors (SMG10, RUVLB1, RUVBL2 and
RPB5) have been added to the components of the NMD
machinery (13). The three UPF (UP-Frameshift) proteins,
UPF1 (SMG2), UPF2 (SMG3) and UPF3 (SMG4) con-
stitute the conserved core of NMD and are found in
almost all eukaryotes with a few possible exceptions
among protists (14–16), suggesting an ancient evolution-
ary origin for NMD. UPF1 is an ATP-dependent RNA
helicase that is directly involved in the recognition of
terminating ribosomes stalled at a PTC (17–19). Human
UPF2 (Q9HAU5) is an 140 kDa protein containing
three conserved MIF4G (Middle portion of eIF4G)
domains that are found in a number of proteins
involved in RNA metabolism and translation such as
the nuclear cap-binding protein CBP80 and eIF4G
(eukaryotic initiation factor 4-gamma) (20). UPF2 inter-
acts via its third MIF4G domain with UPF3b and via its
C-terminal extremity with UPF1, thus forming the central
component of the ternary complex of UPF proteins
(21–23). UPF3b stably binds the exon junction complex
(EJC) (24–26), which is deposited by the splicing machin-
ery on the mRNA 24 nt upstream of the exon
boundaries. The EJC functions as an enhancer of NMD
*To whom correspondence should be addressed. Tel: +33 476207238; Fax: +33 476207199; Email: cusack@embl.fr
Correspondence may also be addressed to Christiane Schafﬁtzel. Tel: +33 476207505; Fax: +33 476207199; Email: bschaff@embl.fr
The authors wish it to be known that, in their opinion, the ﬁrst two authors should be regarded as Joint First Authors.
Published online 23 November 2013 Nucleic Acids Research, 2014, Vol. 42, No. 4 2673–2686
doi:10.1093/nar/gkt1197
 The Author(s) 2013. Published by Oxford University Press.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/), which
permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
 at D










efﬁciency in mammals (27–29) probably by serving as a
recruitment platform for UPF3b (22,24,26) and UPF2
after mRNA export to the cytoplasm (16,30).
Ribosomes stalled at a PTC are recognized by the NMD
factors UPF1 and SMG1 to form the transient SURF
complex, which consists of SMG1-UPF1-eRF1/3 a,
SMG8 and SMG9 (12,19). SMG1 is an 415-kDa
serine/threonine-protein kinase, essential for NMD in
human and Caenorhabditis elegans (31), that belongs to
the phosphatidylinositol 3-kinase–related kinase (PIKK)
protein family (32). The EM structure of SMG1 in
complex with SMG9 has been reported at 24 A˚ showing
a characteristic head and arm architecture as observed
previously for DNA-PKcs, another member of the
PIKK family (33). Interaction of the SURF complex
with NMD factors UPF2 and UPF3b positioned on a 30
EJC is suggested to activate SMG1 to phosphorylate
UPF1 in the ‘decay-inducing complex’ (DECID). UPF1
phosphorylation by SMG1 in the DECID leads to trans-
lation termination and dissociation of eRF3a from UPF1
(12,19). In addition, NMD factors SMG5-7 are recruited,
which promote mRNA decay (34,35) and ultimately
dephosphorylation of UPF1 (36). A major role in the
interaction between the SURF and UPF2/3b-EJC
complexes is played by UPF2 binding to UPF1. This inter-
action is mediated by the intrinsically disordered C-
terminal extremity of UPF2, which structures on binding
to the CH-rich domain of UPF1 (15). Moreover, an inter-
action between UPF2 and the SMG1 C-terminal region
containing the kinase domain has been reported (19).
A recent cryo-EM structure of the UPF1/2/3-EJC
complex indicates that UPF2 acts as a central scaffolding
protein with a ring-like arrangement of the MIF4G
domains (37). According to the quasi-atomic model,
UPF2 forms the crucial contacts with UPF1, UPF3b
and the EJC and positions UPF1 toward the 30-end of
the mRNA where it could exert its helicase activity
during mRNA degradation (37). High-resolution struc-
tural information of UPF2 is limited to the structure of
the MIF4G-3 domain in complex with the RNP domain of
UPF3b (16) and the UPF1-binding region in complex with
UPF1 (15). The latter is separated from MIF4G-3 by a
conserved low-complexity acidic region (88 residues,
50% Asp/Glu, indicated as LR3 in Figure 1A), which
is likely to be disordered (15,23,38). Neither the structure
nor the particular roles of the ﬁrst two MIF4G domains of
UPF2 are known. MIF4G domains have a conserved 3D
structure, comprising an elongated bundle of antiparallel
helices, despite high sequence divergence. They are
thought to serve as molecular platforms for the recruit-
ment of interaction partners (20,39–42) but could also be
molecular spacers or scaffolds to correctly position distant
functional regions.
Here, we present the atomic resolution crystal structures
of the N-terminal (MIF4G-1) and middle (MIF4G-2)
domains of UPF2 and a lower resolution crystal structure
of the combined UPF2 MIF4G-2/MIF4G-3 domains.
These structures allow a reﬁnement of the quasi-atomic
model of the entire UPF-EJC complex. Furthermore, we
test the importance of UPF2 MIF4G-1 and MIF4G-2
domains for NMD in vivo and identify the UPF2
MIF4G-3 domain as the SMG1 interaction site. We also
show that SMG1 kinase phosphorylates UPF2 MIF4G-3
domain in vitro, mainly at the serine residue 1046. In vivo,
however, the UPF2 mutation S1046A did not interfere
with NMD in complementation experiments. These
results highlight the central role of the UPF2 MIF4G-3
domain in the DECID complex since it interacts with both
UPF3 and SMG1 kinase, perhaps activating the latter to
phosphorylate UPF1.
MATERIALS AND METHODS
Full methods are given in the Supplementary Material.
Crystallographic data collection and structure
determination
Crystallographic statistics are given in Supplementary
Table S1. All data collection was performed at 100K at
the European Synchrotron Radiation Facility. The data
were integrated with XDS (43) and analyzed with CCP4i.
Molecular replacement was performed with PHASER
(44), model building with COOT (45) and reﬁnement
with REFMAC5 (46,47). The structures of both
MIF4G-1 and MIF4G-2 were solved de novo by
selenomethionine (SeMet) Single Anomalous Dispersion
(SAD), using SHELXD (48) to ﬁnd sites and SHARP
(49) for reﬁnement and phasing. For the low-resolution
combined MIF4G-2/MIF4G-3 domain structure, molecu-
lar replacement using PHASER (44) using the individual
domains, gave an unambiguous unique solution with log
likelihood gain of 220. This was conﬁrmed by correspond-
ence of predicted methionine positions with anomalous
difference peaks using data from MIF4G-2/MIF4G-3
crystals grown with SeMet. Due to the low resolution,
no further reﬁnement was performed.
Generation of the quasi-atomic UPF-EJC model
Starting from the EM reconstruction of the UPF-EJC
complex (EMD-2048) and the corresponding quasi-
atomic model [Melero et al. (37)], we replaced the UPF2
MIF4G domains and the UPF3b RNA-recognition motif
(RRM) domain by our crystal structure of MIF4G-1
domain and by the MIG4G-2/3/UPF3b RRM complex.
We used Chimera (50) to obtain the best correlation coef-
ﬁcient for the placement of the domains into the density.
To avoid a clash with MIF4G-1 and MIF4G-2 (both are
larger than the MIF4G homology model used in the
original atomic model), the EJC had to be moved by
14 A˚ away from UPF2. Similarly, the UPF1 CH-domain
was moved by 5 A˚ away from UPF2 MIF4G-3
(Supplementary Figure S7). The ﬁgures were generated
with PyMOL (DeLano Scientiﬁc). In the rendering of
the cryo-EM map, the density cutoff was set for the
display of the envelope to represent 130% of the a
priori estimated volume.
In vivo NMD assays
UPF2 tethering assay with the b-globin 4MS2 construct
and the transfection control (wt300+e3) were described
previously (24,51). For NMD rescue experiments, HeLa
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cells were transiently transfected with 100 pmol siRNA
targeting UPF2 or luciferase. On the next day, cells were
split 1:2 into 10-cm plates and 24 h later transfected with
200 pmol siRNA. The next day, cells were transfected by
calcium phosphate precipitation with GFP and siRNA
resistant UPF2 expression plasmids and with the
plasmid encoding the reporter mRNA (TPI-HBB) (52).
Surface plasmon resonance
Surface plasmon resonance (SPR) experiments were
performed on a BIAcore 3000 using SA sensor chips
(GE-Healthcare). One ﬂow cell was not functionalized to
be used as a background control. The second ﬂow cell was
functionalized with puriﬁed SMG1 to a density of 2000
RU. UPF2/UPF3b solutions were injected at 25 ml/min
during 3 or 4min followed by a 10-min dissociation
phase. The surfaces were regenerated by 1-min injection
of 0.5M and 1M NaCl solutions. The data were
analyzed with the Biacore evaluation software by subtract-
ing both the control ﬂow cell and the buffer injection curve.
Apparent equilibrium dissociation constant (KD-app) were
determined using the RU values measured 10 s before the
end of the association phase for all curves (RUmax). These
RUmax were plotted as a function of protein concentration
and ﬁtted assuming a one binding site model.
Data deposition
Coordinates and structure factors for the UPF2 MIF4G-1
and MIF4G-2 domains are deposited in the Protein Data
Bank with accession codes 4CEM and 4CEK, respectively.
RESULTS
For structural studies of human UPF2 we initially used a
construct comprising residues 121–1031 that encompasses
all three predicted MIF4G domains but excludes the N-
terminal low-complexity region (indicated as LR1 in
Figure 1A) and the C-terminal acidic region as well as
UPF1 binding domain (U1BD) (Figure 1A). UPF2(121–
1031) was expressed in Escherichia coli, puriﬁed and
subjected to crystallization trials, but no hits were
obtained. Limited proteolysis of UPF2 (121–1031) led to
the identiﬁcation of three proteolytically stable fragments
(one of 30 kDa and two of 45 kDa), each starting
from residue 121 as determined by N-terminal sequencing
(Supplementary Figure S1A). This information combined
with sequence conservation and secondary structure
[NPS@, (53)] and disorder [DisEMBL, (54)] predictions
provided the basis for the design of different UPF2 con-
structs comprising a single MIF4G domain or two
domains in tandem. Three well-behaved constructs were
successfully crystallized: (i) residues 121–486 encompass-
ing the MIF4G-1 domain, (ii) residues 455–757 encom-
passing the MIF4G-2 domain and (iii) the combined
MIF4G-2/MIF4G-3 domains (residues 455–1054)
(Supplementary Figure S1B). We solved the structure of
UPF2 MIF4G-1 and MIF4G-2 domains at 2.6 and 2.4 A˚
resolution, respectively (Figure 1B and C), using SAD on
seleno-methionine substituted protein crystals.
Subsequently, the structure of the combined MIF4G-2/
MIF4G-3 domains was determined at 5.4 A˚ resolution
using molecular replacement. Crystallographic data are
summarized in Supplementary Table S1.
UPF2 MIF4G-1 domain has an extended coiled coil and
two capping helices
UPF2 MIF4G-1 contains the canonical 10-helix core
MIF4G fold (residues 168–429) with ﬁve pairs of antipar-
allel a-helices forming an N-terminal four-helix bundle
(helices h1–h4) and two parallel layers composed of
three helices each (helices h5–h10) (Figure 1B and struc-
ture annotated sequence alignment in Supplementary
Figure S2). In addition, the domain displays three inter-
esting features: (i) helices h9 and h10 are highly elongated
at their C- and N-terminus, respectively, to form a long
coiled coil that protrudes away from the rest of the
domain into the solvent, the loop at the extremity being
poorly ordered but still possible to be modeled (Figure 1B,
Supplementary Figure S3A); (ii) an additional helix (h8i)
is inserted between helices h8 and h9 via two extended
loops (residues 324–344) (Figure 1B, Supplementary
Figure S3B); (iii) the core MIF4G fold is preceded at the
N-terminus by an extended a-helix (hA, residues 121–149)
followed by a loop and a second shorter a-helix (hB) con-
necting to helix h1 (residues 150–167) (Figure 1B); the N-
terminus of helix hA is packed against helix h8i (Figure 1B
and Supplementary Figure S3B and C).
MIF4G-1 helices hA, hB as well as their adjacent loops
make extensive contacts with the 10-helix MIF4G core
domain, in particular with helices h4, h6 and h8
(Figure 2A and B). This packing involves both hydropho-
bic and charged interactions. Notably, Arg137 and Arg141
on hA form hydrogen bonds and salt bridges with Asp317
and Glu271 on the core MIF4G domain, and Leu144 on
hA interacts with Val223 and Val275 on h4 and h6, respect-
ively (Figure 2A). Pro156, Phe160, Phe161 and Leu164 on
hB form a hydrophobic patch interacting with Arg232
and Tyr233 on helix h4 (Figure 2B). Helix h8i and its
adjacent loops pack against the MIF4G domain as well,
establishing extensive hydrophobic and charged inter-
actions with helices h6, h7, h8 and h9 (Supplementary
Figure S3B). Helix h8i stabilizes the N-terminus of helix
hA with mainly hydrophobic interactions (Supplementary
Figure S3B). Overall, helices hA, hB and h8i create an
extensive network of interactions with the 10 conserved
helices of MIF4G-1 core MIF4G domain.
A highly conserved motif, 164-LDSSLKKNT-172
(Supplementary Figure S2), is located on the ﬁrst turn of
h1 and the loop immediately preceding it (Figure 2C and
D). Mapping of phylogenetically conserved residues on
the solvent-accessible surface of MIF4G-1 shows that
the motif and a series of downstream conserved charged
residues (Lys176, Lys177, Lys179, Asp192, Lys200,
Glu204 and Glu211, Supplementary Figure S2) deﬁne a
conserved patch at one extremity of the domain
(Figure 2C). Asp165 and Lys170 side chains establish a
salt bridge, while Ser167 N-terminally caps h1 by forming
a hydrogen bond with the backbone amino group of
Lys170, both contributing to ﬁx the 3D conﬁguration of
the motif. Absolutely conserved Ser166, on the other
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hand, is solvent exposed and does not interact with other
residues. Phosphorylation of one or both of the serines in
this conserved motif has been reported to be required for
NMD in yeast [(55), see discussion].
Residues 430–486 at the C-terminus of the MIF4G-1
crystallization construct are disordered in the crystal struc-
ture. This is consistent with the fact that the folded part of
MIF4G-2 starts at residue 458 (see below), the region 430–
457 being a ﬂexible connecting loop betweenMIF4G-1 and
MIF4G-2 (indicated as LR2 in Figure 1A) that is predicted
to be disordered by DisEMBL and NPS@.
N-terminal capping helices also occur in the UPF2
MIF4G-2 domain
The crystal structure of UPF2 MIF4G-2 (residues
455–757) shows that the core MIF4G fold of 10 antipar-
allel helices (residues 561–756) (Figure 1C) is preceded by
an 100 amino acid region (residues 458–560) that
contains additional elements essential for stability. The
ﬁrst part of this N-terminal region (458–478) folds into
two short a-helices (hA and hB), which together with
the connecting loops pack against helices h2, h4, h6 and
Figure 1. Crystal structures of UPF2 MIF4G-1 and MIF4G-2 domains. (A) Schematic representation of UPF2 indicating the domain boundaries
(gray) of the conserved MIF4G domains according to SMART prediction. Colors (green, blue and pink) mark regions of the MIF4G domains that
are not part of the classical 10-helix MIF4G domain fold. U1BD indicates the UPF1 binding domain. The N-terminal acidic low complexity region
(residues 1–120) is indicated as LR1 (Linker Region 1). The disordered loop connecting MIF4G-1 and MIF4G-2 (residues 430–457) is indicated as
LR2. The C-terminal acidic low complexity region (residues 1016–1104) connecting MIF4G-3 with U1BD is indicated as LR3 (B) Structure of
MIF4G-1. The 10 helices (gray) of the classical MIF4G domain fold are numbered from 1 to 10. The N-terminal extension of the domain that folds
into two helices (hA and hB) and the additional helix (h8i) inserted between h8 and h9 are depicted in green. The elongated helices h9 and h10 form
a long coiled coil projecting from the otherwise compact domain. (C) Structure of MIF4G-2. The helix annotation is as in B with the N-terminal
extension depicted in blue. It folds into three helices (hA, hB and hC), which are connected by partially disordered loops (shown as dashed lines).
The long disordered loop between residues Ala480 and Thr529 is not represented.
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h8 (Figure 3A and B). The interaction is mainly hydro-
phobic, involving Ile458, Trp459, Phe467 and Tyr468 of
helix hA and Pro620, Phe621, Phe676 and Phe713 of h4,
h6 and h8 (Figure 3A). Two salt bridges are also estab-
lished between Glu460 and Arg712 and Arg716 on helix
h8 (Figure 3A). Helix hB and its adjacent loops pack
against helices h2 and h4 via hydrophobic interactions
(Figure 3B). Residues 481–558 following helix hB are
largely disordered in the crystal structure (apart from
the short helix hC) and indeed this region is highly
variable between species (Supplementary Figure S2).
Similar to MIF4G-1, the N-terminal region stabilizes the
interhelical packing of the MIF4G-2 domain helices. In
fact, residues 458–478 are evolutionarily conserved
within UPF2 (Supplementary Figure S2), and the expres-
sion of MIF4G-2/3 constructs lacking this capping region
yields mostly insoluble protein (Supplementary
Figure S3D). Notably, superposition of MIF4G-1 and
MIF4G-2 shows that the capping helices hA and hB in
the two domains pack against the same region of helices
h2, h4, h6 and h8 (Supplementary Figure S4A).
Interaction of MIF4G-2 with MIF4G-3
We solved the structure of the combined MIF4G-2/
MIF4G-3 domains by molecular replacement at 5.4 A˚
resolution, using the two separate domains as search
models (Figure 4A). To validate this structure we also col-
lected anomalous scattering data on seleno-methionine-
substituted MIF4G-2/MIF4G-3 crystals. The position of
the methionine residues in the molecular replacement two
domain model coincided with the selenium atoms revealed
in the anomalous difference map, conﬁrming the place-
ment of the MIF4G-2 and MIF4G-3 domains
(Supplementary Figure S5). The structure of the
combined MIF4G-2/MIF4G-3 domains reveals a rigid
assembly with the two domains being orthogonally
oriented with respect to each other (Figure 4A). The
buried surface area is estimated to be 750 and 639
A˚2 for MIF4G-2 and MIF4G-3, respectively. The
domains are connected via a short 11-amino acid-long
linker (residues 757–767), which stretches the 23 A˚
distance between the C-terminus of MIF4G domain 2
and the N-terminus of MIF4G domain 3. The interaction
Figure 2. Interaction of the capping helices and adjacent loops with the MIF4G-1 core domain. Helix annotation and color code as in Figure 1B.
(A) Helix hA interacts tightly with helices h4, h6 and h8 of the core domain. Amino acids involved in the interaction are shown in stick represen-
tation. The interaction involves hydrophobic interactions, hydrogen bonds and salt bridges. Notably, glutamate (E271) of the conserved FIGEL
signature motif of MIF4G domains in helix h6 interacts with arginine 141 of helix hA. (B) Helix hB and its N-terminal loop interact via hydrophobic
residues with the C-terminal tip of helix h4 of the conserved MIF4G fold. (C) Mapping of phylogenetically conserved residues on the solvent-
accessible surface of MIF4G-1 based on the sequence alignment displayed in Supplementary Figure S2. Highly conserved residues (depicted in red)
form a patch around the N-terminus of helix h1. For clarity a cartoon representation of MIF4G-1 in the same orientation is given in Supplementary
Figure S3C. (D) Sequence alignment of the highly conserved 164-LDSSLKKNT-172 motif of UPF2 from representative species from yeast to human
(left panel); 3D organization of residues 165–170 adjacent to helix h1 at its N-terminus (right panel).
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is mediated mostly by MIF4G-2 helix h9, which inserts in
a concave surface created by MIF4G-3 helices h6, h8 and
h10 (Figure 4B).
The N-terminal part of MIF4G-2 helix h9 contacts the
loop between MIF4G-3 helices h9 and h10 as well as the
N-terminal part of helix h10. The C-terminal part of
MIF4G-2 helix h9 interacts with the N-terminus of
MIF4G-3 helix h4 (Figure 4B). An additional interaction
is visible between the C-terminus of MIF4G-2 helix h10
and the N-terminus of MIF4G-3 h6.
The MIF4G-3 surface involved in the contact with
MIF4G-2 is located opposite to the UPF3 binding site
and therefore does not interfere with the UPF2-UPF3
interaction (Supplementary Figure S6). Superposition of
MIF4G-3 in the UPF2/UPF3b complex (16) and in the
MIF4G-2/MIF4G-3 structure indicates that the UPF3
RRM does not contact the UPF2 MIF4G-2 domain
(Supplementary Figure S6).
UPF2 MIF4G domain arrangement in the context of the
UPF-EJC complex
Recently, a cryo-EM structure of the UPF1/2/3-EJC
complex has been determined and used to derive a
quasi-atomic model of the entire complex using previously
known crystal structures of UPF1 bound to UPF2-U1BD,
UPF2 MIF4G-3 bound to UPF3b RRM and the RNA-
bound EJC (37). The UPF2 MIF4G-1 and MIF4G-2
domains were modeled only as core MIF4G domains.
The results suggest that the MIF4G domains of UPF2
adopt, together with the UPF1 zinc-knuckle (CH)
domain, a ring-like structure, which forms the central
scaffold for complex assembly (37). We placed the
crystal structure of MIF4G-1 and the MIF4G-2/3
assembly into the EM density of the UPF-EJC complex
(EMD-2048) using Chimera (50) (Figure 4C,
Supplementary Figure S7). The updated quasi-atomic
Figure 4. Crystal structure of combined MIF4G-2 and MIF4G-3
domains of UPF2. (A) Overview showing the perpendicular orientation
of the two interacting domains with MIF4G-2 in blue and MIF4G-3 in
pale pink. The 2mFo-DF electron density obtained by molecular re-
placement (at 5.4 A˚ resolution and contoured at 1s) within 3 A˚ from
the MIF4G-2 and MIF4G-3 domains coordinates is depicted as a gray
mesh. The dotted line represents the 10 residues linking h10 of MIF4G-
2 to h1 of MIF4G-3. (B) Close-up of the interacting helices. Helix h9 of
MIF4G-2 inserts into a cavity formed by helices h6, h8 and h10
of MIF4G-3. The N-terminal part of MIF4G-2 h9 interacts also with
h4 of MIF4G-3 (left panel). Helix h10 of MIF4G-2 contacts h6 of
MIF4G-3 as evidenced by the connecting electron density between
the two helices (right panel). (C) Reﬁned quasi-atomic model of
human UPF2 using the UPF2 C-terminus [Clerici et al. (15)], UPF2
MIF4G-1 (this study) and MIF4G-2/MIF4G-3 (this study) crystal
structures into the cryo-EM reconstruction of the UPF1/2/3-EJC
complex [EMD-2048, Melero et al. (37)]. The table summarizes the
UPF2 domain boundaries, the distances between the UPF2 domains
in the quasi-atomic model as well as the length of the linker peptides
that connect these domains with the subsequent domain.
Figure 3. Interaction of the capping helices and adjacent loops with
the MIF4G-2 core domain. Helix annotation and color code as in
Figure 1C. (A) Helix hA and its N-terminal loop interact with helices
h4, h6 and h8 of the core domain. Amino acids involved in the inter-
action are shown in stick representation. The interaction involves
hydrophobic interactions, hydrogen bonds and salt bridges. Notably,
glutamate (E672) of the conserved FIGEL signature motif in helix h6
interacts with tyrosine 468 of helix hA. (B) Helix hB and its adjacent
loops interact via hydrophobic residues with helix h2 and h4 of the
conserved MIF4G core.
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model indicates that (i) the long coiled coil formed by
helices h9 and h10 protruding from MIF4G-1 is in close
proximity to and could contact the EJC, (ii) the loop
between h9 and h10 contacts MIF4G-2 and (iii) the
MIF4G-2 domain is positioned close to the Y14 subunit
of the EJC likely forming a contact (Supplementary
Figure S7). In conclusion, these observations support the
proposed scaffolding function of UPF2 MIF4G domains
(37) and indicate that UPF2 MIF4G-1 and MIF4G-2
domains are responsible for the positioning of the EJC
in the UPF-EJC complex.
Role of MIF4G domains 1 and 2 on NMD in vivo
To evaluate the role of MIF4G-1 and MIF4G-2 in NMD
we performed a UPF2 complementation assay in HeLa
cells. In this assay the abundance of a NMD-competent
triosephosphate isomerase (TPI) reporter mRNA
harboring a PTC at position 48 is measured on siRNA
silencing of endogenous UPF2 and rescue by transfection
with different siRNA insensitive UPF2 expression con-
structs. Four UPF2 MIF4G-1 and/or MIF4G-2 deletion
mutants were generated (Figure 5A): UPF2 M1 and
UPF2 M2, lacking the core MIF4G-1 domain
(residues 168–431) and the core MIF4G-2 domain
(residues 569–758), respectively; UPF2 N/M1 lacking
MIF4G-1 and the preceding N-terminal region (residues
1–455) and UPF2 N/M1M2 lacking MIF4G-1, MIF4G-
2 and the preceding N-terminal region (residues 1–757).
All four constructs are impaired in their ability to support
NMD (Figure 5B lane 7–10 and Figure 5C) compared
with wild-type UPF2 (Figure 5B lane 3 and Figure 5C).
We noticed that these mutants show enhanced expression
levels compared with wild-type UPF2 (Figure 5B), sug-
gesting that their inability to support NMD is not the
result of decreased protein stability. We also excluded
that this effect is due to altered cellular localization
since all the tested mutants localize in the cytoplasm as
wild-type UPF2 (Supplementary Figure S8A). Next, we
veriﬁed that the UPF2 mutants retained the ability to
co-immunoprecipitate UPF1 and UPF3 (Figure 5D).
Taking into account the differences in expression levels,
UPF2M1 andM2 show a virtually unaltered ability to
interact with UPF1, whereas UPF2 N/M1 and N/
M1M2 show enhanced co-immunoprecipitation of UPF1
(Figure 5D). UPF3 binding is unaltered in all four
mutants. Altogether, these results demonstrate the essen-
tial role of MIF4G-1 and MIF4G-2 during NMD for
reasons independent of protein stability, cellular
localization or UPF3 and UPF1 binding. We also
noticed that in the presence of these UPF2 constructs
the reporter mRNA levels are higher than in the absence
of transfected UPF2 (Figure 5B, lane 2 and Figure 5C).
This dominant negative effect is likely due to the UPF2
mutants sequestering endogenous UPF1 and UPF3 and
thus further reducing NMD in addition to endogenous
UPF2 silencing.
We used the same UPF2 deletion constructs in a NMD
tethering assay (24,51). In this assay, UPF2 is directly
tethered to a beta-globin mRNA downstream of the
PTC, thus bypassing the need for the interaction of
UPF2 with UPF3-EJC for its recruitment to the mRNA.
In this assay UPF2 M1, N/M1 and N/M1M2 are
able to support NMD with a partial impairment
(Figure 5E lane 6–8 and Figure 5F) compared with wild-
type UPF2 (Figure 5E lane 2 and Figure 5F). This indi-
cates that when UPF2 is directly tethered to the mRNA,
MIF4G-1 and MIF4G-2 are partially dispensable for its
downstream interaction with the SURF complex and
the triggering of UPF1 phosphorylation. Surprisingly,
the UPF2 M2 construct appears to be completely
inactive in the tethering assay (Figure 5E lane 9 and
Figure 5F). This is unexpected since the lack of the
MIF4G-2 domain in the UPF2 N/M1M2 construct
did not severely affect NMD. Thus, the mere absence of
MIF4G-2 cannot explain the failure of UPF2 M2 to
support NMD. Rather, the unusual proximity, in this con-
struct, of the MIF4G-1 domain to the MIF4G-3 and
UPF1 binding domains, may sterically interfere with
UPF1 and SMG1 binding, thus affecting NMD.
The ﬁtting of the UPF2 MIF4G domains in the EJC-
UPF envelope (Supplementary Figure S7) suggests that
the MIF4G-1 coiled coil contacts the EJC, thus possibly
having a key role in the stabilization of the EJC-UPF
complex. To test this possibility, we designed a UPF2 con-
struct (coiled coil) where the protruding region of
MIF4G-1 coiled coil (residues 370–406) is replaced by a
short linker (Ala-Gly-Gly-Gly-Ala) (Figure 5A). Both in
the NMD complementation (Figure 5B lane 6 and
Figure 5C) and tethering assay (Figure 5E, lane 5 and
Figure 5F), the loss of MIF4G-1 coiled coil does not inter-
fere with NMD, suggesting that this is not the only region
involved in stabilizing the EJC-UPF complex.
SMG1 binds and phosphorylates UPF2 MIF4G-3
Previous work suggested that the UPF1 kinase SMG1 also
interacts with UPF2 (19). We therefore tested whether
various truncated UPF2 constructs are able to interact
with full-length recombinant SMG1 by SPR. Wild-type
SMG1 was immobilized via an N-terminal SBP-tag onto
a streptavidin sensor chip, and the UPF2 constructs were
injected. First, we determined the apparent dissociation
constant KD-app using UPF2 containing all three MIF4G
domains and the UPF1 binding domain (residues
121–1227). This measurement conﬁrmed that SMG1 and
UPF2 tightly interact with a KD-app of 37±5nM
(Figure 6A). Subsequently, we asked which UPF2
domain interacts with SMG1. To this end, we tested the
individual MIF4G domains as well as UPF2 constructs
carrying different combinations of MIF4G domains. We
were able to demonstrate that MIF4G domain 3 is sufﬁ-
cient for SMG1 interaction. In contrast, MIF4G-1 and
MIF4G-2 do not show binding to SMG1 (Figure 6B).
Moreover, we measured for the MIF4G-3/SMG1
complex a KD-app of 60±5nM (Supplementary Figure
S9A), which constitutes a <2-fold reduction compared
with the KD-app of 37±5nM obtained for UPF2
(121–1227) and SMG1. These results strongly suggest
that MIF4G-3 is the main determinant for UPF2-SMG1
complex formation.
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Figure 6. Characterization of the UPF2-SMG1 interaction. (A) Overlay of SPR sensograms of UPF2(121–1227) comprising all three MIF4G
domains (above) interacting with immobilized SMG1. UPF2 (121–1227) was injected at concentrations ranging from 2.5 to 200 nM. The maximal
resonance unit signal was plotted against the UPF2 concentration (below); the data points result from three independent experiments. The apparent
dissociation constant KD-app was determined assuming a 1:1 interaction of SMG1 and UPF2. (B) SPR interaction proﬁle of different UPF2
constructs with immobilized SMG1. All UPF2 constructs were injected at a concentration of 10 nM. UPF2 constructs containing the MIF4G-3
domain are labeled with red text color. Noninteracting constructs containing MIF4G-1 and/or MIF4G-2 are labeled with black text color.
(C) In vitro phosphorylation experiments of UPF2 MIF4G constructs with SMG1 kinase. SMG1 was mixed with different UPF2
MIF4G domain constructs and with UPF1 as a positive control. The reaction mixture was analyzed by SDS-PAGE and Pro-Q Diamond
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Next, we investigated whether SMG1 is able to phos-
phorylate UPF2 MIF4G domains in vitro. We found that
MIF4G-3, but not MIF4G-1 and MIF4G-2, is signiﬁ-
cantly phosphorylated by SMG1 in the presence of ATP
(Figure 6C). MIF4G-3 shows about three times less phos-
phorylation as measured by Pro-Q staining compared
with the known SMG1 substrate UPF1, which served as
a positive control (Figure 6C). UPF1 has up to ﬁve Ser/
Thr phosphorylation sites, which are recognized by SMG1
in vivo and in vitro (56). UPF2 (121–1227) carrying all
three MIF4G domains is phosphorylated to a similar
extent as MIF4G-3. We performed large-scale phosphor-
ylation of UPF2 MIF4G-3, to purify the in vitro
phosphorylated form. The pure domain was then sub-
jected to mass spectrometry analysis. Three SMG1 phos-
phorylation sites were identiﬁed (Supplementary Table
S2): Ser886, Ser992 and Thr1042, Ser1046 or Ser1050.
Ser886 and Ser992 are located at the N-terminus
of MIF4G-3 helices h7 and h11, respectively
(Supplementary Figure S10). Residues Thr1042, Ser1046
and Ser1050 are located on the linker between the
structured part of MIF4G-3 and the UPF2 C-terminus,
which binds UPF1. In the UPF-EJC quasi-atomic model,
Ser992, Thr1042, Ser1046 and Ser1050 are positioned at
the free surface of the ring formed by UPF2 MIF4G
domains (Supplementary Figure S10). Thus, they are
likely to be exposed and accessible for SMG1 phosphor-
ylation in the UPF-EJC complex. Next, each individual
residue has been substituted to alanine and tested for
in vitro phosphorylation by SMG1. All alanine mutants
except Ser1046 are phosphorylated to a similar extent as
the wild-type MIF4G-3 domain (Figure 6D). Moreover,
mutation of all ﬁve Ser/Thr led to a similar phosphoryl-
ation signal as the single S1046A mutant (Figure 6D),
indicating that Ser1046 is the main phosphosite for
SMG1 in the UPF2 MIF4G-3 construct (residues
761–1054), which we used as substrate in our assays.
Next, we performed NMD complementation and
tethering assays in HeLa cells to assess whether the
UPF2 S1046A mutation would affect NMD in vivo. In
both experiments, the S1046A mutation does not interfere
with NMD in vivo (Figure 5B lane 5 and Figure 5E lane 4).
To rule out the possibility that a single phosphorylation
site mutation is not sufﬁcient to produce a detectable
effect on NMD efﬁciency, we tested a UPF2 construct
carrying alanine mutations for all ﬁve identiﬁed phosphor-
ylation sites and tested it in a complementation assay.
Also for this construct we did not detect any effect on
NMD in vivo (Supplementary Figure S8B). In addition,
the serine residues 166 and 167, which are located in
the highly conserved motif of MIF4G-1 and have been
reported to be important for NMD in yeast (55), were
both mutated to alanines. The mutation of these residues
did not impair UPF2 in complementation as well as in
tethering assays (Figure 5B lane 4 and Figure 5E lane 3).
SMG1 and UPF3b can simultaneously bind to UPF2
MIF4G-3 domain
Since UPF3b and SMG1 both bind to UPF2 MIF4G-3
domain, we tested whether this binding was mutually ex-
clusive using two different approaches. First, we per-
formed a competition experiment where the binding of
MIF4G-3 at constant concentration (50 nM) to SMG1
was measured by SPR in the presence of UPF3b.
Increasing concentrations of UPF3b (50, 250 and
500 nM) do not decrease the binding of UPF2/UPF3b
to SMG1 (Figure 7A). This indicates that UPF3b and
SMG1 do not compete for UPF2 binding and that the
UPF2/UPF3b-SMG1 complex can form. In the case of
overlapping binding sites, i.e. competition, addition of
UPF3b to UPF2 would reduce the SPR signal. Rather,
formation of the UPF3-MIF4G-3 complex leads to
an increased signal in SPR (Figure 7A). Second, we
Figure 7. UPF2 MIF4G-3 binding to UPF3 and SMG1 is not
mutually exclusive. (A) SPR interaction proﬁle of UPF2 with SMG1
in the presence of increasing concentration of UPF3b RRM domain
(red box), and proﬁle of UPF3b RRM domain interacting with SMG1
(blue box). UPF2 was injected at a concentration of 50 nM in the
presence of 0, 50, 250, 500 nM UPF3b. UPF3b alone was injected a
concentrations ranging from 50 to 500 nM. (B) Apparent dissociation
constants (KD-app) of the UPF protein constructs and SMG1
determined by SPR experiments, which identify the MIF4G-3 domain
as the SMG1 binding domain and the existence of a ternary MIF4G-3/
UPF3b/SMG1 complex.
Figure 6. Continued
Staining (Life technologies) (top) staining only phosphorylated proteins. SMG1 is auto-phosphorylated and therefore stains in the experiment as well.
The Coomassie-stained gel (middle) shows all proteins present the experiments. The phosphorylation signal after Pro-Q staining was quantiﬁed with
a Typhoon scanner (bottom). Each bar presents the average of three independent experiments. (D) As for (C), SMG1 was mixed with different UPF2
MIF4G-3 mutants to assess in vitro phosphorylation. The reaction mixture was analyzed by SDS-PAGE and Pro-Q Diamond (top) and Coomassie
staining (middle). The phosphorylation level of each mutant was quantiﬁed using the ratio of its ﬂuorescence signal to the wild-type ﬂuorescence
signal (bottom). Each bar represents the average of four independent experiments.
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measured by SPR the apparent dissociation constant
between SMG1 and the preformed MIF4G-3/UPF3b
complex. The apparent dissociation constant of SMG1
and UPF2 MIF4G-3 in complex with UPF3b
(KD-app=34±2nM) and of SMG1 and MIF4G-3
alone (KD-app=60±5nM) is similar (Figure 7B and
Supplementary Figure S11), conﬁrming that the UPF3b
RRM domain does not compete or interfere with the
UPF2-SMG1 complex formation.
As a control, we tested the binding of UPF3b RRM
domain (residues 42–143) to SMG1. Compared with
UPF2, UPF3b shows an 10-fold weaker interaction
with SMG1 (KD-app=331±31nM) (Figure 7B and
Supplementary Figure S9B) with fast on and off rates.
The UPF3b domain is highly charged at neutral
pH (UPF3b isoelectric point is 8.8), and thus the
observed binding could be due to nonspeciﬁc charged
interactions.
DISCUSSION
UPF2 MIF4G domain 1 and 2 folds are stabilized by
N-terminal capping helices
UPF2 is composed of three conserved tandem MIF4G
domains and a C-terminal UPF1 interacting domain
(Figure 1A). Structural information is available for the
MIF4G-3 interacting with the RRM domain of UPF3b
(16) and of the C-terminus of UPF2 in complex with
UPF1 (15). Here, we present the crystal structures of the
remaining UPF2 folded domains, the N-terminal MIF4G-
1 and MIF4G-2 domains. In both cases, we found that
the canonical 10-helical MIF4G fold is augmented by an
N-terminal extension that packs onto the core and is
essential for overall domain stability (Figure 1). The add-
itional helices in the N-terminus, in particular helix hA,
are located in a similar position in the MIF4G-1 and -2
domains and pack against helices h2, h4, h6 and h8 of
the MIF4G core involving both hydrophobic and
charged interactions (Figures 2 and 3). Consistent with
the multiple interactions of the capping helices with the
MIF4G core, deletion of the N-terminal extension renders
the domains aggregation-prone, indicating that it has
an important stabilizing function. We note that while
UPF2 MIF4G-3 does not have an N-terminal extension
(although its contact with MIF4G-2 may play a stabilizing
role), it does have an extra C-terminal helix (h11) added to
the core MIF4G fold. We provide a more extensive dis-
cussion of the structural conservation of MIF4G domains
in the Supplementary Material.
MIF4G-1 contains unique elongated helices
In addition to the N-terminal extension, MIF4G-1
contains two elongated helices (h9 and h10) (Figure 1).
This is a striking and phylogenetically conserved feature
of the UPF2 MIF4G-1 domain, although a similar
extended coiled coil also occurs in the third, C-terminal,
MIF4G-like domain of CBP80 but formed by helices
equivalent to h8 and h9 and thus pointing in a different
direction (40). When ﬁtting the MIF4G-1 domain into the
EM density of the UPF-EJC complex (37), we observe
that the loop connecting h9 and h10 is in close proximity
and likely to contact MIF4G-2 (Supplementary
Figure S7). Thus, this protrusion may be important for
stabilizing the correct 3D arrangement of the UPF2
MIF4G domains in the UPF-EJC complex, MIF4G-1
and MIF4G-2 otherwise being connected by a ﬂexible
linker. Moreover, MIF4G-1 h9 and h10 are in a position
to establish contacts to the EJC in the complex
(Supplementary Figure S7). Therefore, MIF4G-1 could
contribute to the postulated scaffolding function of
UPF2 (37) by positioning the EJC in the DECID
complex. We tested this hypothesis with in vivo NMD
assays (Figure 5) but found that deletion of the extended
part of h9 and h10 does not affect NMD.
MIF4G domain arrangement in UPF2
The crystal structure of the tandem MIF4G-2/MIF4G-3
domains shows that they form a rigid assembly with a
substantial total buried surface area of 1400 A˚2. The
two domains are oriented perpendicular to each other
with helices h9 and h10 of MIF4G-2 interacting with
helices h4, h6, h8 and h10 of MIF4G-3 (Figure 4).
Interestingly, in MIF4G-1 and 2, these helices (h4, h6,
h8 and partly h10) are contacted by the N-terminal exten-
sion (hA, hB and adjacent loops). In contrast to the
observed rigid juxtaposition of MIF4G-2 and MIF4G-3,
limited proteolysis analysis of UPF2 (Supplementary
Figure S1A) suggests that MIF4G-1 is ﬂexibly linked
with respect to MIF4G-2/MIF4G-3 in free UPF2 and
only becomes ﬁxed in position within the UPF-EJC
complex.
Sequence analysis shows that proteins usually contain
two or more MIF4G or MIF4G-like (HEAT or ARM)
domains in tandem connected by predicted unstructured
linkers (57,58). This is the case for CBP80, eIF4G and
UPF2. The structure of CBP80 provides an example of
three combined MIF4G/MIF4G-like domains (40) where
the middle HEAT domain is the central core of the protein
and the N-terminal MIF4G and the C-terminal HEAT
domains pack against it, forming a compact assembly.
CBP80 thus shows a globular shape different from the
ring-like arrangement of UPF2 MIF4G domains, which
is suggested by the UPF-EJC EM reconstruction (37).
Consistently, the superposition of UPF2 MIF4G-2/
MIF4G-3 to CBP80 MIF4G domains does not indicate
any obvious similarity in the relative domain organization
of the two proteins. Therefore, even though proteins con-
taining tandem MIF4G/MIF4G-like domains may have a
common ancestor [as suggested for eIF4G and CBP80
(58)], the structural arrangement of the MIF4G domains
can clearly differ from protein to protein.
UPF2 MIF4G-1 and -2 scaffold the UPF-EJC complex
but have no direct function in interaction with the
SURF complex
The EM structure of the UPF-EJC complex shows that
UPF2 forms a ring-like scaffold for the assembly of the
UPF-EJC complex (37). Our reﬁned quasi-atomic model
indicates that MIF4G-1 and 2 are key bridging factors
between the EJC and the UPF1 CH domain and the
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UPF2 MIF4G-3 domain, respectively (Supplementary
Figure S7).
By UPF2 complementation assays we tested the impact
of UPF2 MIF4G-1 and MIF4G-2 deletion on NMD
efﬁciency. All tested deletions completely impaired the
ability of UPF2 to activate NMD of a reporter mRNA
(Figure 5B and C), conﬁrming the absolute requirement of
MIF4G-1 and MIF4G-2 for NMD in cells. The same con-
structs were also used in a UPF2 tethering assays. In this
situation it is likely that only the ability of the UPF2
variants to interact with the SURF complex and to
activate UPF1 phosphorylation, which ultimately
triggers mRNA degradation, is tested. Contrary to the
complementation assays, UPF2 M1, N/M1 and N/
M1M2 were only partially impaired to support NMD in
comparison with the wild type (Figure 5E and F). Thus,
by the complementary use of these two assays we were
able to uncouple MIF4G-1 and 2 functions in scaffolding
the UPF-EJC complex (complementation) and in acti-
vating the downstream events (tethering). The diverging
outcome of the two assays strongly indicates that MIF4G-
1 and MIF4G-2 are strictly necessary for NMD to
promote the correct assembly of the EJC and the UPF
proteins, but are partially dispensable for the interaction
of UPF2 with the SURF complex and triggering of UPF1
phosphorylation.
MIF4G domain 3 plays a central role in the DECID
complex
The critical ‘point-of-no-return’ in NMD is the activation
of SMG1 kinase to phosphorylate UPF1 (31,59). This is
achieved through association of the SURF complex with
the UPF2/3-EJC complex to form the decay inducing
complex (DECID) (19). Details of the UPF1 interaction
with UPF2 have been revealed by radiographic crystallog-
raphy (15) and with the UPF2/3-EJC complex by cryo-
EM (37). Immunoprecipitation experiments indicate a
direct interaction between UPF2 and the C-terminal
region of SMG1 that contains the kinase domain (19).
Here, we identify UPF2 MIF4G-3 as the interaction site
with SMG1 kinase (Figure 6). We measured by SPR an
apparent dissociation constant of 37 nM for UPF2
(121–1227) and SMG1 (Figure 6A), which is only
slightly increased to 60 nM when the MIF4G-3 domain
alone binds SMG1 (Supplementary Figures S9A and
Figure 7B). No interaction between SMG1 and MIF4G
domains 1 and 2 could be detected in vitro (Figure 6B).
Our ﬁnding is further supported by the in vivo tethering
assays that indicate that the deletion of the N-terminal
region of UPF2 does not strongly interfere with UPF2
interaction with the SURF complex (Figure 5A).
The UPF2 MIF4G-3 domain is a relatively small
domain that interacts stably with both MIF4G-2
(Figure 4) and the UPF3b RRM domain (16).
Moreover, according to the UPF-EJC cryo-EM structure,
UPF2 MIF4G-3 is also in close proximity with the UPF1
CH domain (37). Therefore, we investigated whether
UPF2 MIF4G-3/UPF3b complex formation would inter-
fere with UPF2 MIF4G-3/SMG1 interaction. The
measured apparent dissociation constant of MIF4G-3
and SMG1 in the presence of UPF3b RRM domain
(34 nM) is comparable with that of MIF4G-3 alone
(60 nM), suggesting that UPF3b does not compete with
UPF2 for SMG1 binding and that the trimeric UPF2/
UPF3b/SMG1 complex can exist also in vivo.
SMG1 kinase is suggested to be downregulated by the
SMG8/SMG9 heterodimer (12). SMG9 has been shown to
bind to the N-terminal HEAT-repeat region of SMG1 and
may act as a recruitment platform for SMG8, which, upon
binding, induces conformational changes in SMG1 and
inhibits its kinase activity (33). UPF2 has been reported
to interact with the C-terminal region of SMG1 carrying
the kinase domain (19), and therefore UPF2 likely
does not compete with SMG8/SMG9 for binding the
N-terminus of SMG1. Consequently, UPF2 could act
directly on the kinase domain to activate SMG1.
UPF2 is a SMG1 kinase substrate
Here we provide further evidence for a direct interaction
of UPF2 with the SMG1 kinase domain. We observed
that UPF2 MIF4G-3 is phosphorylated by SMG1 kinase
in vitro (Figure 6C). A combination of mass spectrometry
and in vitro mutational analyses identiﬁed three
phosphosites: Ser886, S992 and Ser1046 but only the
latter one is quantitatively phosphorylated in vitro
(Figure 6D). Ser1046 is not part of a canonical SQ site.
However, a Gln is present before the Ser1046 and this
residue is located in a Glu-rich region. These two
elements have been found in ATM/ATR phosphosites
identiﬁed by mass spectrometry (60). According to the
quasi-atomic model derived from the UPF-EJC complex
reconstruction [Melero et al. (37)], Ser1046 is positioned
on a ﬂexible loop and thus likely to be exposed.
Furthermore, it is positioned close to the UPF1
phosphosites and thus could be accessible by SMG1
(Supplementary Figure S10). Therefore, the identiﬁcation
of an in vitro phosphorylation site in MIF4G-3 conﬁrms
the direct interaction of UPF2 MIF4G-3 with the SMG1
kinase domain, possibly leading to activation of SMG1 to
phosphorylate UPF1. However, mutation of Ser1046 or of
all ﬁve identiﬁed phosphorylation sites are not sufﬁcient to
interfere with NMD in cells, neither in complementation
assays nor in tethering assays (Figure 5). Consistent with
our ﬁndings, human UPF2 has been reported to be a
phosphoprotein (36), but it has not been identiﬁed as a
SMG1 kinase substrate in vivo, nor has any functional role
for human UPF2 phosphorylation been proposed. In
contrast, UPF2 binding to SMG1 kinase is essential to
trigger NMD (19).
In contrast, a study in Saccharomyces cerevisiae showed
that yeast Upf2p is phosphorylated in vivo (55), most
likely including serines 32 and/or 33 in the highly
conserved motif near the beginning of the MIF4G-1
domain (30-LDSSIKRNT in yeast, see above and
Figure 2C and D). Mutational analyses showed that the
residues 21-DSS are important for interaction of Upf2p
with the yeast-speciﬁc NMD factor Hrp1p and for trigger-
ing NMD in vivo (55). If this motif adopts the same con-
ﬁguration as observed in the human MIF4G-1 structure,
only Ser32 (equivalent to Ser166 in human UPF2) is
solvent exposed and could be phosphorylated. In fact,
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Ser32 is phylogenetically absolutely conserved. However,
an interaction partner for this motif in higher eukaryote
UPF2 remains to be identiﬁed. UPF2 constructs with mu-
tations, S166A, S166D (data not shown) and SS166/
167AA (Figure 5) in this motif were tested in tethering
and complementation experiments. However, no effect
on NMD was observed (Figure 5B and E), suggesting
that the intact motif is not required for DECID complex
formation. Therefore, it remains to be shown whether
UPF2 phosphorylation by SMG1 (which has no homo-
logue in yeast) or by any other kinase has a signiﬁcant role
in NMD in higher eukaryotes.
In summary, we elucidate here the structure of UPF2
MIF4G domains 1 and 2 and show that they exert a role
in the structural organization of the EJC-UPF complex.
UPF2 MIF4G domain 3 interacts with the SMG1 kinase
domain and UPF3b and plays the key role in DECID
complex formation and SMG1 activation, which
triggers NMD.
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Supplementary Data are available at NAR online.
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Supplementary text
Structural conservation of MIF4G domains. 
A global pair-wise structure comparison (DaliLite, http://www.ebi.ac.uk/Tools/dalilite/) 
of UPF2 MIF4G-1 and MIF4G-2 domains with other MIF4G domain structures of eIF4G, 
CBP80, UPF2 MIF4G-3 and MIF4Gdb (PDB accession codes 1HU3, 1H6K, 1UW4 and 
2I2O respectively) (Bae, 2010; Kadlec, 2004; Marcotrigiano, 2001; Mazza, 2001) indicates 
that core MIF4G domains share a similar overall fold with RMSDs between 2.0 and 4.0 Å, 
despite low sequence identity of between 10 and 23% (Supplementary Table 3, 
Supplementary Figure S4B). UPF2 MIF4G-1 has the highest structural similarity to eIF4G 
MIF4G domain (C RMSD 2.9 Å, residues 752-986, 13% identity), whereas MIF4G-2 is 
most similar to MIF4G-3 (CRMSD 2.5 Å, residues 768-983, 16% identity) (Supplementary 
Table 3). The identity in primary sequence does not correlate with the similarity in the 
structure, in agreement with the observation that structure-based alignments do not show any 
strictly conserved residues in MIF4G domains with the exception of the FIGEL motif (see 
below). Rather, they contain a pattern of hydrophobic residues important for interhelical 
packing (Kadlec, 2004). The structural comparison also shows a conservation of the position 
of the helices, with the exception of the N-terminal four-helix bundle of MIF4Gdb. The helix 
length is also generally conserved, with the exception of UPF2 MIF4G-1 helices h9 and h10 
which are elongated (Supplementary Figure S4B). In contrast, the loops connecting the 
helices vary considerably. UPF2 MIF4G-1 and CBP80 contain an additional helix inserted 
between helices h8 and h9 and helices h9 and h10 respectively. All MIF4G domains share a 
conserved ‘FIGEL’ sequence motif on helix h6, with the hydrophobic residues being 
involved in interhelical packing and the glutamic residue pointing to the exterior (Kadlec, 
2004; Letunic, 2002). In MIF4G-1, the glycine residue is mutated into an alanine (268-
FIAEL-272), while the canonical motif is present in MIF4G-2 (669-FIGEL-673). In UPF2 
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MIF4G-1 and MIF4G-2, the exposed glutamic residue of the FIGEL motif is involved in the 
binding of the capping helix hA: in MIF4G-1, Glu271 establishes a salt bridge with Arg141 
of helix hA (Figure 2A); in MIF4G-2, Glu672 interacts with helix hA forming a hydrogen 
bond with the hydroxyl group of a conserved tyrosine, Tyr468 (Figure 3A). In the light of 
these observations, we re-examined the context of the first, canonical, MIF4G domain of 
human CBP80. The ten helices of this domain are followed by a long proline-rich linker 
(residues 245-308), containing three short helices, which completely encircles the domain 
(Figure 1 of (Mazza, 2001) and Supplementary Figure S12A) making many specific contacts 
with it (Supplementary Figure S12B). Some regions of this linker make analogous 
interactions to that observed in the UPF2 MIF4G-2 structure. In particular Asp133 of the 
‘FIGEL’ motif (129-FLSDL-134 in human CPB80) makes a hydrogen bond with Tyr253 of 
the linker (Supplementary Figure S12B). Thus, it seems possible to distinguish two categories 
of MIF4G domains. On one hand those such as the MIF4G domains of eIF4G, MIF4Gdb and 
UPF2 MIF4G-3 which are stable as ‘naked’ canonical MIF4G domains. On the other hand, 
those where the interhelical packing is stabilised by peptide extensions to the core domain, 
perhaps to limit flexibility of the helical bundle, such as the first two MIF4G domains of 
UPF2 and that of CBP80. Very recently, the structure of the MIF4G domain of Not1 has been 
published as part of the yeast Ccr4-Not complex (Basquin, 2012; Fabian, 2013; Petit, 2012). 
This shows another example of stabilisation of the core helical fold by N- and C-terminal 
extensions that wrap around the helices. 
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Materials and Methods 
Protein expression, purification and crystallisation 
DNA fragments encoding his-tagged UPF2(121-1031), UPF2(121-486), UPF2(455-
757) and UPF2(455-1054) were cloned into the pProExHTb expression vector (Invitrogen). 
Plasmids were transformed into E. coli BL21Star(DE3), and the cells grown overnight at 
20°C after induction with 1 mM IPTG. The proteins were purified by immobilised Ni2+ 
affinity chromatography. After His-tag removal using TEV protease (leaving a Gly-Ala-Met-
Gly extension at the N-terminus), the UPF2 constructs were loaded a second time onto a Ni2+ 
column. The last purification step included size exclusion chromatography (Superdex 200) in 
20 mM Tris pH 7, 150 mM NaCl and 2 mM DTT followed by concentration of the proteins. 
Crystallisation trials were performed with a Cartesian robot which makes 100nl+100nl drops, 
and positive hits conditions were refined by the hanging-drop vapour diffusion technique. 
UPF2-MIF4G-1 (121-486) crystals were obtained in 100 mM bicine pH 9, 100 mM NaCl, 
11% PEG 6000 and at a protein concentration of 16 mg/ml; UPF2 MIF4G-2 (455-757) 
crystals were obtained in 100 mM MES pH 6.0, 19% PEG 3350 and at a protein concentration 
of 8 mg/ml; UPF2 MIF4G-2/MIF4G-3 (455-1054) crystals were obtained in 100 mM HEPES 
pH 7.0, 100 mM NH4SO4, 200 mM NaKHPO4 pH 7, 840 mM sodium malonate, 1% w/v 
PEG MME 2K and at a protein concentration of 10 mg/ml. Expression of  seleno-methionine 
labelled MIF4G-1, MIF4G-2 and MIF4G-2/MIF4G-3 was carried out in E. coli 
BL21Star(DE3) growing in M9 minimal medium. Thirty minutes before induction (1 mM 
IPTG) the cells were supplemented with a cocktail of aminoacids containing seleno-
methionine (final concentration 60 mg/l). The labelled proteins were purified and crystallised 
in the same conditions as the native ones.
Crystallographic data collection and structure determination 
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Crystallographic statistics are given in Supplementary Table I. All data collection was 
performed at 100K at the European Synchrotron Radiation Facility with crystals being briefly 
soaked in a solution containing mother liquor and 20% glycerol as cryoprotectant and snap-
frozen into liquid nitrogen. The data were integrated with XDS (Kabsch, 2010) and analysed 
with CCP4i. Molecular replacement was performed with PHASER (McCoy, 2007), model 
building with COOT (Emsley, 2010) and refinement with REFMAC5 (Murshudov, 1997; 
Vagin, 2004). As molecular replacement with previously known MIF4G domains did not 
work, the structures of both MIF4G-1 and MIF4G-2 were solved de novo by 
selenomethionine (SeMet) SAD, using SHELXD (Sheldrick, 2008) to find sites and SHARP 
(De la Fortelle, 1997) for refinement and phasing. For the MIF4G-1 structure, the SeMet data 
was the best quality and therefore used for refinement. For the low resolution combined 
MIF4G-2/MIF4G-3 domain structure, molecular replacement using PHASER (McCoy, 2007) 
using the individual domains, gave a unambiguous unique solution with log likelihood gain 
(LLG) of 220. This was confirmed by correspondence of predicted methionine positions with 
anomalous difference peaks using data from MIF4G-2/MIF4G-3 crystals grown with SeMet. 
Due to the low resolution, no further refinement was performed. 
 
Generation of the quasi-atomic UPF-EJC model 
Starting from the EM reconstruction of the UPF-EJC complex (EMD-2048) and the 
corresponding quasi-atomic model (Melero, 2012), we replaced the UPF2 MIF4G domains 
and the UPF3b RRM domain by our crystal structure of MIF4G-1 domain and by the 
MIG4G-2/3/UPF3b RRM complex. We used Chimera (Pettersen, 2004) to obtain the best 
correlation coefficient for the placement of the domains into the density. To avoid a clash 
with MIF4G-1 and MIF4G-2 (both are larger than the MIF4G homology model used in the 
original atomic model), the EJC had to be moved by 14 Å away from UPF2. Similarly, the 
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UPF1 CH-domain was moved by 5 Å away from UPF2 MIF4G-3 (Supplementary Figure S7). 
The figures were generated in PyMOL (DeLano Scientific). In the rendering of the cryo-EM 
map, the density cutoff was set for the display of the envelope to represent ~130% of the a 
priori estimated volume. 
 
In vivo NMD assays 
The -globin 4MS2 plasmid construct and the transfection control (wt300+e3) for the 
tethering assay were described previously (Gehring, 2005; Gehring, 2003). HeLa cells were 
grown in DMEM and transfected by calcium phosphate precipitation in 6-well plates with 0.8 
μg of MS2-UPF2 fusion constructs, 0.5 μg of the control plasmid, 2 μg of the 4MS2 reporter 
plasmid, and 0.5 μg of a GFP expression plasmid. Total RNA was extracted with TRI 
Reagent (Sigma) and analyzed by northern blotting as described (Gehring, 2005; Gehring, 
2003). Signals were quantified using a Typhoon Trio (GE Healthcare) and percentages ± 
standard deviations were calculated from three independent experiments.  
For NMD complementation experiments HeLa cells were grown in 6 cm plates and 
transiently transfected with 100 pmol siRNA (UPF2 target sequence: 5’-
CACGTTGTGGATGGAGTGTTA-3’; Luc target sequence: 5’-
CGTACGCGGAATACTTCGATT-3’) using Lipofectamine RNAiMAX (Life Technologies). 
On the next day, cells were split 1:2 into 10 cm plates and 24 h later transfected with 200 
pmol siRNA. The next day, cells were seeded into 6-well plates and transfected by calcium 
phosphate precipitation with 0.5 μg of a GFP expression plasmid, 0.8 μg of expression 
plasmid for FLAG or siRNA insensitive (targeting sequence 5’-
CACGTTGTGGATGGAGTGTTA-3’ replaced by 5’-CATGTGGTTGACGGCGTCCTG-3’)  
UPF2, SS166/167AA, S1046A and coiled coil, 0.4 μg plasmid for N/M1 and N/M1M2, 
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0.6 μg for M1 and M2,  1.5 μg control plasmid (LacZ-HBB) and 2 μg plasmid encoding 
the reporter mRNA (TPI-HBB) (Steckelberg, 2012), harbouring a stop codon at position 48. 
 For UPF2 localisation HeLa cells were transfected with 600 ng of pCI-mVenus-UPF2 
plasmids. Cells were plated on coverslips 24 hours post transfection. 48 hours after 
transfection cells were fixed with 3.7% formaldehyde. Images were recorded on a FV1000 
confocal microscope (Olympus). 
 
Immunoprecipitation, immunoblotting and antibodies 
SDS-polyacrylamide gel electrophoresis and immunoblot analysis was performed 
using protein samples derived either from TRI Reagent extractions (Figure 5D) or from 
lysates (RIPA buffer supplemented with protease inhibitor) of parallel transfections (Figure 
5B). For coimmunoprecipitation UPF2 mutants were expressed as FLAG-tagged proteins in 
HeLa cells. Fusion proteins were immunoprecipitated with FLAG-beads (Sigma-Aldrich) and 
co-purified proteins analysed by immunoblotting. The antibodies against tubulin (T6074) and 
FLAG (F7425) were from Sigma, the antibody against V5 (18870) was from QED 
Bioscience, the antibody against GFP (ab290) was from Abcam and the antibodies against 
UPF1 and UPF2 were kindly provided by Jens Lykke-Andersen. UPF3B antiserum was raised 




SMG1 was expressed and purified as described in (Izumi, 2010) with some 
modifications. Lysed cells in SMG1 buffer (20 mM Hepes pH 7.5, 100 mM NaCl, 1 mM 
MgCl2, 0.5 mM DTT, 0.05% tween-20, 5% glycerol) supplemented with protease and 
phosphatase inhibitors (Roche) were ultracentrifuged at 100 000x g for 30 minutes. The 
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supernatant was mixed with streptavidin beads and incubated for 2 hours at 4 °C with mixing. 
After washing with SMG1 buffer containing 100 mM NaCl and then 500 mM NaCl, SMG1 
was eluted with SMG1 buffer with 1.5 mM biotin. Subsequently, SMG1 was concentrated 
and applied on a Superose-6 column equilibrated with SMG1 buffer. The fractions 
corresponding to monomeric SMG1 were pooled, concentrated, snap-frozen and stored at -80 
°C. 
 
SMG1 kinase assay 
0.2 μg of SMG1 were mixed with 1 μg of either UPF1-FL, UPF2 (121-486), UPF2 
(455-757) or UPF2 (761-1054) in SMG1 buffer containing 2 mM DTT, 5 mM MnCl2 and 5 
mM ATP. The mixture was incubated 1 h at room temperature. Proteins were separated on 12 
% SDS-PAGE gels first stained with Pro-Q Diamond Staining (Life Technologies) and then 
with Coomassie staining. The Pro-Q stained gel was revealed with a Typhoon scanner using 
532 nm and 580 nm as excitation and emission wavelength, respectively. 
 
Surface Plasmon Resonance 
SPR experiments were performed on a BIAcore 3000 using SA sensor chips (GE-
Healthcare). One flow-cell was not functionalized to be used as a background control. The 
second flow-cell was functionalized with purified SMG1 to a density of about 2000 RU. The 
running buffer was 20 mM Hepes pH 7.5, 100 mM NaCl, 1 mM MgCl2, 0.5 mM DTT, 0.05% 
Tween-20. UPF2/UPF3b solutions were injected at 25 μl/min during 3 or 4 min followed by a 
10 min dissociation phase. The surfaces were regenerated by 1 minute injection of 0.5 M and 
1 M NaCl solutions. The data were analyzed with the Biacore evaluation software by 
subtracting both the control flow cell and the buffer injection curve. The apparent equilibrium 
dissociation constants (KD-app) were determined using RU values 10 seconds before the end of 
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the association phase for all curves (RUmax). These RUmax were plotted as a  function of 
protein concentration and fitted assuming a one binding site model. 
 
Phosphosites identification by mass spectrometry 
500 μg of UPF2 (761-1054) in SMG1 buffer containing 2 mM DTT, 5 mM MnCl2 and 
5 mM ATP were mixed with or without 10 μg of SMG1. The mixtures were incubated 5 h at 
room temperature. UPF2 and SMG1 were then separated using a Superose-6 column 
equilibrated with SMG1 buffer containing 500 mM NaCl. The peak corresponding to UPF2 
was collected and concentrated to 100 μl. Samples were then diluted with 50mM NH4HCO3 
to obtain 20 μL of 0.5 μg/μl of protein , which was reduced with DTT (50 mM, 2 μL) for 30 
min at 56 °C and alkylated with iodacetamide (110 mM, 2μL) for 20 min at room temperature 
in the dark. Incubation with trypsin (0.1 μg enzyme/10 μg protein) was carried out overnight 
at 37 °C. Digestion was stopped by adding 4 μl of 10% trifluoracetic acid. Prior to analysis by 
liquid chromatography - mass spectrometry (LC-MS/MS), the peptides were diluted to 0.1 
μg/μl with 0.1% formic acid. Peptides were separated using the nanoAcquity UPLC system 
(Waters) fitted with a trapping (nanoAcquity Symmetry C18, 5μm, 180 μm x 20 mm) and an 
analytical column (nanoAcquity BEH C18, 1.7μm, 75μm x 200mm).  The outlet of the 
analytical column was coupled directly to an LTQ Orbitrap Velos (Thermo Fisher Scientific) 
using the Proxeon nanospray source. The mass spectrometric raw data was processed using 
MaxQuant (version 1.1.1.36) (Cox, 2008). 
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Identified peptide Phosphorylated residue Score
LCNSLEESIR S992 188.85 
MVESAVIFR S886 179.75 
DSMTEGENIEEDEEEEEGGAETEEQSGNESEVNE T1042 or S1046 or S1050 136.66 
 
 
Supplementary Table 2. Identification of the SMG-1 in vitro phosphorylation sites of UPF2 
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14 
eIF4G MIF4Gdb MIF4G-1 MIF4G-2 MIF4G-3 CBP80
eIF4G










3.8 3.4 3.5 -
MIF4G-3
(1UW4, 768-983) 
3.6 3.7 3.7 2.5 -
CBP80
(1H6K, 26-244) 
3.5 3.2 4.0 2.5 2.0 -
Supplementary Table 3. RMSD (Å) of C position for the superposition of MIF4G domains 
of published structures and UPF2 MIF4G-1 and 2. PDB accession codes and domain 
boundaries used for superposition are indicated in brackets. The structures were superposed 








Supplementary Figure S1. A. UPF2(121-1031) limited proteolysis time course and results of 
N-terminal sequencing on stable bands. UPF2(121-1031) was mixed with trypsin in 1000:1 
weight ratio and the reaction stopped at different time points and loaded on SDS-PAGE gel. 
Stable bands were excised from the gel and analysed by N-terminal sequencing. The N-terminal 
four residues GAMG are left on the protein from the plasmid used for expression  after TEV cleav-
age. B. Schematic representation of UPF2 (rectangle) as in figure 1A. UPF2 constructs used in 











































Supplementary Figure S2. (continues in the  next page)
84
Supplementary Figure S2. Sequence alignment of UPF2 MIF4G domains 1 and 2 of representative 
UPF2 proteins from yeast to human (Accession numbers. Hs: AAG60689; Gg: XP_004937542; Am: 
XP_003249451; Dm: NP_572434; At: NP_199512; Vv: XP_002275646; Eh: EOD19187; Nc: 
XP_961757.2; An:    XP_664299.1 ; Ca: XP_720987.1; Sc: NP_011944.2). Residues with similarity 
>85% are displayed in red. The secondary structure (all alpha-helices) of human UPF2 MIF4G 











MIF4G-2h10 end of MIF4G-1
end of MIF4G-2
85
Supplementary Figure S3. A. Helices h9 and h10 of UPF2 MIF4G-1 form an elongated 
coiled-coil structure protruding away from the domain. Hydrophobic residues involved in 
helices h9 and h10 packing are depicted as sticks. B. Detailed view of the interaction 
between MIF4G-1 helix h8i with its N- and C-terminal loops and helices h6, h8 and h10. 
Residues involved in the packing are depicted as sticks. C. MIF4G-1 domain represented 
in the same orientations as in figure 1C. D. Coomassie-stained SDS-PAGE of total lysate 
(non induced and induced), soluble and insoluble fractions of UPF2 MIF4G-2/3 constructs 
with MIF4G-2 helices hA-hB and disordered linker (constructs 455-1054) and without 
(556-1054) showing that In the absence of helices hA and hB the solubility of UPF2 












































































Supplementary Figure S4. A. Superposition of UPF2 MIF4G-1 (light green) and MIF4G-2 
(light  blue) showing the partial overlap of MIF4G-1 helix hA (green) with MIF4G-2 helix hA 
(blue). B. Superposition of UPF2 MIF4G-1 (green) to eIF4G and MIF4Gdb MIF4G domains 
(orange); superposition of UPF2 MIF4G-2 (light blue) to UPF2 MIF4G-3 and CBP80 MIF4G 








Supplementary Figure S5. A. Anomalous difference map (orange mesh) of seleno-
methionine substituted UPF2 MIF4G-2/MIF4G-3 domains (contoured at 3.5 	indicat-
ing the position of the methionine residues (depicted as sticks). B. Detailed view of the 














Supplementary Figure S6. Two views of the reconstructed UPF2 MIF4G-2/MIF4G-3 
assembly in complex with UPF3 RRM domain. The complex was obtained by super-










Supplementary Figure S7 A. Fitting of the EJC-UPF3, UPF1 complex with the UPF2 C-terminus, 
UPF2 MIF4G-1 (this study) and MIF4G-2/MIF4G-3/UPF3 RRM (this study) crystal structures into the 
cryo-EM reconstruction of the UPF-EJC complex (EMD-2048, Melero et al., 2012). The view in the 
lower panels is rotated 90 degrees with respect to the upper panel. B. The same representation as 
in A showing only the MIF4G-1 and MIF4G-2/MIF4G-3/UPF3 RRM structures (this study) placed into 
the EM reconstruction. C. Original quasi-atomic model showing the MIF4G-1 homology model, the 
MIF4G-2 homology model and the MIF4G-3/UPF3 RRM crystal structure placed into the cryo-EM 
reconstruction (Melero et al., 2012). D. Table listing the correlation coefficients obtained by rigid 
body fitting of UPF domains and the EJC for the published quasi-atomic model and for the new 
model. The overall quality of the fitting is very similar for the two quasi-atomic models. The correla-
tion coefficients were determined using Chimera. 
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Supplementary Figure S8. A. Subcellular localisation of UPF2 mutants. HeLa cells were trans-
fected with plasmids expressing the indicated mVenus-UPF2-constructs and transferred to cover-
slips 24 hours afterwards. Cells were fixed 48 hours post-transfection and analysed by confocal 
microscopy. Images of representative cells from each transfection are shown. Scale bars = 2 and 
5mm. All analysed UPF2 mutants localise to the cytoplasm. B. Complementation assay 
performed using UPF2 S1046A mutant and UPF2 carrying all five phosphorylation sites muta-
tions (S886A, S992A, T1042A, S1046A and S1050A). The assay was performed as described in 




Supplementary Figure S9. Overlay of SPR sensograms of (A) UPF2 MIF4G-3 and (B) 
UPF3b RRM interacting with immobilized SMG1. UPF2 MIF4G-3 was injected at concentra-
tions ranging from 5 nM to 200 nM. UPF3 RRM was injected at concentrations ranging from 
31.2 nM to 2000 nM. The maximal resonance unit signal was plotted against the injected 
protein concentration (right panels); the data points result from three independent experi-
ments. The apparent dissociation constants were determined assuming a 1:1 interaction.
92
Supplementary Figure S10. Location of the SMG1 phosphorylation sites of UPF2 
identified by in vitro phosphorylation and mass spectroscopy of UPF2. Phosphory-
lated serines are depicted as spheres in the quasi-atomic model of the UPF2 – 
UPF1 CH domain complex which is shown together with the UPF-EJC EM density 
(Melero et al., 2012). The main in vitro phosphorylation site of UPF2 (Ser1046) is 
highlighted in red; it is located on a flexible linker between the MIF4G domain 3 and 
the UPF2 C-terminal domain
93
Supplementary Figure S11. Overlay of SPR sensograms of the preformed UPF2 
MIF4G-3/UPF3b RRM complex interacting with immobilized SMG1. The UPF2/UPF3 
complex was injected at concentrations ranging from 5 nM to 200 nM. The maximal 
resonance unit signal was plotted against the injected protein concentration; the data 
points result from three independent experiments. The apparent dissociation constant 











Supplementary Figure S12. A. Structure of human CBP80 MIF4G-1 domain. The ten helices 
(grey) of the MIF4G domain fold are numbered from one to ten. The extended C-terminal linker of 
the domain (which contains three helices) and the additional helix (h9i) inserted between h9 and 
h10 are depicted in pink. B. Helix annotation and colour code as in (A). Detailed view of one of 
the helices of the extended C-terminal linker which interacts tightly with helices h2, h4, h6 and h8 
of the core domain. Amino acids involved in the interaction are shown in stick representation. 
Notably, aspartic acid (D133) of the conserved FIGEL signature motif (FLSDL in CBP80) of 
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SUMMARY
Nonsense-mediated mRNA decay (NMD) degrades
different classes of mRNAs, including transcripts
with premature termination codons (PTCs). The
NMD factor SMG6 initiates degradation of substrate
mRNAs by endonucleolytic cleavage. Here, we aim
to delineate the cascade of NMD-activating events
that culminate in endocleavage. We report that
long 30 UTRs elicit SMG6-mediated endonucleolytic
degradation. The presence of an exon-junction com-
plex (EJC) within the 30 UTR strongly stimulates en-
docleavage in a distance-independent manner. The
interaction of SMG6 with EJCs is not required for
endocleavage. Whereas the core NMD component
UPF2 supports endonucleolytic decay of long 30
UTR mRNAs, it is mostly dispensable during EJC-
stimulated endocleavage. Using high-throughput
sequencing, we map endocleavage positions of
different PTC-containing reporter mRNAs and an
endogenous NMD substrate to regions directly
at and downstream of the termination codon. These
results reveal how messenger ribonucleoprotein
(mRNP) parameters differentially influence SMG6-
executed endonucleolysis and uncover central
characteristics of this phenomenon associated with
translation termination.
INTRODUCTION
Nonsense-mediated mRNA decay (NMD) is a cellular quality
control mechanism that degrades transcripts containing prema-
ture termination codons (PTCs) (Chang et al., 2007; Nicholson
et al., 2010). NMD exists in all eukaryotic organisms and sup-
presses the synthesis of C-terminally truncated proteins, which
might have inadvertent activities or dominant-negative effects
(Holbrook et al., 2004). Whereas a small number of mRNAs car-
rying disease-causing nonsense mutations have been originally
identified to be degraded by NMD (Culbertson, 1999), many
so-called endogenous NMD targets are also recognized and
degraded by the NMD machinery (Tani et al., 2012). Hence,
NMD functions as a general modulator of gene expression and
alters the expression levels of 5% of the transcriptome in eu-
karyotes (Kervestin and Jacobson, 2012).
In mammalian cells, efficient NMD requires a distance of >50
nt between the termination codon and a downstream exon-
exon junction that is marked by an exon-junction complex
(EJC) (Neu-Yilik et al., 2001; Thermann et al., 1998). In addition
to the canonical EJC-dependent NMD, an alternative EJC-inde-
pendent NMD targets mRNAs with an aberrant architecture
downstream of the termination codon, such as unusually long
30 UTRs (Bu¨hler et al., 2006; Eberle et al., 2008; Singh et al.,
2008). EJC-independent NMD is activated when the ribosome
fails to terminate properly, for example, when the interaction of
the cytoplasmic poly(A)-binding protein (PABPC1) with the eu-
karyotic release factors (eRFs) is impaired (Eberle et al., 2008;
Fatscher et al., 2014; Singh et al., 2008). As a consequence of
any aberrant termination event, the conserved proteins UPF1,
UPF2, and UPF3 (UPF3a and UPF3b in humans) assemble into
a surveillance complex onto the mRNA and initiate its degrada-
tion. According to current models of NMD, UPF1 interacts with
the release factors and with the kinase SMG1 upon translation
termination, forming the so-called SURF complex (Kashima
et al., 2006). In the presence of a downstream EJC, UPF1 is
phosphorylated by SMG1 within its extended N- and C-terminal
regions (Kashima et al., 2006), which function as docking sites
for SMG6 and the SMG5-SMG7 heterodimer (Okada-Katsuhata
et al., 2012). SMG5, SMG6, and SMG7 are homologous proteins
that interact with phosphorylated UPF1 via their 14-3-3-like
domains (Fukuhara et al., 2005; Okada-Katsuhata et al., 2012).
An additional phosphorylation-independent interaction between
SMG6 and UPF1 has been recently identified (Chakrabarti
et al., 2014; Nicholson et al., 2014). SMG6 also contains
two N-terminal exon-junction-complex-binding motifs (EBMs),
which mediate its direct interaction with EJCs (Kashima et al.,
2010).
The degradation of NMD targets is accomplished via redun-
dant pathways that include endonucleolytic cleavage and
exonucleolytic degradation (Mu¨hlemann and Lykke-Andersen,
2010). The exonucleolytic decay is primarily coordinated by the
SMG5-SMG7 heterodimer (Loh et al., 2013), whereas the endo-
nucleolytic cleavage of NMD targets is mediated by the C-termi-
nal PilT N terminus (PIN) domain of SMG6 (Eberle et al., 2009;
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Glavan et al., 2006). Endocleavage occurs in the vicinity of the
termination codon, and the 50 and 30 mRNA fragments are exo-
nucleolytically degraded by the RNA exosome and XRN1,
respectively (Eberle et al., 2009; Gatfield and Izaurralde, 2004;
Huntzinger et al., 2008).
In view of the many different degradation pathways that are
used by the NMD machinery, the rules by which individual
NMD targets are selected for a particular degradation pathway
remain elusive. Particularly, the incidence of endocleavage by
SMG6 has not been systematically studied and the role of
trans-acting factors is not well defined. Hence, central decisions
during the degradation of NMD substrates are not yet fully
understood.
In this work, we have analyzed the 30 fragments (i.e., decay in-
termediates) of different NMDsubstrates in cultured humancells.
We find that EJCs stimulate the generation of 30 fragments but
do not influence the site of endocleavage. Tethering of individual
EJC components and NMD factors recapitulates the stimulation
of endocleavage by EJCs and enables the analysis of isolated
proteins and their domains. Furthermore, we show that all clas-
ses of NMD substrates, including mRNAs with long 30 UTRs,
are degraded via SMG6-dependent endocleavage, suggesting
that a common mechanism of SMG6 recruitment underlies
EJC-dependent and independent NMD. Using biochemical and
high-throughput methods, we analyzed 30 fragments with nucle-
otide resolution to show that endocleavage is determined by the
position of the termination codon in different NMD substrates.
RESULTS
Endocleavage Is Determined by the Position of the
Termination Codon in Multiexon mRNAs
The degradation of NMD substrates in human cells involves
SMG6-mediated endonucleolytic cleavage, which generates
two mRNA fragments (Figure 1A). Knockdown of the exoribo-
nuclease XRN1 stabilizes 30 fragments and thereby enables
their detection. In this work, we analyze 30 fragments in XRN1-
depletedHeLa cells as an explicit readout for the endonucleolytic
activity of NMD.
Previously, the sites of endocleavage during human NMD
were mapped to positions in close vicinity of PTCs within short
reporter mRNAs (Eberle et al., 2009). In order to analyze endo-
cleavage of complex reporter mRNAs, we first established the
detection of 30 fragments with the well-studied NMD substrate
b-globin PTC39mRNA (Figure S1A; Thermann et al., 1998). After
small interfering RNA (siRNA)-mediated depletion of XRN1 (Fig-
ure S1B), a specific band for the 30 fragment was detectable by
northern blotting with a probe that hybridizes to the 30 end of the
b-globin mRNA (Figure S1C). Next, we set out to systematically
investigate the 30 fragments of the seven exon triosephosphate
isomerase (TPI) reporter mRNA with PTCs located in different
exons and at varying distances to the next EJC. Considering
the specific and sensitive detection of the b-globin 30 fragment,
we included multiple copies of a short b-globin 30 UTR sequence
(HBS) in the 30 UTR of the TPI expression construct to facilitate
the analysis of TPI 30 fragments. This modification enabled the
detection of the TPI mRNA with a heterologous 30 probe and
enhanced the sensitivity of the northern blot (Figures S1D and
S1E). Because stronger 30 fragment signals were observed
with TPI-PTC reporters containing a quadruple HBS cassette
(TPI-4H), this cassette was used in all subsequent TPI reporters
(Figure S1F).
We studied the expression and 30 fragment generation of TPI
mRNAs with PTCs at positions 48, 100, 120, 160, or 189, which
are located in exon 2, 3, 4, 5, and 6, respectively (Figure 1B).
Upon XRN1 depletion, we observed abundant 30 fragments
generated from all PTC-containing mRNAs but for the wild-
type (WT) mRNA (Figure 1C). Notably, the length of the 30 frag-
ments inversely correlated with the length of the translated
open reading frame up to the PTC, suggesting that the site of
endonucleolytic cleavage is primarily determined by the position
of the PTC and occurs in close proximity thereof. To confirm
our results with an unrelated mRNA, we used the six exon
T cell receptor b (TCR) mRNA containing one HBS in the 30
UTR. Strikingly, we observed a pattern of 30 fragments for
PTCs at positions 49, 122, 180, or 240 located in exons 2 and
3 of the TCR mRNA, which was similar to the 30 fragments
obtained with the TPI mRNA (Figures 1D and 1E). Although we
detected slightly different amounts of 30 fragments for different
reporter mRNAs, our results demonstrate that NMD substrates
with a complex molecular architecture undergo efficient endo-
cleavage at the termination codon.
Figure 1. Endocleavage of NMD Targets near the PTC Occurs Independently of the Distance to or Position of the Downstream EJC
(A) Schematic overview of SMG6 endocleavage of substrate mRNAs and degradation of 30 fragments in 50-30 direction by XRN1.
(B) Schematic representation of the transfected triosephosphate isomerase (TPI) reporter mRNAs. The position of premature translation termination codons
(PTC) are indicated below; the position of exon junction complexes (EJCs) and their distance in nt to the next upstream NMD-activating PTC is indicated above
themRNA. Exons are depicted aswhite boxes, introns as two connecting black lines, and b-globin 30 UTR sequences (HBS) as gray boxes. Vector-derived 50 UTR
intron and SV40 poly(A) signal (pA) are indicated. The four repetitions of HBS (4H) serve as binding sites for the heterologous northern probe.
(C) Northern blot of RNA samples extracted from HeLa cells transfected with the indicated siRNAs and reporter constructs. Cotransfected LacZ-H4 served as
control mRNA.
(D) Schematic representation of the transfected T cell receptor b (TCR) reporter mRNAs as in (B).
(E) Northern blot analysis as in (C). TCR alt mRNA is an alternative splice variant of the TCR, skipping part of the second exon.
(F) Schematic representation of the transfected TPI reporter mRNAs lacking introns 1–5 as in (B).
(G) Northern blot analysis as in (C).
(H) Schematic representation of the transfected TCR reporter mRNAs lacking intron 2 as in (B).
(I) Northern blot analysis as in (C).
(J) Schematic representation of the transfected TPI reporter mRNAs as in (B).
(K) Northern blot analysis as in (C).
See also Figure S1.
Cell Reports 9, 555–568, October 23, 2014 ª2014 The Authors 557
99
The PTCs in our reporter mRNAs are located 39–133 (TPI) or
31–385 (TCR) nt upstream of the next downstream EJC. Accord-
ing to the current model of NMD, the interaction of ribosome-
associated UPF1 with EJC-bound UPF2-UPF3b initiates the
degradation of the mRNA (Kashima et al., 2006). Because the
bridging between UPF1 and the EJC is believed to be critical
for the activation of NMD, we aimed to disturb this interaction
by increasing the distance between the PTC and the EJC. To
this end, we deleted all but the last intron of the TPI reporter
(TPI-Di(1-5)), which increases the distance between PTC and
EJC up to a maximum of 460 nt for the PTC48 construct (Fig-
ure 1F). Notably, despite the increased spacing of PTC and
EJC, the average position of endocleavage remained unaltered
when we compared the different TPI-Di(1-5) mRNAs to the cor-
responding TPI mRNAs with all introns (compare Figures 1C
and 1G). Hence, the position of endocleavage does not change
when the first EJC downstream of the PTC is moved farther
away. To verify this finding, we deleted the second intron of
the TCR construct (TCR-Di2) to create an even larger PTC-EJC
distance, which places PTC49 600 nt upstream of the next
EJC located on exon 3 (Figure 1H). Again, the average cleavage
position did not change and the 30 fragments of the TCR-Di2
mRNAs were comparable in size to those of the matching TCR
mRNA (Figure 1I). In summary, our analysis of two different
mRNAs with multiple exons indicates that the position of the
EJC does not affect the site of endocleavage, which occurs
exclusively proximal to the PTC.
EJCs Are Required for Efficient Endocleavage
Whereas most NMD substrates require at least one EJC down-
stream of the PTC for their efficient degradation, a small subset
of mRNAs has been shown to be degraded in an EJC-indepen-
dent manner with somewhat reduced efficiency (Bu¨hler et al.,
2006). In order to test if the presence of a downstream EJC is
dispensable for endocleavage, we removed all introns or all
but the first intron from the TPI (TPI-Di(1-6)) or the TCR (TCR-
Di(2-5)) constructs, respectively (Figures S1G and S1H). Owing
to the lack of introns, no EJCs are present downstream of the
PTCs in both mRNAs. Although we did not detect a distinct 30
fragment pattern for both reporters upon XRN1 depletion (Fig-
ures S1I and S1J), minor amounts of 30 fragments appear to be
generated at PTCs 100 and 160 of the TPI mRNA, indicating
that minimal levels of endocleavage can also occur in the
absence of downstream EJCs (Figure S1I). No 30 fragments
were visible for the PTC48 mRNA, which appears to undergo
very little or no endocleavage in the absence of splicing. The
expression levels of the PTC-containing mRNAs were compara-
ble to that of theWTmRNA, confirming that NMD is not efficiently
initiated when all downstream EJCs are removed (Figures S1I
and S1J; Neu-Yilik et al., 2001). Because the presence of a
downstream EJC appears to be required for efficient endocleav-
age, we decided to directly compare the endocleavage activity
between mRNAs with and without EJCs. To this end, we studied
the amount of 30 fragments generated from three different
PTC160-containing mRNAs (TPI, TPI-Di(1-5), and TPI-Di(1-6);
Figure 1J). Whereas both intron-containing reporters produce
strong 30 fragments of the same size, we did not detect clear 30
fragments for the intronless construct (Figure 1K). Notably, the
expression levels of the reporter mRNAs were increased when
at least one intron was present within the open reading frame.
We speculate that the lack of EJCs within a large region of the
open reading frame may be responsible for the decreased
expression levels, although all reporter mRNAs contain an intron
in their 50 UTR and are therefore expected to profit at least
partially from the expression-enhancing effects of splicing and
EJC deposition (Nott et al., 2004). Together, our data indicate
that EJCs support endocleavage at PTCs and directly connect
the efficiencies of endocleavage and NMD.
Long 30 UTRs Trigger Endocleavage at the Termination
Codon
Several mRNAswith long 30 UTRs are regulated byNMD, despite
lacking an EJC downstream of the termination codon (Singh
et al., 2008). AlthoughmRNAswith long 30 UTRs represent an es-
tablished class of NMD substrates, the role of SMG6-mediated
endocleavage in mammalian cells has not been addressed. To
this end, we either inserted the full-length (5-FL) 30 UTR of
SMG5, a shortened (5) version thereof, the 30 UTR of UPF3b
(3b), or the coding sequence of GFP (GFP) into the 30 UTR of
the TPI WT construct (Figure 2A). Whereas the mRNAs encoding
SMG5 and UPF3b are natural NMD targets due to their long 30
UTR, the heterologous GFP coding sequence is sufficiently
long to activate NMD as well (Singh et al., 2008). Strikingly, we
observed 30 fragments produced from all four reporter mRNAs
upon XRN1 depletion. The sizes of these 30 fragments corre-
sponded to the lengths of the respective 30 UTRs and hence
indicate that endocleavage occurs in the vicinity of the TPI
stop codon (Figure 2B). The levels of these 30 fragments were
strongly reduced when XRN1 and SMG6 were codepleted,
demonstrating that they originate from SMG6-dependent,
bona fide NMD (Figure 2B, lanes 9–12).
Whereas our results suggest that the 30 fragments of long 30
UTRs are generated at positions surrounding the TPI termination
codon, we cannot exclude that this region is particularly suscep-
tible to endocleavage independently of translation termination.
To this end, we generated intronless TPI constructs containing
different PTCs and the SMG5 or UPF3b 30 UTR, respectively
(Figure 2C). Thereby, we moved the stop codon to more up-
stream positions and simultaneously extended the 30 UTR, while
preventing the deposition of EJCs downstream of the PTC.
Hence, endocleavage within these mRNAs is activated by the
long 30 UTR and not stimulated by an EJC. In line with our earlier
observations, the length of 30 fragments corresponded to the
length of the 30 UTRs and longer 30 fragments were detected
for mRNAs with earlier PTCs (Figure 2D). In summary, our results
show that endocleavage at the termination codon occurs
independently of the mechanism of NMD activation and is
a common unifying feature of different classes of mammalian
NMD substrates.
SMG6 EBMs Are Dispensable for Endocleavage
Thus far, our results demonstrate that the presence of an EJC
strongly stimulates endocleavage even over a long distance.
This raises the question of how the surveillance complex, which
is assembled at the termination codon, recognizes the presence
of a downstream EJC. Notably, SMG6 itself contains two
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N-terminal EBMs, which are short peptide sequences that bind
directly to EJCs (Kashima et al., 2010). Because the EBMs of
SMG6 have been shown to be essential for mammalian NMD
(Kashima et al., 2010), we speculated that the EBMs may
either promote the formation of a stable degradation complex
including the EJC or stimulate the endonuclease activity of
SMG6 in an EJC-dependent manner. In order to delineate the
role of the SMG6 EBMs during endocleavage, we established
a complementation assay for SMG6 in HeLa cells. After siRNA-
mediated depletion, the expression of SMG6 is rescued by the
transfection of a siRNA-insensitive SMG6 expression plasmid.
Consistent with previous reports, the knockdown of SMG6 in
XRN1-depleted cells greatly reduced the levels of 30 fragments
generated at all PTCs in the TPI mRNA (Figure 3A). These 30 frag-
ments are not generated from decapped and XRN1-degraded
mRNAs, because we did not detect substantial differences in re-
porter and 30 fragment levels when DCP2 and XRN1 were code-
pleted (Figures S2A–S2C). After SMG6 depletion, the generation
of 30 fragments of TPI-Di(1-5)-PTC160 could be fully restored by
the expression of SMG6 WT, whereas SMG6 with a mutant PIN
domain (PINMut), lacking the catalytically important triad of
aspartate residues in the active site (Eberle et al., 2009; Glavan
et al., 2006; Huntzinger et al., 2008), was inactive (Figures 3B–
3D). Surprisingly, full recovery of endocleavage was also
achieved with a SMG6 mutant that did not contain functional
EBMs (EBMMut; RRP45-47AAA and KKP139-141AEA; Figures
3C and 3D). This effect was independent of the position of the
PTC, because similar results were obtained with mRNAs con-
taining PTCs 100 and 189 (Figures S2D and S2E). We observed
comparable results in the SMG6 complementation assay with a
reporter mRNA that contained a long 30 UTR (TPI-5). SMG6 WT
and SMG6 EBMMut were able to support 30 fragment generation,
whereas the SMG6 PINMut was not (Figures S2F and S2G),
showing that the catalytic activity is responsible for the endo-
cleavage at long 30 UTR mRNAs. To verify that the mutations
in the EBM of SMG6 (EBMMut construct) abolish binding to the
EJC, we tested this mutant in binding assays in vitro as purified
FLAG-tagged N-terminal fragment of SMG6 (1–207). This
fragment contains both EBMs and has previously been shown
to be sufficient for binding to EJCs (Kashima et al., 2010).
We observed that the WT fragment immunoprecipitated preas-
sembled EJC proteins, whereas the SMG6 EBMMut and an
EBM1+2 deletion mutant failed to interact with the EJC (Fig-
ure 3E). To exclude that a residual EJC-binding activity of the
EBMMut SMG6 protein mediates its function in the complemen-
tation assays, we performed additional complementation assays
with EBM deletion mutants (DEBM1, DEBM2, and DEBM1+2;
Figure S2H). Remarkably, also EBM deletion mutants restored
reporter and 30 fragment levels to the full extent (Figures S2I
and S2J). Hence, the interaction of the SMG6 EBMs and down-
stream EJCs is not required for endocleavage of both EJC-
dependent and EJC-independent NMD substrates.
UPF2 Is Required for Endocleavage Triggered by
Long 30 UTRs
The dispensability of the SMG6 EBMs during endocleavage
prompted us to explore the role of the canonical bridging factor
UPF2 during the generation of 30 fragments. As described above,
UPF2 is thought to link the EJC-bound UPF3b to the ribosome-
bound UPF1. The depletion of UPF2 has been shown to upregu-
late certain NMD substrates, but an UPF2-independent NMD
pathway has also been described (Gehring et al., 2005). To study
the function of UPF2, we used a knockdown protocol that we es-
tablished previously to analyze the function of different UPF2 do-





Figure 2. Long 30 UTRs Trigger SMG6-Mediated Endocleavage near
the Termination Codon
(A) Scheme of the long 30 UTR reporter mRNAs depicted as in Figure 1, with the
inserted sequences (SMG5 full length [5-FL] or shortened [5] and UPF3b [3b] 30
UTR or GFP coding sequence) shown as colored boxes. Length of the inserts
is indicated above the mRNA in brackets. EJC positions and poly(A) signal are
not shown.
(B) Northern blot analysis of RNA samples derived from HeLa cells as
described in Figure 1, with b-globin WT serving as control mRNA.
(C) Schematic representation of the transfected reporter mRNAs as in (A).
(D) Northern blot analysis as in (B).
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generated at PTCs 100, 120, 160, and 189 in UPF2-depleted
cells (Figure 4A). In contrast, the 30 fragment resulting from endo-
cleavage at PTC48 was clearly reduced by the knockdown of
UPF2 (Figure 4B). Hence, our data indicate that some EJC-
dependent endocleavage events (PTC48) require normal levels
of UPF2, whereas others (PTCs 100–189) do not. However, the
molecular basis for the differential response to the depletion of
UPF2 was not further investigated.
In order to investigate the possibility that SMG6 and UPF2
represent redundant bridging factors, we performed SMG6
complementation assays in XRN1-UPF2-SMG6 triple-knock-
down cells (Figure S3A). 30 fragment levels were restored by
both SMG6 WT and EBMMut (Figures S3B and S3C), showing
that UPF2 and the EBMs of SMG6 do not overlap in function
and are neither individually nor in combination required for
EJC-dependent endocleavage.
We next investigated whether the endocleavage of mRNAs
with long 30 UTRs was affected by UPF2 depletion. Although
EJC-dependent endocleavage at PTCs was not or only mildly
decreased in UPF2-depleted cells, 30 fragments of long 30
UTRs were reduced to undetectable levels after UPF2 knock-
down (Figure 4C). These data reveal a striking difference
between the endocleavage of PTC containing mRNAs, which
is mainly UPF2 independent, and the UPF2-dependent endo-
cleavage of mRNAs with long 30 UTR.
To validate the role of UPF2, we investigated the endocleav-
age at long 30 UTRs with a complementation assay for UPF2
(Clerici et al., 2014). UPF2 binds to UPF1 via the UPF1-binding
A B
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Figure 3. Functional SMG6 PIN Domain Is Required for Endocleavage of Both Types of NMD Substrates
(A) Total RNA of HeLa cells, transfected with the indicated siRNAs and reporter plasmids, was analyzed by northern blotting.
(B) SMG6 protein architecture is depicted schematically, highlighting the N-terminal EJC-binding motifs (EBMs), the central 14-3-3-like domain, and the
C-terminal PIN domain. Mutant constructs with the respective mutated residues and their positions are indicated.
(C and D) Complementation assay of SMG6-depleted cells using TPI-Di(1-5)-PTC160 as mRNA reporter. Knockdown and rescue with siRNA-resistant SMG6
constructs is shown by western blots, using tubulin as loading control (C, lower panels). Northern blotting was performed of RNA extracted from the same cells
used for western blot analysis (C, upper panel). Mean values of reporter and 30 fragment signal ± SD (n = 3) were quantified and normalized to the XRN1 + Luc
control knockdown (D). The ratio of 30 fragment to reporter mRNA levels is indicated above the bars.
(E) FLAG-immunoprecipitation of recombinant SMG6 fragments. FLAG-tagged glutathione S-transferase (GST)-SMG6 1-207WT ormutant proteins were used to
coprecipitate preassembled EJC complexes containing eIF4A3, Y14 (5-154), MAGOH, and BTZ (110-372) (denoted by +). FLAG-tagged BTZ (110-372) was used
as a control; untagged BTZ (110-372) was omitted from this reaction, denoted by (+).
See also Figure S2.





Figure 4. UPF2 and the Interaction with UPF1 Are Required for Endocleavage of Long 30 UTR mRNAs
(A and B) Transfection with the indicated siRNAs and reporter plasmids was performed in HeLa cells, and total RNA was analyzed by northern blotting. mRNA
levels of XRN1 + UPF2 knockdown samples (A) were quantified (mean ± SD; n = 3) and normalized to the respective XRN1 knockdown lanes (B). The ratio of 30
fragment to reporter mRNA levels is indicated above the bars. LacZ-4H-expressing plasmid was cotransfected as control mRNA.
(C) HeLa cells were transfected with the indicated siRNAs and reporter plasmids, and total RNA was analyzed by northern blotting. b-globin WT-expressing
plasmid was cotransfected as control mRNA.
(D) Domain architecture of UPF2 and position of mutations in the MIF4G3- and UPF1-binding domain (U1BD) are shown schematically as in Figure 3B.
(E) Interaction between FLAG-tagged immunoprecipitated UPF2 proteins and endogenous UPF1 and UPF3b in RNase A-treated HeLa cell lysates was analyzed
by western blotting.
(F and G) Complementation assay of UPF2 knockdown in HeLa cells. The indicated siRNAs and plasmids were transfected, and TPI reporter mRNA as
well as UPF2 protein levels were analyzed by northern and western blotting, respectively. Tubulin serves as a loading control for western blotting. Quantification
(mean ± SD; n = 3) of the northern blots is shown in (G), and the ratio of 30 fragment to reporter mRNA levels is indicated above the bars.
See also Figure S3.









Figure 5. EJC and NMD Factors Enhance NMD and Endocleavage of Long 30 UTRs
(A) SMG5 30 UTR-containing TPI-PTC160 reporters with (Di(1-5)) or without (Di(1-6)) the last TPI intron are depicted schematically as in Figure 2.
(B) Northern blot of RNA samples extracted from HeLa cells transfected with the two reporters described in (A) in control (Luc), XRN1, and XRN1+UPF2
knockdown conditions. LacZ-4H-expressing vector was cotransfected and served as transfection control.
(C) Scheme of the TPI-4MS2-5-tethering reporter. The four MS2-binding sites allow tethering of MS2 coat protein fusion proteins to the position upstream of the
long 30 UTR but downstream of the stop codon.
(D) HeLa cells were transfected with the indicated siRNAs and plasmids. The effects of tethering the indicated proteins to the TPI-4MS2-5 reporter mRNA were
analyzed by northern blotting (top panel). V5-tagged MS2 coat protein served as tethering control. Western blot shows the expression levels of the MS2V5-
tagged constructs (lower panel). Cotransfected GFP serves as transfection control.
(E) Mean values ± SD (n = 3) of the mRNA levels in (D) were quantified. The ratio of 30 fragment to reporter mRNA levels is indicated.
(F) Northern blot analysis as in (D).
(G) Quantification of the mRNA levels in (F) as in (E).
(H) Schematic illustration of UPF3b domains, showing the position of UPF2-binding region (blue) and EBM (green). Deletions and point mutations are depicted.
(legend continued on next page)
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domain (U1BD) in the C terminus, whereas the binding to UPF3b
is mediated by the third MIF4G domain (Figure 4D). We gener-
ated several point mutants in UPF2 to explore the function of
these interactions during endocleavage. The mutation of gluta-
mate at position 858 (E858R) has been previously reported to
abolish the UPF2-UPF3b interaction in vitro and in cultured cells
(Kadlec et al., 2004; Kashima et al., 2006). Notably, in our immu-
noprecipitation (IP) experiments, the E858R mutant was still
able to co-IP UPF3b, albeit with reduced efficiency (Figure 4E).
Therefore, we mutated more residues of UPF2 at the interface
involved in UPF3b binding (Kadlec et al., 2004) and identified
two variants of UPF2 (847-858Mut and 847-867Mut) for which
the co-IP of UPF3b was reduced to background levels (Fig-
ure 4E). Importantly, both UPF2 mutants retained full interaction
with UPF1 and we used UPF2 847-858Mut for further analysis.
We also confirmed that the previously characterized 1173Mut
construct (Clerici et al., 2009), in which the U1BD was mutated,
did not bind UPF1 but still interacted with UPF3b in co-IPs (Fig-
ure 4E). In the UPF2 complementation assay, we were able
to fully rescue NMD and endocleavage of the TPI-SMG5
mRNA with the UPF2 WT, whereas the 847-858Mut construct
only partially complemented the knockdown (Figures 4F and
4G). Strikingly, UPF2 1173Mut was not able to complement
the UPF2 depletion and no 30 fragments were detected. This
demonstrates that the UPF2-UPF1 interaction is absolutely
required, whereas the interaction of UPF2 with UPF3b partially
contributes to the endocleavage and degradation of mRNAs
with long 30 UTR.
EJCs Enhance Endocleavage of Long 30 UTR mRNAs
In comparison to EJC-activated NMD substrates, only a small
quantity of 30 fragments was generated from mRNAs with long
30 UTRs. To directly compare the efficiencies of endocleavage
upstream of EJCs or long 30 UTRs, we introduced a PTC at po-
sition 160 in the TPI reporter with a long 30 UTR, which contains
a single intron (Di1-5) or lacks all the introns (Di1-6; Figure 5A).
Both reporters contain a long 30 UTR, but the intron-containing
TPI mRNA (Di1-5) has an additional EJC downstream of the
PTC, i.e., in the beginning of the 30 UTR. In control conditions,
we observed elevated levels of the EJC-containing mRNA
(Di(1-5); Figure 5B) comparable to our previous results (Fig-
ure 1K), which are likely caused by the general expression-
enhancing function of EJCs. Notably, in XRN1 knockdown
conditions, very small amounts of endocleavage products
were detected for the intronless compared to the EJC-contain-
ing mRNA (Figure 5B, lanes 3 and 4), although the Di1-6
construct produces detectable amounts of 30 fragments when
examined in isolation (Figure 2D). This indicates that the pres-
ence of an EJC activates NMD and thereby endocleavage to a
larger extent than a long 30 UTR alone. Markedly, the knockdown
of UPF2 did not impede the endocleavage of the EJC-containing
NMD substrate with a long 30 UTR, which is in good agreement
with our finding that UPF2 is required only for a subset of
EJC-dependent endocleavage events (Figure 4A).
Tethering of NMD-Inducing Factors Promotes
Endocleavage
The function of EJCs during NMD has been previously studied
with tethering assays (Gehring et al., 2008). Owing to the strong
stimulation of endocleavage by EJCs, we aimed to recapitulate
this effect by tethering individual EJC components or NMD fac-
tors downstream of the termination codon. To this end, wemodi-
fied the TPI-SMG5 reporter by introducing four MS2-binding
sites between the termination codon and the SMG5 30 UTR (Fig-
ure 5C). Tethering of the EJC core components Y14 and BTZ
as MS2V5-tagged fusion proteins to the reporter resulted in a
reproducible reduction of the reporter levels, confirming the
functionality of our tethering system (Figures 5D and 5E). In
XRN1-depleted cells, we detected low levels of 30 fragments
that were generated upstream of the long 30 UTR. Strikingly,
the basal endocleavage efficiency at the termination codon
was strongly stimulated when Y14 or BTZ were tethered. This
supports our earlier finding that EJCs stimulate endocleavage
and demonstrates that this function of the EJC can be recapitu-
lated by tethering of individual EJC components.
We used the same reporter construct to investigate whether
endocleavage is also stimulated by tethered NMD factors,
such as UPF2 and UPF3b. Tethering UPF2 WT decreased the
levels of the reporter mRNA and strongly activated 30 fragment
generation, both comparable to the effects observed with EJC
components. In contrast, UPF2 1173Mut, which is deficient in
UPF1 binding, was inactive in the tethering assay (Figures 5F,
lane 8, and 5G), in agreement with the results of our UPF2
complementation assay (Figure 4F). Tethering of UPF2 847-
858Mut, which is unable to bind UPF3b, stabilized the reporter
and even further decreased the low constitutive endocleavage
to undetectable levels (Figures 5F and 5G). Hence, when this
mutant of UPF2 was directly bound to the mRNA, it exerted
a dominant-negative effect, which was not observed in the
complementation assay (Figure 4F).
We next aimed to understand the role of UPF3b in SMG6-
mediated endocleavage. Previous studies have shown that the
depletion of UPF3b only moderately impairs degradation of
different NMD substrates, potentially due to the functional sub-
stitution of UPF3b by UPF3a (Chan et al., 2009). In line with these
previous studies, we observed mainly unaltered reporter mRNA
levels upon a combined XRN1 and UPF3b knockdown using
different TPI reporter mRNAs (Figures S4A–S4C). Interestingly,
we detected increased endocleavage at several PTCs, which
we did not observe with the reporter mRNA containing a long
30 UTR. This unexpected finding prompted us to further charac-
terize the effect of UPF3b on endocleavage in a tethering assay.
To this end, we generated a variant of UPF3bwith a K52D/RR56-
57EE triple mutation (UPF3b 52/56Mut; Figure 5H) in the region
(I) FLAG-UPF3b WT or mutant proteins were immunoprecipitated from RNase-A-treated HeLa cell lysates. Coprecipitated endogenous UPF2 was detected by
immunoblotting.
(J) Northern blot analysis as in (D).
(K) Quantification of the mRNA levels in (J) as in (E).
See also Figure S4.
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required for UPF2 binding (Kadlec et al., 2004). This UPF3b 52/
56Mut did not co-IP UPF2, whereas an UPF3b deletion mutant
(D421-434), lacking the EBM and therefore deficient in EJC bind-
ing (Gehring et al., 2003), still interacted with UPF2 (Figure 5I). In
tethering experiments, UPF3b WT and also UPF3b 52/56Mut
strongly activated endocleavage of the reporter mRNA, confirm-
ing the previous observation that the interaction with UPF2 is not
required for UPF3b to activate degradation (Figures 5J and 5K;
Gehring et al., 2003). However, we observed an upregulation of
reporter mRNA levels and reduced endocleavage when the
mutant of UPF3b lacking the EBM (UPF3b D421-434) was teth-
ered. These results confirm that EJCs are critical for endocleav-
age and support the notion that the UPF3b-UPF2 interaction
does not bridge the surveillance complex to a downstream
EJC during NMD (Gehring et al., 2003).
30 Fragments Are Polyadenylated and 50 Phosphorylated
Previous studies demonstrated that the 30 fragments generated
by SMG6 are polyadenylated (Eberle et al., 2009; Gatfield and
Izaurralde, 2004). The similarity of the SMG6 PIN domain with
FLAP family proteins (Glavan et al., 2006) also suggests that
SMG6 leaves a 50 monophosphate at the 30 fragment during en-
docleavage. Hence, it is likely that the 30 fragments generated at
PTCs in an EJC-dependent manner and 30 fragments generated
upstream of long 30 UTRs have identical termini. To verify this
assumption, we first performed a poly(A)-enrichment step with
RNA samples obtained from XRN1-depleted cells transfected
with TPI-Di(1-5)-PTC160 or TPI-5. The 30 fragments of both sam-
ples were efficiently precipitated, whereas rRNA was retained
in the supernatant, showing that the 30 fragments contain an
accessible poly(A) tail (Figure 6A). To confirm the presence of
the 50 monophosphate, we performed an in vitro digest with re-
combinant yeast XRN-1 (rXRN-1), which only degrades 50 phos-
phorylated RNAs in a highly processive manner. As expected,
the treatment with rXRN-1 degraded the 30 fragments of different
reporter mRNAs, whereas the control and reporter mRNA itself
remained intact (Figures 6B and 6C).
Mapping the Sites of Endocleavage
The 50 monophosphate on the 30 fragments makes them
amenable to linker ligation at the 50 end, and the poly(A) tail en-
ables oligo(dT)-primed reverse transcription. On this basis, we
developed amethod to identify the cleavage sites of 30 fragments
by high-throughput sequencing (Figure 6D). Notably, the size of
amplified 30 fragments we obtained after the final PCR and prior
to high-throughput sequencing corresponded to the length of 30
fragments of different PTC-containing mRNAs (Figure 6E). We
used the same strategy to amplify 30 fragments of endogenous
SMG5 mRNA.
Sequencing results had increased resolution and sensitivity
compared to northern blotting and therefore allowed precise
mapping of endocleavage sites. We sequenced the 30 fragments
of TPImRNAswith different positions of PTCs in triplicates (Table
S1). The reproducibility of the single replicates is shown for TPI-
PTC189 (FigureS5A). For initial analysis,weassessed thedensity
of reads in 5 nt windows of TPI mRNAs, such that the density in
TPI mutants was normalized by subtraction of the TPI-WT, which
we considered as background (Figure S5B). The normalized den-
sity of sequencing reads was highest in the region up to 100 nt
downstream of the endocleavage positions in all TPI mutants
(Figure S5B). Moreover, a nucleotide-resolution analysis of the
PTC-proximal region (±100 nt around the PTC) showed that en-
docleavage events were rare upstream of the PTC but instead
mapped to positions immediately downstream of the PTC (Fig-
ure S5C). We observed a mild preference for Gs in the area sur-
rounding the cleavage sites (Figure S5D). Upon pooling the
normalized reads from all PTC samples, we noticed two major
cleavage sites around 0 and 24 nt downstream of the PTC (Fig-
ure 6F). Notably, high-throughput sequencing of 30 fragments
that were generated from the endogenous SMG5mRNA showed
asimilar patternwith twoverydistinct peakswithmaximaat 3and
38 nt downstream of the stop codon (Figures 6G and S5E). In
summary, single-nucleotide resolution analysis demonstrates
that endocleavage occurs at two sites, one overlapping with
the stop codon and another in the region of 20–40 nt downstream
of the PTC, both in the TPI reporter and the endogenous SMG5
mRNAs.
DISCUSSION
Several mRNA-degradation pathways are involved in the
removal of NMD substrates (Loh et al., 2013). These include
nonsense-specific decay mechanisms, such as SMG6-medi-
ated endocleavage, but also the recruitment of the general
mRNA decay machinery. Despite several years of intensive
work, the determinants and factors that govern the activation
of individual decay routes are not well understood. In this
work, we present a systematic analysis of SMG6-dependent en-
docleavage using different classes of NMD substrates and
define the molecular characteristics of this NMD-specific decay
pathway.
Splicing and EJCs Stimulate Endocleavage
Our analysis of mRNAs with PTCs in different exons clearly indi-
cates that endocleavage occurs in close proximity to the PTC,
which is in line with the results of previous studies (Eberle
et al., 2009; Gatfield and Izaurralde, 2004; Huntzinger et al.,
2008). However, we also observe a hitherto unrecognized stim-
ulation of endocleavage in the presence of a downstream EJC.
Notably, endocleavage is also stimulated by tethering individual
EJC components, which confirms the specific effect of EJCs on
endocleavage activity. Whereas our findings explain the NMD-
activating function of EJCs, they also raise the question of how
a distant EJC is detected during the initial phases of NMD.
Current models suggest that ribosome-associated UPF1 is
phosphorylated by its kinase SMG1 in response to a physical
interaction with the EJC. Whichever molecular mechanism is
responsible for the initial contact of UPF1 and the EJC, it must
be able to bridge a large distance on the mRNA. Our data indi-
cate that an EJC as far as 600 nt downstream of a PTC can still
efficiently stimulate endonucleolytic cleavage at the PTC, which
is in line with the observation that EJCs can exert long-range
effects during NMD (Neu-Yilik et al., 2001). It remains to be deter-
mined whether such large distances are overcome by spreading
of EJCs to noncanonical upstream positions or by a mecha-
nism involving UPF1-dependent mRNA scanning, threading, or
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looping to establish the physical interaction of UPF1 with the
EJC. Interestingly, our data suggest that a hypothetical tag ear-
marks the position of the termination codon until endocleavage
occurs in its vicinity. It will therefore be an important goal for
future research to identify the tag and to explore the molecular
mechanism that directs endocleavage to the position of transla-
tion termination.
In contrast to canonical NMD substrates that are degraded
when at least one EJC is located downstream of the termination
codon, long 30 UTRs activate NMD in an EJC-independent
manner. Nonetheless, our analysis of four reporter mRNAs with
different 30 UTR lengths provides clear evidence for endocleav-
age at the position of the termination codon. We show that this





Figure 6. Mapping of 30 Fragments Reveals Preference for Endocleavage at and Downstream of the Termination Codon
(A) Poly(A)+ purification of total RNA extracted from XRN1 knockdown HeLa cells transfected with the indicated TPI reporters. Equal fractions of input total RNA,
LiCl-precipitated unbound RNA, and poly(A)+ RNA were analyzed by northern blotting. Ethidium-bromide-stained rRNA served as unbound nonpolyadenylated
control (bottom).
(B and C) In vitro degradation assay of 50 monophosphate RNA using recombinant yeast XRN-1 (rXRN-1). XRN1 knockdown cells were transfected with TPI
reporter constructs; total RNA was isolated and treated with or without rXRN-1. Samples were analyzed by northern blotting (B) and mRNA levels quantified and
normalized to untreated mRNA levels (C).
(D) Schematic overview of the 30 fragment cloning strategy. The 50 monophosphate containingmRNA endocleavage fragment is ligated to an RNA linker, followed
by reverse transcription using oligo(dT) primer. Two cycles of PCR amplify specific 30 fragments and introduce the sequences required for Illumina sequencing (P5
and P3 primers).
(E) Final PCR products before Illumina sequencing were separated on a 2.5% NuSieve GTG agarose Tris-borate-EDTA gel and stained with SYBR Gold. Red
boxes indicate amplified 30 fragments of the expected size for the respective PTC-containing reporter.
(F) Combined sequencing reads of PTC-proximal (±100 nt) 30 fragments of all TPI reporter mRNAs are shown. For each reporter, the background (TPI-WT) was
subtracted and the reads were normalized to the total read number of the respective reporter, pooled, and plotted against the position on the mRNA. The
Gaussian distribution of the two major peaks has been calculated and is charted together with positions of their maxima and their distance.
(G) Reads of three replicates of endogenous SMG5 samples in the region ± 100 nt around the stop codon were combined, andmajor peaks are indicated as in (F).
See also Figure S5 and Table S1.
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the deposition of an EJC downstream of the termination codon.
Hence, our data suggest that an endocleavage-competent NMD
machinery is recruited upon translation termination upstream of
long 30 UTRs and EJCs.
Functions of SMG6 and UPF2 during Endocleavage
The PIN domain of SMG6 executes the endocleavage of the
target mRNA during NMD (Eberle et al., 2009; Huntzinger et al.,
2008). Because the EBMs of SMG6 have been reported to be
essential during NMD (Kashima et al., 2010), we speculated
that they directly or indirectly regulate the activity of the PIN
domain. Whereas our complementation assays confirm the
essential role of the PIN domain of SMG6 during endocleavage
of EJC-dependent/independent NMD substrates, an EBM point
mutant and EBM deletion mutants of SMG6, which are unable to
interact with the EJC, exhibit wild-type endonuclease activity on
the NMD substrates. Therefore, our results question the view
that a direct interaction of SMG6 with the EJC is required during
the endocleavage of NMD substrates.
UPF2 interacts with UPF1 and UPF3 in human cells and has
been suggested to bridge EJCs and the NMD machinery during
EJC-dependent NMD (Kashima et al., 2006). Hence, we hypoth-
esized that the endocleavage-stimulating effect of the EJC is for-
warded by UPF2. However, we find that UPF2 depletion inhibits
endocleavage at long 30 UTRs, whereas endocleavage at PTCs
with downstream EJCs is mainly unaffected. UPF2 binding
to UPF3b was also dispensable for endocleavage stimulated
by tethered UPF3b. Although we observed a dominant-negative
effect upon tethering of a UPF2 protein unable to interact with
UPF3b, the complementation assay showed that this interaction
is not absolutely necessary for endocleavage. Our findings chal-
lenge the current model of UPF2 functioning as the bridging fac-
tor between the surveillance complex and a downstream EJC
but also argue against a direct link between SMG6 and the
EJC. Importantly, we also provide evidence against redundant
roles of UPF2 and the EBMs of SMG6 as bridging factors. Hence,
the stimulation of endocleavage by EJCs either does not require
Figure 7. Model for SMG6-Mediated Endo-
cleavage at Different Classes of Target
mRNAs
Schematic representation of the influence of NMD
factors and 30 UTR composition on endocleavage
efficiencies of various NMD substrates. For details,
see Discussion.
a physical contact between EJC and
the surveillance complex or involves as-
yet-unknown proteins that mediate this
contact.
Mapping of Endocleavage Sites
To compare the characteristics of endo-
cleavage at different PTCs, we developed
a strategy to isolate and amplify 30 frag-
ments. With this strategy, we observed
that endocleavage occurs with the high-
est efficiency directly at the termination
codon and closely downstream thereof. Importantly, we detect
30 fragments generated at the termination codon of the endo-
genous SMG5 mRNA, which indicates that SMG6-dependent
endocleavage efficiently targets endogenous long 30 UTR NMD
substrates. For both EJC-dependent (PTC reporters) and inde-
pendent substrates (SMG5), we noticed two main sites of endo-
cleavage: one overlapping with the stop codon and another
at 20–40 nt downstream. Compared to previous studies, this
refines the sites of endocleavage by SMG6 and suggests
that components of the NMD machinery are positioned closely
downstream of the terminating ribosome. We propose that
SMG6-mediated cleavage is thereby promoted at positions
up- and downstream of the NMD complex. Furthermore, the
presence of differently sized protein complexes, e.g., lacking
or including UPF2, on different mRNA substrates may explain
specific cleavage site preferences and hence distinct patterns
of 30 fragments. Additionally, our data indicate that the endo-
cleavage step of NMD likely occurs after disassembly of the
ribosome, because the region around the stop codon is not
protected from cleavage. Indeed, endocleavage at the termina-
tion codon may represent a default mechanism of mRNA turn-
over. Such endocleavage is expected to occur at a very low
frequency, which, besides the short length of the resulting
30 fragments, provides an explanation why endocleavage at
normal termination codons has not been described so far. Tran-
scriptome-wide analyses of degradation intermediates will be
required to test this hypothesis.
The previous work of several labs suggests that the composi-
tion of the messenger ribonucleoprotein downstream of the stop
codon determines whether an mRNA is recognized as aberrant
and is degraded by the NMD pathway. Based on our results,
we suggest that the same signals that activate NMD are also
used to determine the efficiency of endocleavage at the termina-
tion codon. A regular termination event upstream of a short 30
UTR promotes efficient translation termination and ribosome
recycling, thereby largely preventing degradation by SMG6-
executed endocleavage (Figure 7, top panel). However, in the
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presence of a long 30 UTR, inefficient translation termination
leads to the assembly of a UPF2-dependent surveillance com-
plex and an increased frequency of endocleavage (Figure 7, mid-
dle panel). The highest frequency of endocleavage is observed
in the presence of downstream EJCs, which strongly stimulate
the endocleavage activity of SMG6 in a distance-independent
manner. Notably, this effect does not require any physical
bridging by UPF2 or the EBMs of SMG6 (Figure 7, bottom panel).
In conclusion, our results identify a single mechanism for the
endonucleolytic decay of different classes of NMD substrates.
Furthermore, we define the factors and sequence elements gov-
erning the generation of endocleavage products, thus providing
methodological and biological insights into the molecular mech-
anisms of human NMD.
EXPERIMENTAL PROCEDURES
Plasmid Transfections
HeLa cells were split to 6-well plates the day after siRNA transfection and
transfected by calcium phosphate precipitation with 0.5 mg of a GFP expres-
sion plasmid, 1.5 mg control plasmid (LacZ-4H), and 1.5 mg plasmid encoding
for reporter mRNA. For long 30 UTR reporters, 3 mg reporter and 0.75 mg
control plasmid (b-globin) were transfected. For tethering or rescue assays,
1 mg of FLAG- or MS2V5-tagged expression plasmid was included in the
transfection mix.
RNA Extraction and Northern Blotting
Total RNA was extracted with Isol-RNA Lysis Reagent (5PRIME) and analyzed
by northern blotting as described (Gehring et al., 2009). Signals were quanti-
fied using a Typhoon FLA 7000 (GE Healthcare).
Immunoblot Analysis and Immunoprecipitation
SDS-polyacrylamide gel electrophoresis and immunoblot analysis was
performed using protein samples derived from Isol-RNA Lysis Reagent
extractions.
Magnetic M2 anti-FLAG beads (Sigma-Aldrich) were used to immunoprecip-
itate FLAGcomplexes fromRNaseA-treated (50mg/ml) HeLacell lysates in lysis
buffer (50mMTris [pH7.2], 150mMNaCl, and0.5%TritonX-100) supplemented
with protease inhibitor (Sigma-Aldrich). Complexes were eluted with SDS-sam-
ple buffer, separated by SDS-PAGE, and analyzed by immunoblotting.
cDNA Library Preparation for High-Throughput Sequencing
Two hundred picomoles of RNA linker was ligated to 20 mg of total RNAwith T4
RNA Ligase I. After RT-PCR with VNN oligo(dT)20 primer, a gene-specific PCR
using P5 and P3 Fusion primers (see Supplemental Experimental Procedures)
was performed using Accuprime Taq Polymerase (Life Technologies). For the
final PCR, P5 and P3 primers were used.
Analysis of High-Throughput Sequencing Data
Libraries of 30 fragments were sequenced on the HiSeq 2500 machine from
Illumina. For further details, see Supplemental Experimental Procedures.
ACCESSION NUMBERS
The ArrayExpress accession number for the 30 fragment sequencing data
reported in this paper is E-MTAB-2907. The input raw sequencing data and
the detailed documentation are available from Bitbucket (https://bitbucket.
org/nebo56/3-prime-fragment-sequencing).
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Figure S1, Related to Figure 1. XRN1 knockdown stabilizes 3′ fragments of PTC- and 
EJC-containing mRNA. 
 (A) Scheme of the β-globin reporter mRNA, showing the position of normal (Ter) stop codon 
and PTC, as well as canonical EJC deposition sites. The vector-derived 5′ UTR intron and 
poly(A) signal are illustrated. Hybridization position of the northern probe is indicated. (B) 
Western blot analysis of protein samples obtained from control (Luciferase) or XRN1 
knockdown in HeLa cells. Tubulin serves as a loading control. (C) Northern blot analysis of 
total RNA derived from HeLa cells transfected with the indicated siRNAs and plasmids 
expressing β-globin WT or PTC reporter mRNA. An elongated β-globin WT mRNA 
(WT300+e3) serves as transfection control.  
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(D) Representation of TPI reporter mRNA without β-globin binding site (HBS; 0H) or multiple 
copies (up to 4H) fused to the 3 UTR. Position of 5 and 3 northern blot probes are 
indicated. (E-F) HeLa cells were transfected with the indicated TPI reporters and RNA was 
analyzed by northern blotting using the heterologous probe targeting the HBS (E-F) or the 
TPI 5 probe (E). Three independent experiments were quantified in (E) and the mean ± SD 
is plotted. The asterisk marks the position of endogenous TPI. TPI-5 (E) and LacZ-4H (F) 
served as transfection control. For (F), the indicated siRNAs were transfected prior to 
plasmid transfections. (H-I) Schematic overview of TPI and TCR reporter mRNAs lacking 
introns 1-6 and 2-5, respectively. (J-K) Northern blot analysis of RNA obtained from HeLa 
cells transfected with the indicated siRNA and plasmids expressing TPI (J) or TCR (K) 





Figure S2, Related to Figure 3. Complementation assays for different PTC containing 
TPI reporter mRNA and SMG6 constructs. 
(A-C) Transfection with the indicated siRNAs and reporter plasmids was performed in HeLa 
cells and total RNA was analyzed by northern blotting. mRNA levels (A-B) of XRN1 + DCP2 
knockdown samples were quantified (mean ± SD; n = 3) and normalized to the respective 
XRN1 knockdown lanes (C). The ratio of 3′ fragment to reporter mRNA levels is indicated 
above the bars. LacZ-4H expressing plasmid was co-transfected as control mRNA. (D-G, I-J) 
Complementation assay of SMG6-depleted cells using TPI-∆i(1 -5)-PTC100 (D), TPI-∆i(1 -5)-
PTC189 (E), TPI-5 (F-G) or TPI-PTC160 (I-J) as mRNA reporter. Knockdown and rescue 
with siRNA-resistant SMG6 constructs is shown by western blots, using tubulin as loading 
control (D-F, I lower panels). Northern blotting was performed of RNA extracted from the 
same cells used for western blot analysis (D-F, I upper panel). Mean values of reporter and 
siRNA




























































































































































































































































1 2 3 4










































































































































3 fragment signal ± standard deviation of three independent experiments were quantified 
and normalized to the XRN1 control knockdown (G and J). The ratio of 3 fragment to 
reporter mRNA levels is indicated above the bars. (H) SMG6 protein architecture is depicted 




Figure S3, Related to Figure 4. UPF2 and SMG6 do not act as redundant bridging 
factors. 
(A) Knockdown efficiencies in HeLa cells with the indicated mixtures of siRNA were analyzed 
by western blotting. Tubulin served as a loading control. (B-C) Complementation assay of 
XRN1-UPF2-SMG6-depleted cells using TPI-∆i(1 -5)-PTC160 as mRNA reporter. Plotted in C 


























































































































Figure S4, Related to Figure 5. Effect of UPF3b knockdown on endocleavage. 
(A-C) Transfection with the indicated siRNAs and reporter plasmids was performed in HeLa 
cells and total RNA was analyzed by northern blotting. mRNA levels (A-B) of XRN1 + UPF3b 
knockdown samples were quantified (plotted is the mean ± SD, n = 3) and normalized to the 
respective XRN1 knockdown lanes (C). The ratio of 3′ fragment to reporter mRNA levels is 
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Figure S5, Related to Figure 6. Analysis of endocleavage patterns of amplified 3 
fragments. 
(A) The sequencing results for the three individual replicates (black, orange and blue) of the 
TPI-PTC189 3 fragments were plotted against the length of the mRNA, the overlay is shown 
as bottom panel. (B) Analysis of Illumina sequencing of amplified TPI reporter mRNA derived 
3 fragments. The reads from three replicates for each reporter were combined, binned to 5 
nt, normalized to the TPI-WT reads (shown at the bottom) and plotted against the mRNA 
length. Regions upstream (gray) and downstream (black) of the PTC or stop codon are 
indicated. (C) Unprocessed reads for each reporter were plotted individually in a region 100 
nt up- and downstream of the respective PTC. TPI-WT background signal is shown in red. 
(D) Weblogo of the motifs of 3 fragments of TPI-PTC120. A region from the stop codon to 
100 nt downstream was selected and for each position the TPI sequence ± 20 nt around the 
cleavage site was used as input for the Weblogo software 
(http://weblogo.threeplusone.com/). (E) Analysis of Illumina sequencing of endogenous 
SMG5 derived 3 fragments. The reads from three replicates were combined, binned to 5 nt 









TPI-WT GGTT 3640873 113407 (3.11 %)  3453194 (94.85 %) 74272 (2.04 %) 96.89 % 
TPI-48 TTGT 3585582 178790 (4.99 %) 3299545 (92.02 %) 107247 (2.99 %) 95.01 % 
TPI-100 CAAT 4314198 222428 (5.16 %) 4002566 (92.78 %) 89204 (2.07 %) 94.84 % 
TPI-120 ACCT 4298651 247132 (5.75 %) 3959238 (92.10 %) 92281 (2.15 %) 94.25 % 
TPI-160 GGCG 3802357 145296 (3.82 %) 3574438 (94.01 %) 82623 (2.17 %) 96.18 % 
TPI-189 CCGG 4279615 148727 (3.48 %) 4064336 (94.97 %) 66552 (1.56 %) 96.52 % 
Endo SMG5 TTAG 5772261 136730 (2.37 %) 5593111 (96.90 %) 42420 (0.73 %) 97.63 % 
TPI-WT AATG 4558091 211047 (4.63 %) 4259623 (93.45 %) 87421 (1.92 %) 95.37 % 
TPI-48 TGGC 3858131 206103 (5.34 %) 3556974 (92.19 %) 95054 (2.46 %) 94.66 % 
TPI-100 GGTC 4164955 219168 (5.26 %) 3864372 (92.78 %) 81415 (1.95 %) 94.74 %  
TPI-120 AACC 4493269 262049 (5.83 %) 4135441 (92.04 %) 95779 (2.13 %) 94.17 %  
TPI-160 CCAC 4881517 213287 (4.37 %) 4578675 (93.80 %) 89555 (1.83 %) 95.63 % 
TPI-189 CGGA 4502097 137642 (3.06 %) 4301835 (95.55 %) 62620 (1.39 %) 96.94 %  
Endo SMG5 GGCA 6279656 158329 (2.52 %)  6074804 (96.74 %) 46523 (0.74 %) 97.48 %  
TPI-WT AATA 4758532 205831 (4.33 %) 4475072 (94.04 %) 77629 (1.63 %) 95.67 % 
TPI-48 TTAA 3864607 212178 (5.49 %) 3527323 (91.27 %) 125106 (3.24 %) 94.51 %  
TPI-100 ATTT 3547887 180814 (5.10 %) 3289785 (92.73 %) 77288 (2.18 %) 94.90 % 
TPI-120 CCTT 4515341 279297 (6.19 %) 4144777 (91.79 %) 91267 (2.02 %) 93.81 % 
TPI-160 TATT 4370708 198061 (4.53 %) 4093747 (93.66 %) 78900 (1.81 %) 95.47 % 
TPI-189 GCGT 4588353 168078 (3.66 %) 4361838 (95.06 %) 58437 (1.27 %) 96.34 % 
Endo SMG5 AAGT 5621097 172804 (3.07 %)  5414339 (96.32 %) 33954 (0.60 %) 96.93 % 
 
Table S1. Statistics of high-throughput sequencing. 
Indicated are the mRNA samples from which the cloned 3 fragments were derived, the 
barcode used in the P5 fusion primer, the total number of reads and mapping statistics. 
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Supplemental Experimental Procedures  
Plasmids and cell culture 
Plasmid constructs β-globin WT and PTC39, pCI-FLAG, pCI-Venus, WT300+e3, pCI-TPI, 
pCI-TCR-HBB, LacZ-HBB and expression vectors for UPF3b, BTZ and Y14 were described 
previously (Gehring et al., 2005; Gehring et al., 2009; Gehring et al., 2003; Steckelberg et al., 
2012). Single or multiple (up to 4) copies of a 100 nt sequence of β-globin third exon and 3 
UTR, were cloned in cassettes downstream of the reporter sequence. Using the same 
cassette cloning strategy, HeLa cDNA-derived 3 UTRs of SMG5 and UPF3b, GFP coding 
sequence or 4MS2 binding sites were introduced in the vectors. Intron-less reporter 
constructs were generated by PCR mutagenesis, either deleting introns (TCR) or inserting 
introns into TPI cDNA. All reporter mRNAs expressed from the pCI-neo contain a single 
intron in their 5 UTR, which is encoded by the vector sequence. Point mutants of SMG6, 
UPF2 and UPF3b were generated by site-directed mutagenesis, cloned in the designated 
vector and verified by sequencing. siRNA insensitive UPF2 constructs were described 
previously (Clerici et al., 2013) and SMG6 was mutated accordingly (targeting sequence 5- 
GTCACAGTGCTGAAGT -3 replaced by 5- GTGACCGTCCTCAAA -3).  
siRNA transfections 
5x105 HeLa cells were grown over night in 6 cm plates and transiently transfected with 300 
pmol siRNA for single or 600 pmol total siRNA for double knockdowns using Lipofectamine 
RNAiMAX (Life Technologies). 24 h post transfection the cells were split 1:2 in 10 cm plates 
and the day after transfected again with 600 pmol (single knockdown) or 1200 pmol (double 
knockdown) siRNA. For triple knockdown, 400 pmol of the single siRNAs were used (1200 
pmol in total). The following siRNA target sequences were used for luciferase 5-
CGTACGCGGAATACTTCGA-3, for XRN1 5-AGATGAACTTACCGTAGAA-3, for SMG6 5-
GGGTCACAGTGCTGAAGTA-3 and for UPF2 5-CGTTGTGGATGGAGTGTTA-3, for DCP2 
5-GGACTGGCTTTCTCGAAGA-3, for UPF3b an equal mix of  
5-GAGCATACATCAACTTTAA-3 and 5-GGAATATCCCGCTATAGTA-3. 
Expression and purification of recombinant proteins 
N-terminally GST- and C-terminally FLAG-tagged SMG6 (1-207) wild type and mutant 
constructs were transformed in E.coli Rosetta 2 (DE3) pLysS (Novagene) cells. Bacteria 
were grown in LB medium at 37 °C until OD600 = 0.6 – 0.8. Protein expression was induced 
with 0.2 mM IPTG and the cells were grown for 20 h at 20 °C. The cells were resuspended in 
lysis buffer (50 mM Tris-HCl pH 8.0, 500 mM NaCl, 1 mM DTT) supplemented with 0.2 mg/ml 
lysozyme, 5 µg/ml DNase I, 0.5 mM EDTA, 0.5 mM Pefabloc, 1x Protease Inhibitor (Sigma-
Aldrich) and proteins were purified via affinity chromatography using Glutathione HiCap 
columns (Qiagen). Elution was performed with lysis buffer supplemented with 25 mM L-
glutathione and proteins were buffer exchanged in 25 mM Tris-HCl pH 8.0, 250 mM NaCl, 1 
mM DTT.  
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In vitro immunoprecipitation analysis 
7.5 µg of eIF4A3, untagged or FLAG-tagged BTZ and 10 µg of MAGOH/Y14 dimer were 
incubated in rEJC buffer (20 mM HEPES pH 7.5, 125 mM NaCl, 2 mM CaCl2, 2 mM NaAc, 1 
mM MgCl2, 10 % glycerol, 1 mM DTT) supplemented with 10 µM poly(U)15 RNA and 4 mM 
AMPPNP. Pre-assembly of the EJC was performed for 6 h at 4 °C. 12.5 µg FLAG-tagged 
SMG6 WT or mutants were added to the EJC and incubated over night at 4 °C. 20 µl of pre-
washed anti-FLAG beads (50 % slurry; M2 magnetic beads; Sigma-Aldrich) were added and 
incubated for 2 h at 4 °C in rEJC buffer containing 0.1 % NP-40 (wash buffer). Beads were 
washed three times with 600 µl wash buffer and co-precipitated proteins were eluted with 1x 
SDS loading buffer. 10 % of the protein mix was used as input control, all samples were 
separated on 12 % SDS PAGE gels and stained with Coomassie Brilliant Blue. 
Antibodies 
The antibodies against tubulin (T6074) and FLAG (F7425) were from Sigma, the antibody 
against V5 (18870) was from QED Bioscience, the antibodies against GFP (ab290) and 
SMG6 (ab87539) were from Abcam, the antibody against XRN1 (A300-443A) was from 
Bethyl and the antibodies against UPF1 and UPF2 were kindly provided by Jens Lykke-
Andersen. UPF3B antiserum was raised in rabbits by Eurogentech against a C-terminal 
fragment of UPF3B (300-483) and affinity purified. 
Poly(A)+ and rXRN-1 assays 
250 µg of total RNA samples extracted from HeLa cells transfected with the indicated 
reporter and control plasmids were used for isolation of poly(A)+ RNA with the magnetic 
mRNA isolation kit (New England Biolabs). Unbound RNA was LiCl precipitated and fractions 
of input, supernatant and elution were analyzed by northern blotting. For rXRN-1 assay, 4 µg 
of total RNA was incubated with or without 1 unit of rXRN-1 (New England Biolabs) for 2 h at 
37 °C. RNA was precipitated with LiCl and analyzed by northern blotting. 
Analysis of high-throughput sequencing data 
High-throughput sequencing of 3 fragment libraries was performed in two lanes of an 8-lane 
flow cell on the HiSeq 2500 machine from Illumina. Before mapping the reads, we removed 
random barcodes and adapter sequences. Mapping of reads against the appropriate 
transcript was performed by using Bowtie2.1 alignment software where we did not allow any 
mismatches. More than 90 % of reads mapped uniquely to the appropriate transcript. If 
multiple reads with the same random barcode mapped to the same starting position on the 
transcript, these were considered to be artefacts of variable PCR amplification and were 
collapsed to a single read. The position at the beginning of mapped reads was used to 
produce RNA maps. For normalized maps, we analyzed bins of 5 nucleotides, where the 
number of reads in TPI-WT (considered as background) was subtracted from the TPI 
mutants. The package of scripts performing the full analysis, along with the input raw 
sequencing data and the detailed documentation are available from Bitbucket 
(https://bitbucket.org/nebo56/3-prime-fragment-sequencing).  
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 List of primers used for 3 fragment cloning protocol. 
RNA Linker VB rGrCrUrGrArUrGrGrCrGrArUrGrArArUrGrArNrNrNrNrNrNrArArA 
VNN oligo(dT)20 TTTTTTTTTTTTTTTTTTTTVNN 
P5 Fusion #1 TCTACACTCTTTCCCTACACGACGCTCTTCCGATCTGGTTGCTGATGGCGATG
AATGA 
P5 Fusion #2 TCTACACTCTTTCCCTACACGACGCTCTTCCGATCTTTGTGCTGATGGCGATG
AATGA 
P5 Fusion #3 TCTACACTCTTTCCCTACACGACGCTCTTCCGATCTCAATGCTGATGGCGATG
AATGA 
P5 Fusion #4 TCTACACTCTTTCCCTACACGACGCTCTTCCGATCTACCTGCTGATGGCGATG
AATGA 
P5 Fusion #5 TCTACACTCTTTCCCTACACGACGCTCTTCCGATCTGGCGGCTGATGGCGATG
AATGA 
P5 Fusion #6 TCTACACTCTTTCCCTACACGACGCTCTTCCGATCTCCGGGCTGATGGCGATG
AATGA 
P5 Fusion #7 TCTACACTCTTTCCCTACACGACGCTCTTCCGATCTTTAGGCTGATGGCGATG
AATGA 
P5 Fusion #8 TCTACACTCTTTCCCTACACGACGCTCTTCCGATCTAATGGCTGATGGCGATG
AATGA 
P5 Fusion #9 TCTACACTCTTTCCCTACACGACGCTCTTCCGATCTTGGCGCTGATGGCGATG
AATGA 
P5 Fusion #10 TCTACACTCTTTCCCTACACGACGCTCTTCCGATCTGGTCGCTGATGGCGATG
AATGA 
P5 Fusion #11 TCTACACTCTTTCCCTACACGACGCTCTTCCGATCTAACCGCTGATGGCGATG
AATGA 
P5 Fusion #12 TCTACACTCTTTCCCTACACGACGCTCTTCCGATCTCCACGCTGATGGCGATG
AATGA 
P5 Fusion #13 TCTACACTCTTTCCCTACACGACGCTCTTCCGATCTCGGAGCTGATGGCGATG
AATGA 
P5 Fusion #14 TCTACACTCTTTCCCTACACGACGCTCTTCCGATCTGGCAGCTGATGGCGATG
AATGA 
P5 Fusion #15 TCTACACTCTTTCCCTACACGACGCTCTTCCGATCTAATAGCTGATGGCGATG
AATGA 
P5 Fusion #16 TCTACACTCTTTCCCTACACGACGCTCTTCCGATCTTTAAGCTGATGGCGATG
AATGA 
P5 Fusion #17 TCTACACTCTTTCCCTACACGACGCTCTTCCGATCTATTTGCTGATGGCGATG
AATGA 
P5 Fusion #18 TCTACACTCTTTCCCTACACGACGCTCTTCCGATCTCCTTGCTGATGGCGATG
AATGA 
P5 Fusion #19 TCTACACTCTTTCCCTACACGACGCTCTTCCGATCTTATTGCTGATGGCGATG
AATGA 
P5 Fusion #20 TCTACACTCTTTCCCTACACGACGCTCTTCCGATCTGCGTGCTGATGGCGATG
AATGA 





















information. To  assure  the  accurate production of  full‐length proteins, NMD  identifies  and 
degrades mRNPs with premature or unusual translation termination. The role of NMD  is not 
only to protect the cell from the accumulation of potentially harmful truncated peptides, but 
also  to  regulate  error‐free mRNPs  via  certain NMD‐activating  signals. Despite more  than  a 
decade  of  intensive  research,  it  is  still  not  fully  understood  how  these  signals  are  to  be 






these  studies  provide  a  substantial  improvement  of  our  current  NMD  model  and 
simultaneously identify critical points, which need to be investigated in the future.  
In the following, the advancements and remaining uncertainties  in the understanding of the 
















































































Figure 9: Improved model of mammalian NMD. The indicated mRNP elements and factors are depicted as in Figure 1 and Figure 
8. For details, see Discussion.  
When analyzed from a mechanistic point of view, NMD activation via long 3ʹ UTRs is only poorly 
understood. According to the faux 3ʹ UTR model, the competition between PABPC1 and UPF1 
for eRF3 binding is the main determinant for NMD suppression or activation. In the presented 
work, it was conﬁrmed that tethering of PABPC1 closely downstream of a stop codon inhibits 
the degradation-inducing eﬀect of a long 3ʹ UTR (Fatscher et al., 2014). Contrary to the 
common model, the interaction of PABPC1 with eRF3 was not essential for the NMD 
suppression conferred by tethered PABPC1. Conversely, tethered eRF3 required the intact 
PABPC1-interacting PAM2 motif for the inhibition of reporter mRNA degradation. Interestingly, 





mutant. Using co‐immunoprecipitation experiments,  it was shown  that  the binding sites  for 
PABPC1 (N‐terminus) and UPF1 (GTPase domain) do not overlap, suggesting that the eRF3 F76A 
mutant is still able to interact with UPF1 (Ivanov et al., 2008). According to the prevalent model, 
this  would  lead  to  strong  NMD  activation,  which  was  not  observed.  A  more  technical 
explanation for this phenomenon is that tethered eRF3 might not be able to enter the ribosome 
and therefore cannot properly initiate normal translation termination. This might be required, 
as  the eRF3‐UPF1  interaction  alone might not be  sufficient  for NMD  activation, which  is  a 
hypothesis that is currently difficult to implement in the common NMD models. To explore this 
more  in  depth,  complementation  assays  in  eRF3‐depleted  cells  could  be  performed.  A 
complication for this kind of approach is that two homologs of eRF3 exist in mammalian cells, 
eRF3a and eRF3b, both of which can  fulfill  the  function  to mediate  translation  termination 




only  siRNA‐mediated  silencing  of  eRF3a,  but  not  eRF3b,  had  an  effect  on  read‐through 
efficiency  (Chauvin  et  al.,  2005).  Therefore,  eRF3a  is  the  logical  candidate  for  further 




layer  of  complexity  to  the model  of  long  3′ UTR  induced NMD  and  to  normal  translation 
termination in general. The eIF4F complex plays an important role in translation initiation and 
eIF4G represents the versatile scaffolding factor  in this trimeric complex consisting of eIF4A, 
eIF4E  and  eIF4G  (Hinnebusch,  2014).  The  eIF4G‐PABPC1  interaction  is  required  for  the 
circularization  of  the  mRNA,  which  positively  stimulates  translation  (Sonenberg  and 
Hinnebusch, 2009; Wells et al., 1998). It is conceivable that NMD‐suppression requires specific 
interactions involving eIF4F, in order to stimulate the eRF3‐regulated progression of translation 
termination. Alternatively,  the  close proximity of  eIF4G  to  the  terminating  ribosome  could 
promote  efficient  ribosome  recycling  by  allowing  reinitiation  at  the  5′  end  of  the mRNA. 
Supporting  this  hypothesis,  it was  recently  shown  that  the  presence  of  certain  translation 





subunits  (Skabkin  et  al.,  2013).  eIF4G  interacts  directly with multiple  subunits  of  the  eIF3 
complex,  which  was  one  of  the  important  factors  for  reinitiation,  suggesting  that  eIF4G 
indirectly facilitates the recycling of ribosomal subunits (Villa et al., 2013). In vitro experiments 
revealed  that  under  certain  conditions,  eIF3  together  with  eIF1  and  eIF1A  can  promote 
ribosome recycling independently of other factors like ABCE1 (Pisarev et al., 2007; Pisarev et 
al.,  2010). Moreover,  studies  in  yeast  showed  that  one  peripheral  component  of  the  eIF3 
complex, eIF3j,  is  involved  in  the dissociation of eRF3:GDP  from  the  ribosome and  thereby 
promotes  translation  termination  (Beznoskova  et  al.,  2013).  Along  this  line,  the  NMD‐
suppressing effect of  tethered eIF4G was decreased upon  knockdown of eIF3  components 
(Joncourt  et  al.,  2014).  Consequently,  the  improved model  for  normal  and NMD‐inhibiting 
translation  termination  involves  the  interaction  between  eRF3  and  PABPC1, which  in  turn 
recruits  the eIF4F  complex  via eIF4G. This probably  leads  to  the generation of a  “figure of 
eight”‐like  structure, with  the  5′  and  3′  ends  of  the mRNA,  bound  by  eIF4F  and  PABPC1, 
recruited  together  to  the  ribosomal  stop  site  (Figure 9,  step 5). Multiple  lines of  evidence 
indicate  that  eIF3‐mediated  accelerated  translation  termination  and/or  ribosome  recycling 
achieves  fast  and  efficient  clearance of  stalled  ribosomes. Whereas  this  cascade of  events 
improves our understanding of normal translation termination, we still lack important insight 
into  the mechanism by which UPF1 and subsequently  the whole NMD pathway  is activated 








translation  termination. This  is because  calculations based on approximately 15000 human 
RefSeq mRNA 3′ UTRs estimated that the average 3′ UTR  length  is around 1300 nucleotides 
(Zhao et al., 2011). Since the insertion of the GFP coding sequence (719 nucleotides) is already 










insensitive to NMD and  it was proposed that the A/U content  is an  important factor for the 
degradation‐evading mechanism (Toma et al., 2015). The underlying principle is unclear, but it 





could  prevent  or  decrease  the  association  of UPF1,  since  genome wide  studies  showed  a 
preference  of  UPF1  for  binding  to  GC‐rich  sites  (Hurt  et  al.,  2013).  Most  certainly,  the 
involvement of many possible trans‐acting factors results  in a unique mRNP composition for 
any  given mRNA,  which  requires  intensive  genome‐wide  analyses  to  uncover  the  central 
determinants. 
3.2 EJC loading on the mRNP and the involvement in NMD 
Contrary  to  long  3′  UTRs,  which  represent  a  heterogeneous  group  of  NMD  targets  with 
potentially vastly different mRNP compositions,  the EJC as NMD‐inducing element  is a well‐
defined mark on the mRNA. EJCs in general are important components of spliced mRNPs and 
regulate  multiple  gene  expression  processes.  Early  studies  showed  that  single  EJCs  are 





attached  tightly on  the mRNA,  the question  remained how and by which protein  the EJC  is 
positioned  there  in  the  first  place.  In  this work,  the  essential  splicing  factor  CWC22 was 
identified as  the EJC‐loading  factor  (Figure 9,  step 1)  (Steckelberg et al., 2012). Specifically, 
mutations  in eIF4a3, which abolish  the  interaction with CWC22,  rendered eIF4A3 unable  to 
assemble EJCs in splicing assays. The proposed role of CWC22 as the spliceosomal EJC assembly 
factor was supported by two independent publications from other labs (Alexandrov et al., 2012; 










When  ribosomes  stop  translation  sufficiently upstream of an EJC,  strong NMD activation  is 
observed (Boehm et al., 2014). According to the prevalent model of NMD, the EJC induces or 









degradation  upon  tethering  to  the  transcript  (Boehm  et  al.,  2014;  Gehring  et  al.,  2003). 
Providing evidence from another angle, tethering of a MAGOH mutant which assembles into 






















(Boehm  et  al.,  2014).  This  difference  in  degradation  potency  could  be  connected  to  the 





event, whereas  this could be more prevalent  in  the case of EJC‐NMD. Recent  temporal and 
spatial analysis of EJC‐induced NMD showed  that degradation via  this pathway occurs most 






















not supported anymore (unpublished data).  It  is not clear yet, whether UPF3b  is needed for 
this kind of NMD pathway, as the results obtained by complementation assays and tethering 
assays  are  not  entirely  congruent  (Boehm  et  al.,  2014).  Interestingly,  tethering  of  a UPF2 
mutant which  is unable  to  interact with UPF3b,  results  in over‐stabilization of  the  reporter 
















this effect  is direct or  involves  the activation of,  for example, SMG1  is unclear. Of  interest, 




the MIF4G‐3  are  not mutually  exclusive  (Clerici  et  al.,  2014).  Although we  lack  structural 
information about  the UPF2‐UPF3‐SMG1  interaction on  the atomic  level,  it  is possible  that 
UPF3b  is bound to UPF2  in close proximity to SMG1 and, therefore,  is  in the spatial position 
that allows  regulation of  the SMG1 kinase activity. This  is especially  interesting, because as 











UPF2,  the  function of  these domains was  tested  in complementation and  tethering assays. 
Interestingly, both domains were  required  for normal NMD activity, while  the UPF1/UPF3b 
binding and the cytoplasmic localization was unchanged by the deletions (Clerici et al., 2014). 
Combined with  the  data  from  the UPF‐EJC  cryo‐EM  structure,  it was  proposed  that  these 
domains  likely serve a scaffolding role (Clerici et al., 2014; Melero et al., 2012). However, as 
conserved patches of the first MIF4G were found to be important for yeast NMD, it cannot be 




pathways.  These  involve  the  accelerated  deadenylation  by  SMG7  recruited  CCR4‐NOT 
deadenylase  complex,  the  deadenylation‐independent  decapping  via  direct  or  PNRC2‐
mediated DCP1/2 activation, and the SMG6‐catalyzed endonucleolytic cleavage (Figure 9, step 
7).  All  these  pathways  have  in  common  that  the  involved  factors  are  supposedly  directly 
recruited to the phosphorylated N‐ and C‐terminus of UFP1. Consequently, phosphorylation of 
UPF1  represents  the  step  in NMD  upon which  the  degradation  of  the mRNA  is  ultimately 




analyzed.  Specific  detection  of  SMG6  activity  is  possible  due  to  the  accumulation  of  3′ 











the  region around  the  stop codon  should be protected by  the  ribosome. Furthermore,  this 
raises the question, whether only the UPF1 molecules which are located closest to the stalled 
ribosome are activated and phosphorylated, although UPF1 molecules are spread along the 3′ 
UTR.  If UPF1  phosphorylation  occurs  position‐independently, we would  expect  to  observe 
endocleavage products at various downstream regions as well, which was not the case. In line 
with  this  hypothesis,  RNA‐immunoprecipitations  showed  that  phosphorylated  UPF1 
preferentially  associates  with  the  5′  end  of  the  3′  UTR  (Kurosaki  et  al.,  2014).  Further 
transcriptome‐wide nucleotide‐resolution analysis of the phospho‐UPF1 position on the mRNA 
could  provide more  information  about  this  distribution  and  subsequently  about  the UPF1 
activation mechanism.  
In order to cleave the mRNA endonucleolytically, SMG6 first needs to be recruited to the mRNP. 
Although  the  interaction with  the  phosphorylated  N‐terminus  of  UPF1  via  the  14‐3‐3‐like 
domain of SMG6 is the currently accepted mechanism, two alternative recruitment pathways 












no  stable  interaction of  the SMG6 14‐3‐3‐like domain with hyperphosphorylated UPF1 was 



















to  the unprotected 5′ and 3′ ends and SMG6‐mediated cleavage  is  therefore most  likely an 
irreversible step of mRNA decay (Figure 9, step 8). Although the exosome was reported to be 
required  for  the  3′‐5′  degradation  of  5′  fragments  in  flies,  these  fragments  could  not  be 
stabilized  in  mammalian  cells  depleted  for  core  exosome  components,  suggesting  that 
additional factors are involved in the degradation (Eberle et al., 2009; Huntzinger et al., 2008).  
In contrast to SMG6, SMG5/7‐ and PNRC2‐mediated induction of exonucleolysis requires the 
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DNA  via mRNA  to  protein.  Cellular  surveillance mechanisms  exist  to  detect  and  eliminate 
erroneous  mRNA  in  order  to  prevent  the  production  of  incorrect  transcripts.  Nonsense‐
mediated mRNA  decay  (NMD)  targets mRNA  for  degradation, which  terminate  translation 
prematurely or  incorrectly. Thereby, NMD prevents the synthesis of unfunctional or harmful 












complex  component  eIF4G  is  required.  This  suggests  that  efficient  ribosome  recycling  is 
important for the normal termination of translation, which in turn prohibits the activation of 
NMD.  To  gain  insight  into  the mode  of  EJC  assembly  during  splicing,  CWC22,  an  essential 
splicing component, was  identified as the critical EJC  loading factor. Remarkable differences 





impairing  regular  translation  termination and  leading  to  infrequent and  less efficient mRNA 








Die  eukaryotische  Genexpression  besteht  aus  einer  Reihe  von  Abläufen,  welche  den 
Informationsfluss  von  der  DNA  über  mRNA  bis  zum  Protein  vermitteln.  Dabei  existieren 
zelluläre Überwachungsmechanismen die fehlerhafte mRNA detektieren und eliminieren, um 
dadurch die Produktion  von  inkorrekten Transkripten  zu  verhindern. Nonsense‐vermittelter 








Der  exakte  Mechanismus  wie  diese  mRNP  Elemente  NMD  induzieren  können  ist  unklar. 
Weiterhin sind der Ablauf der molekularen Ereignisse welche schlussendlich zum Abbau der 
mRNA  führen,  wie  auch  das  präzise  Zusammenspiel  der  NMD  Faktoren  während  dieses 
Prozesses, nicht gut definiert. 
In  dieser  kumulativen  Arbeit  wurden  mehrere  wichtige  Schritte  des  NMD  Abbauweges 
untersucht. Dabei konnte ich zeigen, dass eine Interaktionskaskade für die Unterdrückung von 
NMD  notwendig  ist,  welche  den  eukaryotischen  Terminationsfaktor  3  (eRF3),  das 
zytoplasmatische  poly(A)  Bindeprotein  (PABPC1)  und  eIF4G,  ein  Bestandteil  des  Kappe‐
bindenden eIF4F Komplexes, beinhaltet. Dies weist darauf hin, dass effizientes Recycling des 
Ribosoms wichtig  ist  für  die  normale  Termination  der  Translation, welche wiederum NMD 
verhindert. Zudem wurde das essentielle Spleißprotein CWC22 als der entscheidende Faktor 
für  die  Assemblierung  von  EJCs  während  des  Spleißens  identifiziert.  Bemerkenswerte 
Unterschiede  wurden  deutlich  beim  Vergleich  von  langen  3'  UTR  und  EJCs  als  NMD 
induzierenden Elementen. Dies betrifft nicht nur die Effizienz des mRNA‐Abbaus, die Art und 
Weise  der  NMD‐Aktivierung,  sondern  auch  die  Anforderungen  an  NMD  Faktoren.  Diese 
Ergebnisse  zeigen,  dass  EJCs  hochentwickelte  mRNP  Marker  sind,  die  einen  spezifischen 
Mechanismus  verwenden,  um  einen  effizienten  Abbau  der  Ziel‐mRNA  zu  erreichen.  Im 














 3′  UTR  length  and  mRNP  composition  determine  endocleavage  efficiencies  at 
termination codons 






experiments.  I was  involved  in  the  analysis  and  interpretation  of  the  data  and wrote  the 
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